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EXPLORING THE BIOMEDICAL POTENTIAL OF A NOVEL ALGAE ORIGIN 
POLYSACCHARIDE  
 
ABSTRACT 
During the past decades, marine organisms have been the focus of considerable 
attention as potential sources of valuable materials. The sustainable exploitation and 
valorisation of natural marine resources constitutes a highly attractive and strategic 
platform for the development of novel biomaterials, with both economic and 
environmental benefits. In this context, algae are well known to synthesise large 
quantities of polysaccharides. In fact, algae are well established sources of these 
particularly interesting molecules, many of which are known for their applicability in the 
design of biomaterials. Among the three main divisions of macroalgae, green algae 
remain largely unexploited in the biomedical arena. While the demand for novel 
materials and technologies increases, so does the amount of research focused on 
these unexploited marine green algae including its unique polysaccharide ulvan. As 
research on this polysaccharide evolves towards the study of its potential application in 
a biomedical context, the definition of effective processing routes becomes rather 
crucial. The main objective of the herein described work is the development of 
biomedical applications for this green algae polysaccharide, with the additional 
advantage of adding value to a quite unexploited biomass. The innovative character 
lays on the application of traditional methodologies to extract and develop medical 
devices based on ulvan, a polysaccharide extracted from green algae, which presents 
a large, but yet untapped biomedical potential.  
In order to attain the proposed objectives and in a first stage, a novel method of 
polysaccharide extraction from green algae has been designed and the resulting 
material characterized. The polysaccharide ulvan was obtained from the green algae 
Ulva by step extraction using hot aqueous solutions and precipitation with organic 
solvents. However and despite the care that is fundamental in the extraction of any 
natural material and the robustness of the employed methodologies, variability is 
frequently associated with natural extracts. Nevertheless, applying a simple extraction 
and purification methodology it was possible to extract a polysaccharide from green 
algae without significant changes in the overall structure of the polysaccharide. 
Extracted ulvan is a non-meltable semi-crystalline polysaccharide with high 
hygroscopic nature, highly sulphated and rich in ulvanobiuronic acid A and with minor 
amounts of ulvanobiuronic acid B. In general, ulvan is a high molecular weight 
polysaccharide, composed of rhamnose, glucuronic acid, xylose, iduronic acid and 
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glucose. Besides physicochemical categorization, toxicity data is regarded as a crucial 
and fundamental knowledge prior to any advances in the application development of 
natural derived polymers. In order to evaluate ulvan‟s potential cytotoxic behaviour, 
standard in vitro cytotoxicity screening assays were performed. Extracted ulvan 
demonstrated good results in terms of its non-cytotoxicity, comparable to a hyaluronic 
acid control, which suggests that ulvan can be considered as a non-toxic 
polysaccharide for the range of concentrations studied. Due to its unique structure and 
interesting inherent properties, ulvan can be considered as a versatile polymer for 
different applications in a biomedical context. In order to understand the limits of 
processability of ulvan extracted from green algae, different polymer processing 
methodologies were attempted. In a first approach, ulvan membranes envisioned 
towards applications as a medicated dressing were studied and revealed the potential 
as drug delivery devices for the envisaged applications as a wound medicated 
dressing. 3D porous scaffolds are widely used in tissue engineering contexts providing 
a three dimensional template for cell colonization and neo-tissue formation. In this 
regard, 3D porous structures based on ulvan were also produced by freeze drying and 
revealed a remarkable ability to uptake water and increased mechanical performance 
related with both polysaccharide concentration and cross-linking ratios. These 
structures are highly porous, interconnected, and undergo non-toxic degradation. At 
this point it is important to stress that ulvan is a polysaccharide soluble in water and 
prone to hydrolytic degradation, hence a modification step is necessary to render ulvan 
structures insoluble in water and stable at physiological conditions. Cross-linking with 
1,4- butanediol diglycidyl ether (BDDE), a frequently used cross-linker for biomedical 
applications, was the chosen method to modify ulvan in order to produce both ulvan 
membranes and 3D porous structures. This cross-linking agent demonstrated to be 
successful in the cross-linking of this polysaccharide. Besides membranes and 3D 
porous structures, ulvan particles were developed by extrusion-dripping method and 
incorporated within a in a poly-D, L-lactic acid matrix in order to produce a novel 
scaffold with appropriate physicochemical and cytocompatible features to be used in 
bone engineering.  
The knowledge gathered during this work encompass necessary and crucial steps to 
uncover the innovative biomedical potential of the marine derived polysaccharide 
ulvan, since the design of extraction methodologies from green algae to the study of 
diverse processing routes focused on the development of structures envisaged for 
specific biomedical applications. 
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ESTUDO DO POTENCIAL BIOMÉDICO DE UM POLISSACÁRIDO EXTRAÍDO DE 
ALGAS VERDES 
 
RESUMO 
Organismos marinhos têm sido alvo de considerável atenção como potenciais fontes 
de materiais de elevado valor económico e tecnológico. A exploração sustentável e 
valorização de recursos marinhos constitui uma plataforma estratégica para o 
desenvolvimento de novos materiais, com benefícios tanto económicos como 
ambientais. Neste contexto, as algas sintetizam diferentes polissacáridos, muitos dos 
quais são conhecidos pela sua aplicabilidade no desenvolvimento de biomateriais para 
aplicação biomédica. Entre as principais divisões de macroalgas, as algas verdes 
permanecem largamente inexploradas nesta área. Enquanto a procura de novos 
materiais e tecnologias aumenta, o mesmo acontece com o estudo sobre algas 
verdes, em particular sobre o polissacárido ulvano. Há medida que o conhecimento 
sobre este polissacárido evolui no sentido do seu potencial de aplicação na área 
biomédica, a descrição de metodologias de processamento eficazes torna-se crucial. 
Assim, o principal objectivo do presente trabalho centra-se no desenvolvimento da 
aplicabilidade deste polissacarídeo extraído de algas verdes na área biomédica, com a 
vantagem suplementar de adicionar valor a um recurso marinho bastante inexplorado. 
O carácter inovador deste trabalho reside na aplicação de metodologias tradicionais 
para extrair e desenvolver dispositivos médicos com base em ulvano, que apresenta 
elevado, mas também insondado potencial biomédico.  
Para atingir os objectivos aqui propostos e, numa primeira fase, um novo método de 
extracção de ulvano de algas verdes será desenvolvido e o material resultante será 
caracterizado. O polissacárido ulvano foi obtido a partir da alga verde Ulva por 
extracção com soluções aquosas a quente e precipitação com solventes orgânicos. No 
entanto, e apesar do cuidado que é fundamental na extracção de qualquer material de 
origem natural e da robustez das metodologias aplicadas, a variabilidade está 
frequentemente associada a extractos naturais. Ainda assim, a aplicação de 
metodologias de extracção e purificação simples permitiu a obtenção de um 
polissacárido com características interessantes sem alterações significativas na 
estrutura geral do polímero. O ulvano extraído é um polissacárido semi-cristalino, sem 
ponto de fusão detectado, com uma natureza higroscópica, rico em grupos sulfato e 
em ácido ulvanobiurónico A, com pequenas quantidades de ácido ulvanobiurónico B. 
Em geral, é um polissacárido de elevado peso molecular, constituído por ramnose, 
ácido glucurónico, xilose, ácido idurónico e glucose. Além do estudo da estrutura, 
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composição e propriedades físico-químicas, é necessário um estudo relativo à 
toxicidade deste polissacárido, considerado como um conhecimento fundamental 
anterior a qualquer avanço no seu desenvolvimento aplicativo. Neste sentido, ensaios 
padronizados de toxicidade foram efectuados e o ulvano demonstrou bons resultados 
em termos de citotoxicidade, comparável ao ácido hialurónico, o que sugere que pode 
ser considerado como não tóxico, nas condições estudadas. Devido à sua estrutura e 
propriedades, o ulvano poderá ser utilizado como um polímero versátil para diferentes 
aplicações num contexto biomédico. A fim de compreender os limites de 
processamento deste polissacárido, foram testadas diferentes metodologias de 
processamento de polímeros. Numa primeira abordagem, foram estudadas e 
confirmadas as propriedades filmogénicas deste polissacárido, com o objectivo de 
caracterizar a aplicabilidade de membranas de ulvano capazes de funcionar como 
sistemas de libertação de fármacos. Estruturas porosas são amplamente utilizadas em 
contextos de engenharia de tecidos fornecendo um modelo tridimensional para a 
colonização de células e formação de tecidos. Neste contexto, foram também 
produzidas estruturas porosas com base em ulvano, por liofilização, caracterizadas por 
uma morfologia porosa, com uma notável capacidade de absorção de água, 
propriedades mecânicas influenciadas tanto pela concentração do polissacárido como 
pela quantidade de agente reticulante utilizada e degradação não citotóxica. Neste 
ponto é importante realçar que o facto de este ser um polissacárido solúvel em água e 
susceptível a degradação por hidrólise, torna necessária uma etapa de modificação 
para tornar as estruturas produzidas à base de ulvano insolúveis em água e estáveis 
em condições fisiológicas. No presente trabalho, foi seleccionada a reticulação com 
um agente époxido como método passível de modificar o ulvano; este procedimento 
foi utilizado tanto na produção de membranas como de estruturas porosas aqui 
descritas. O uso deste agente, frequentemente utilizado em aplicações biomédicas, 
farmacêuticas ou cosméticas, demonstrou ser bem sucedido na modificação química 
por reticulação do ulvano. Além de membranas e estruturas porosas, foram 
desenvolvidas partículas à base de ulvano e incorporadas numa matriz de ácido poli-
D, L-láctico, com o objectivo de desenvolver uma estrutura com características 
apropriadas para aplicações num contexto de engenharia de tecidos.  
O conhecimento reunido durante a execução desta tese representa um passo 
necessário e fundamental para revelar a aplicabilidade biomédica do ulvano, desde a 
elaboração de metodologias de extração de algas verdes até ao estudo de diferentes 
métodos de processamento, focado no desenvolvimento de estruturas específicas 
previstas para aplicações biomédicas. 
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INTRODUCTION TO THE THESIS FORMAT 
 
The present thesis is organized in 5 sections reflecting the main goals defined for the 
thesis and the nature of the performed experiments. These sections are divided into 
chapters which are based in papers already published or submitted for publication in 
international journals, which are identified at the front page of each chapter.  
As a preamble to the work, a concise introduction about ulvan, its properties and the 
present state of the art is presented (Section I, Chapter 1). Following this introductory 
note, a description of the chosen materials and methods is presented in order to 
facilitate the understanding of the herein presented work and its principles (Section II, 
Chapter 2). Although the following chapters are accompanied by specific materials and 
methods sections, Chapter 2 intends to complement these sections with additional and 
relevant information about the materials and methodologies employed in the present 
research work. 
After gathering knowledge about ulvan and its peculiarities and assembling the tools to 
work this polysaccharide, the main objective of the herein described work was the 
study of potential development of biomedical applications based on ulvan. A simple 
way to contextualize the complexity and diversity of work developed is to define this 
thesis as the application of fundamental research principles for the development of 
basic and applied knowledge towards translational science of ulvan. An explanatory 
scheme of the general overview and objectives of the present thesis is depicted in 
Figure 1.  
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Figure 1. Representative scheme of the thesis work and format. (Adapted from 
Clemens van Blitterswijk & Jerome Sohier, in Tissue Engineering, Academic Press, 
Elsevier, UK, 2008) 
In this context, traditional methodologies were applied to extract and develop medical 
devices based on ulvan, a polysaccharide extracted from green algae, which presents 
a large, but yet untapped biomedical potential.  
In a first experimental stage, the polysaccharide itself was explored, namely its 
extraction from green algae and subsequent characterization (Section III, Chapter 3 
and 4). 
The polysaccharide ulvan was obtained from green algae Ulva by step extraction using 
hot aqueous solutions and precipitation with organic solvents (Chapter 3). The use of 
simple extraction and purification methodologies allowed the extraction of a 
polysaccharide from green algae. At this point, it is important to stress that a concise 
study on the composition of ulvan extracted from green algae and the effect of 
purification methodologies on the final extract was performed within the scope of the 
present PhD work plan, in cooperation with an external research laboratory. However, 
xxxvii 
 
this study was not included in the present compilation of results. It resulted in a a paper 
that can be consulted in addition to this thesis for a better understanding of applied 
extraction methodologies and composition of the extracted ulvan (Costa C, Alves A, 
Pinto P, Sousa RA, Silva E, Reis RL, Rodrigues A, Characterization of ulvan extracts to 
assess the effect of different steps in the extraction procedure. 2012. Carbohydrate 
Polymers, doi:10.1016/j.carbpol.2011.12.041). 
Following the design of a novel extraction procedure, additional characterization was 
performed by focussing on particular characteristics regarded as important for future 
studies based on this polysaccharide (Chapter 3). Besides physicochemical 
characterization, toxicity data is a critical knowledge prior to any advances in research 
of natural derived polymers, especially if biomedical applications are intended. Hence, 
standard cytotoxicity tests were used for investigating the toxicity of ulvan extracts. 
(Chapter 4). 
The structure and properties of ulvan make this biodegradable polymer an interesting 
option for different biomedical applications. In this context, and in order to understand 
the processing versatility of ulvan, different processing methodologies were attempted 
(Section IV, Chapter 5, 6 and 7). Within the scope of this thesis, three approaches 
were followed. In the first study, ulvan membranes and its properties were evaluated 
towards applications as a medicated dressing (Chapter 5). In another study, 3D porous 
structures based on ulvan were produced by freeze drying and also characterized 
(Chapter 6). In addition to membranes and 3D porous structures based on ulvan, ulvan 
capsules were also produced and incorporated within a in a Poly-DL-Lactic acid matrix 
in order to produce a novel and functional scaffold with appropriate physicochemical 
and cytocompatible properties to be used in tissue engineering (Chapter 7).  
The knowledge gathered during this work, including those related with polysaccharide 
extraction, characterization and processing into diverse type of structures constitutes 
an important step to elucidate on the biomedical potential of this marine derived 
polysaccharide. The concluding remarks are presented in the final chapter of this thesis 
(Section V, Chapter 8). 
  
 xxxviii 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SECTION I – GENERAL INTRODUCTION 
  
  
  
  
 
 
Chapter 1 
 
 
A practical perspective on ulvan extracted from green algae 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Alves A, Sousa RA and Reis RL, A practical 
perspective on ulvan extracted from green algae. 2012. Submitted. 
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1. Introduction 
World‟s oceans are a rich environment containing over 300,000 invertebrates and algal 
species (as cited in Pomponi, S. A., 1999).1 These species survive and live within 
complex communities and in close association with other organisms. This diversity of 
living systems and habitats define the basis of the wide variety of chemical classes 
typical of marine derived molecules. Some organisms withdraw their rich chemistry 
from dietary sources, whilst others synthesize these compounds de novo.2 Molecular 
diversity represents a vast and valuable chemical library, including saccharides, 
pigments, phenols or peptides, among others, which together are estimated to possess 
a potential market value of several billion dollars.1 
In this scenario, marine algae, rich in different compounds of interest, are used in 
several industrial application contexts totalizing a consumption total of 3.5 million tons 
of algae per year worldwide (as cited in Michel, C. and McFarlane, G. T, 1996).3 
Applications include for example food and the industrial use of hydrocolloids, like 
alginate, agar and carrageenan.3 The importance of these organisms and their 
constituents to Mankind has justified intense research work; however the full potential 
of algae molecules is yet to be unveiled. 
Marine algae can be divided in three main groups – red (Rhodophyceae), brown 
(Phaeophyceae) and green (Chlorophyceae) – classified on the basis of their 
photosynthetic pigments.4 These algae also differ on the type of storage material and 
cell wall polysaccharides.4-5 Brown algae synthesize laminaran as storage material 
while floridean starch (glycogen) and starch are found in red and green algae, 
respectively.4-5 All algae possess varying amounts of cellulose in their cell walls.5 
However, the main polysaccharide found in the cell wall varies from alginates and 
fucans in brown algae to different sulphated polysaccharides, xylans and mannans 
found in red and green algae.5-6 Algae polysaccharides are strikingly different of those 
found in higher plants, especially on what concerns to the presence of sulphate groups 
and unusual sugar residues, high content of ionic groups, high water solubility and 
unique rheological properties.3, 7-8 This results in a range of distinctive characteristics 
and is the basis of their widespread industrial applicability. A large fraction of the world 
commercially exploitated polysaccharides are of marine origin, namely alginate, agar 
and carrageenan.3, 7, 9 Within this context, green algae are still rather unexploitaded. 
Although they have been used in food for many centuries, it was the discovery of an 
important constituent of green algae, ulvan, which dramatically increased interest in 
these algae. 
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In this regard, focused research on ulvan‟s characteristics and applicability is required 
in order to grasp the full range of its capabilities and boost the industrial interest in 
green algae. 
 
2. Historical outline 
Classification of alga hasn‟t always been an easy task. Complexity is enhanced when 
recent genetic studies reveal that Chloropelta, Enteromorpha and Ulva in fact belong to 
the same genera.10 In general, Chloropyceae consist of an uni- or pluri-cellular plant 
body, containing bright-green chromatophores, producing starch and with a cellulosic 
cell wall, that can be solid or mucilaginous.4, 11 
As the work with brown and red macroalga evolved to a well established field of 
knowledge, the interest in green algae, and especially its polysaccharides had a late 
and bumpy start. An interesting and complex polysaccharide composed of sulphate 
ester, uronic acids and xylose, rhamnose and glucose residues, was identified in the 
early 40-50‟s. This pioneer work was however interrupted for several years due to the 
Second World War.12 In these early studies, Brading and co-workers12 already 
identified a possible structure present in this sulphated polysaccharide as –CH(OH)-
CH(O-SO3Na)-CH(OH)-. However, no evidence was found on what concerns the true 
position of the sulphate groups on the polysaccharide structure, although it seemed 
possible that they should be linked to glucose or rhamnose.12 This was also one of the 
first times rhamnose was identified as being part of an algal polysaccharide. In 1962, 
McKinnell and co-workers13 found evidences that the sulphate groups were in fact 
linked to rhamnose. Ten years later, Abdel-Fattah and Edrees14 concluded on the 
heteropolysaccharidic nature of this polysaccharide, composed of particular entities of 
oligosaccharides of rhamnose and uronic acids composing its backbone, intercalated 
with sequences involving glucose, arabinose and xylose. The particularly acidic nature 
of the polysaccharide was assigned to the presence of glucuronic acids.14 In these 
early years, researchers were struggling with the identification and characterization of 
this unusual and complex polysaccharide. Extracts were obtained from different green 
algae genus and species and were characterized and compared between each other. 
Despite the fact that different researchers were extracting a polysaccharide from 
different genus and species of green algae, through diverse extraction methodologies, 
they all came to similar conclusions and agreed that the water soluble polysaccharide 
from green algae was mainly composed of uronic acid and sulphated rhamnose with 
residues of diverse sugars, like xylose and glucose. 9, 12-18 It was only in 1993 that the 
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designation „ulvan‟ was proposed.9 It is now generally accepted that ulvan designates a 
class of sulphated polysaccharides mainly composed of glucuronic acid and sulphated 
rhamnose.18 The important discovery that iduronic acid was a constituent of ulvan‟s 
backbone was only made in 1997.19 
There is still a long way to go until the true nature of this polysaccharide is unravelled. 
However, in the last decade research on ulvan has evolved as the knowledge on its 
occurrence and physiological function, chemical composition, polysaccharide 
conformation and properties has improved. This knowledge is now driving research a 
step forward towards the application development of this polysaccharide.  
 
3. Occurrence and physiological function 
Marine algae are simpler organisms compared to land plants; however, they produce 
larger quantities of polysaccharides.20 These polysaccharides differ from the ones 
produced by land plants mostly due to the presence of uronic acid and/or sulphate 
ester residues.8, 20 In fact, algae synthesise sulphated polysaccharides as key 
constituents of the extracellular matrix.8 
In general, green algae are composed of: ~11% protein, ~36% carbohydrates, ~53% 
ashes and are rich in minerals like calcium, iron, phosphorous and chloride.21 
Carbohydrates include cell-wall water soluble sulphated ulvan, alkali-soluble 
hemicellulosic β(1,4)-D-glucuronan and β(1,4)-D-glucoxylan and amorphous α-
cellulose with xylose residues.18, 22-25  
Ulva sp. possess a characteristic blade-shaped frond, two-cell thick, with no tissue 
differentiation.25 However, their cellular walls are well organized in layers and rich in 
polysaccharides.8, 25 Within this scheme, ulvan is mostly homogeneously distributed 
throughout the frond being more predominant within the intercellular space and in the 
ﬁbrillar wall.25 Within this cell wall moiety, it is suggested that ulvan may be arranged in 
a bead-like structure, stabilized by cell wall proteins or strong physical interactions.26 It 
is well known that boron is accumulated in algae, in the form of boric acid in green 
algae, and it was suggested that complexes with carbohydrates.27 Given that ulvan is 
able to gel in the presence of boric acid, in a reaction mechanism mediated by calcium 
ions9, it is easy to hypothesize that this polysaccharide may be present in green algae 
cell wall in the form of a gel, cross-linked by boron ions. 
As far as ulvan‟s physiological function within the cell wall goes, literature is rich in 
hypothesis.8, 19-20, 25, 28-31 In general, the presence of sulphated polysaccharides can be 
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associated with the organism‟s adaptation to ionic environments; this is true for marine 
plants and algae (seawater) as well as for vertebrates (physiological saline serum).8 In 
this scenario, ulvan, as part of the cell wall of green algae, would possess osmotic 
functions, including a role on ionic balance or on the prevention of algae desiccation, 
due to their highly hygroscopic nature.20, 31 On the other hand, ulvan is resistant to 
bacterial degradation and inhibits the activity of cellulase, which indicates a protective 
role towards cell wall amorphous α-cellulose, protecting it from bacterial attack.25, 28, 30 
This protective function is also related with the fact that ulvan is associated with the low 
porosity of green algae.25, 30 Furthermore, ionic polysaccharides may be involved in 
mechanical regulation, spore release and adhesivity.8, 29 The presence of acidic 
moieties in ulvan‟s polysaccharidic chain, particularly glucuronic and iduronic acid, may 
indicate that this polysaccharide is also involved in cell wall cohesion, in a parallelism 
with mammalian glycosaminoglycans rich in uronic acids.19, 30 
 
4. Extraction of ulvan from green algae 
This section is intended to provide guidance to those interested in extraction of natural 
products, especially from green algae. Success in working with nature derived 
materials is very well summarized by Cannell and co-workers2 “one should always 
keep an open mind, expect the unexpected, use as many methods for purification as 
possible, and save all fractions.”  
The overall procedure to obtain polysaccharides from green algae can be divided in 
several different steps: 
 Selection, collection, and identification of the raw material; 
 Algae stabilization and grinding; 
 Extraction and purification; 
 Precipitation; 
 Drying. 
A representation summarizing the general procedure to extract ulvan from green algae 
is illustrated in Figure 1.1. 
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Figure 1. 1. Scheme for the extraction of ulvan from green algae. 
When working with nature derived materials, one should always recognize and 
consider the inherent variability of extracted molecules from nature origin sources.32 
This can be due to varying organism species, extraction methodologies, seasonality, 
habitat or life cycle.9, 14, 33-36 One practical example is the variability of the obtained 
polysaccharide related with source reported by Lahaye and Axelos9, when comparing 
the rheological behaviour of a polysaccharide obtained from proliferating Ulva with one 
obtained from Ulva lactuca.  
4.1. Selection, collection, and identification of the raw material  
The first step in extraction of algae derived materials involves the selection, collection 
and identification of the raw material. During these initial stages, one should try to 
answer some questions: 
 What is the rational for the extraction of a particular polysaccharide? 
 What is the most accessible source of algae available suitable for the extraction 
of such polysaccharide? 
 Can a compromise between yield and purity be obtained by appropriately 
selecting the algae species? 
 Is it possible to have access to large quantities of the selected algae species? 
The answer to these questions defines the basis of any future extraction work and 
allows the establishment of good criteria for potential industrial applications of ulvan. 
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In order to obtain the selected algal raw material, it is possible to collect it in loco, 
culture it or obtain it through specialized enterprises (Table 1.1). To address this issue 
one should keep in mind that besides source dependence, cross-contamination by 
other organisms, habitat, geography and seasonality are relevant factors that influence 
and further complicate the work with marine natural products.2, 37 Furthermore, among 
the biggest challenges when working with algae is its identification, which many times 
can only be done correctly by an expert algologist.2, 37  
Algae can be obtained by harvesting natural seaweed beds or by algaculture.3 The 
availability of green algae allows a sustainable exploitation of this resource.1 They are 
many times involved in algal blooms with detrimental health and socio-economic 
impact.9, 38-39 These algal blooms occur in nutrient rich waters, stimulated by human 
activity in coastal regions.9, 38-39 Partial or total utilization of these algae and particularly 
of its polysaccharide ulvan would alleviate the effect of accumulation and elimination of 
these deleterious biomasses. Furthermore, it is easily cultured in (semi-) artificial 
conditions, both in-the-sea and land-based, alone or in integrated systems.4, 40-42 These 
facts make green algae easily accessible to research work and application 
development. 
 
Table 1. 1. Examples of enterprises specialised in the commercialization of algae. 
4.2. Algae stabilization and grinding 
The first extractions of polysaccharides from green algae usually started with washing 
of algae prior to thermal drying.5 Nowadays, relevant advances in seaweed and 
hydrocolloid industries reveal other alternatives to algae stabilization treatments prior to 
polysaccharide extraction. Robic and co-workers43 have studied the effect of different 
Company Location Algae Culture System Website 
Sinaloa 
Seafields 
International 
Inc. 
California, 
USA 
Ulva sp. 
Algae culture in 
non-arable land 
with sea water 
irrigation 
http://www.sinaloa-
seafields.com/home/ 
Atlantic 
Mariculture 
Ltd. 
Grand 
Manan 
Island, 
Canada 
Ulva sp. 
Local harvest of 
native sea 
vegetables 
http://organicdulse.com/ 
Setalg 
Pleubian, 
France 
Ulva 
lactuca 
Harvest on algae 
fields 
http://www.setalg.com/ 
Mariculture 
Technologies 
International, 
Inc. 
Florida, USA Ulva sp. 
Local harvest (wild 
collected) 
http://www.mariculturete
chnology.com/ 
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green algae pre-treatments, prior to polysaccharide extraction, including freezing, 
drying methods, brining and dry salting. These different algae stabilization treatments 
demonstrate a marked effect on the final yield of extraction and on ulvan‟s 
physicochemical traits, including molecular weight and viscosity. Higher yield is 
calculated for algae brined for seven weeks; however, higher molecular weight and 
viscosity is calculated for frozen and freeze dried algae.43 These results emphasise the 
need for a concise evaluation of the final application of the extracted polysaccharide 
and the expected cost and efficiency of the extraction procedure. Furthermore, it is 
important to note the effect of these pre-treatments on the chemical composition of the 
polysaccharide, in particular due to polysaccharide modification or even degradation.43 
4.3. Extraction and purification 
Before and after extracting the polysaccharide per se, one must be aware of interfering 
substances that can be co-extracted with the molecule of interest, and of other 
contaminants introduced during extraction, etc. These substances and contaminants 
can either affect purity of the extract or interfere with biological responses towards the 
polysaccharide.2 
Removal of photosynthetic pigments (decoloring) and lipids (defating) may be 
considered the as the first steps of purification. Decoloring and defating can be 
achieved by different methods, including supercritical extraction, soxhlet extraction or 
simple immersion in organic solvent.2, 12-13, 15-17, 44 Being considered a green technology, 
the use of supercritical fluids avoids or reduces the use of organic solvents. However, 
this is an expensive technology and the use of organic solvents is still more effective 
and widely used, both for decoloring and defating.45 In this regard, soxhlet extraction is 
an old but effective technique.46 Different organic solvents may be used to remove 
pigments, including acetone12, 15-16, 47, ethanol13, 47-49, methanol17, 47, petroleum ether32, 50 
or chloroform32. However, McKinnell and co-workers13 found that the best solvent to 
remove colouring matter from green algae is 85 % aqueous ethanol. Kitada and co-
workers45 also found ethanol a more effective solvent to extract pigments, when 
compared to acetone; furthermore and considering safety issues, ethanol presents 
lower toxicity compared to acetone. On the other hand, treatment of algae with ethanol 
prior to polysaccharide extraction increases the total sugar content of the extract and 
decreases the presence of minor sugars and glucose on the final polysaccharide 
extract.26, 51  
Effective extraction of a natural origin polysaccharide is mainly dependent on its 
solubility, stability, and functional-group considerations.2 Being a water soluble 
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polysaccharide, ulvan can be effectively extracted with water.18, 49 Some studies report 
that hot water extraction results in good extraction yields.13, 26, 35 Hot water disrupts the 
cell walls, allowing easier access to its content.52 High temperatures, in the range of 
80-90ºC, allow the extraction of higher molecular weight polysaccharides.35 However, 
above 100ºC, lower viscosity is detected, when compared with ulvan extracted at 80-
90ºC35, which may reflect some instability of the polysaccharide extracted in this range 
of temperature.37 Ulvan can also be successfully extracted with sodium carbonate 
solution12, calcium chelating agents, such as ammonium oxalate or 
ethylenediaminetetraacetic acid (EDTA) 14, 26, 36, 47 or acidic solutions.14, 17, 26, 30, 36 The 
use of calcium chelating agents facilitates ulvan extraction by means of sequestering 
calcium ions and disrupting chemical bonds formed by ulvan in the presence of calcium 
ions within the cell wall of green algae.14, 26 On the other hand, decrease of pH of the 
extraction media will destabilize aggregates of ulvan within the cell wall, increasing 
extraction yield.26 The use of different solvents to extract ulvan will result in extracts 
with varying physicochemical and biological properties.14, 26, 36, 44, 47 In this regard, it is 
important to define the objective of the extraction and the final properties expected from 
the resulting polysaccharide.  
Being a cell wall material, common contaminants of this polysaccharide are amino 
acids and peptides.12-13, 53 In fact, direct extraction with hot aqueous solutions will result 
in an extract mixture of polysaccharides, proteins, polyphenols and pigments.52 
Methods to remove nitrogenous materials include enzymatic treatment with proteinase 
K49 or precipitation with trichloroacetic acid.13 Besides nitrogenous material, McKinnell 
and co-workers found evidences of contamination by starch-like materials in hot water 
extracts.13 However, this starch can be effectively removed with salivary α-amylase.13, 
16, 54-55 Smaller molecular weight contaminants, including the ones responsible for odour 
and also colour can be removed with activated charcoal2, 17, 49; hydrogen peroxide can 
also be used as a decoloring agent.56 Further purification may be achieved by other 
methods, including dialysis (salting-out) or even through final precipitation.51  
4.4. Precipitation 
In general, water soluble polysaccharides are removed from solution by precipitation 
with organic solvents. In the particular case of ulvan, it precipitates from aqueous 
solutions with ethanol or acetone, usually four volumes of the chosen organic 
solvent.17, 44, 49 Ethanol precipitation allows the separation of the polysaccharide from 
low molecular ethanol-soluble compounds52 and the removal of some pigments6; thus it 
is considered as a purifying step as well.51, 57-58 
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4.5. Drying 
Extracted polysaccharide can be dried by different methods. However, Jani and co-
workers32 highlight the need to apply low temperature or vacuum on drying, in order to 
avoid degradation of the polysaccharide. 
4.6. Yield 
Cell wall carbohydrate content of green algae ranges from 38 to 54% and ulvan content 
may vary between 18 to 29%.37, 59 Yield of extraction of ulvan varies between 1.2 to 
27.5% and the maximum extraction efficiency is in the range of 70%. 13-14, 16-18, 26, 31, 34-36, 
43-44, 47, 49-50, 60 
In general, a decrease in algae particle size will increase the yield of extraction.26 This 
is also influenced by factors including algae pre-treatments, solvent used to extract the 
polysaccharide per se, number, duration and temperature of extractions, purification 
methodologies, algae species and seasonality.14, 16, 26, 34-37, 43-44  
4.7. Storage 
As polysaccharides, and ulvan in particular, are hydrophilic and readily uptake water 
from the atmosphere, it is recommended to store the extracted polysaccharide in a dry 
environment, ideally on desiccators, to avoid moisture uptake and degradation.32, 49 
 
5. Chemical structure and conformation 
Ulvan has been identified as being a sulphated single polydisperse 
heteropolysaccharide composed of variable amounts of uronic acids, including 
glucuronic and iduronic acids alternating with neutral sugar moieties, such as 
rhamnose, xylose and glucose residues, connected by α- and β-1→4 bonds.12, 16, 19, 23-
24, 30, 53, 61 This polysaccharide accounts for 18-29% of the carbohydrate fraction of 
green algae.59 Important insights on the structure of this polysaccharide were provided 
by McKinnell and co-workers.13 They found evidences that the sulphate groups were in 
fact linked to rhamnose, possibly  in position 2; they suggested possible branching of 
the heteropolysaccharide and uronic acid residues are pointed as possible end groups, 
being these attached to position 4 in rhamnose.13 Later on, it was proposed that 
sulphate groups may be linked to C-2 or C-3 in rhamnose and there are evidences of 
the presence of some sulphated xylose, with sulphate occurring in position 2. 16, 18, 22 In 
1997, an important work of Quemener and co-workers19 exposed the presence of 
iduronic acid within ulvan‟s backbone. In general, green algae synthesise the same 
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sulphated polysaccharide. However, the particular amount of each monosaccharide 
residue or the arrangement of the polysaccharide may vary with different factors, 
including methodology of extraction16, 44, 54, geographical distribution or species44, 53, 61, 
maturity, environmental condition and seasonality34, 62, resulting in varying ulvan 
structures.37 This variability influences the establishment of accurate ulvan sugar 
composition, complicated by the difficulty to determine the presence of different 
characteristic sugars. This is due to the resistance of aldobiuronic acid to acid 
hydrolysis and due to the labile nature of iduronic acid, easily degraded by the strong 
acidic conditions needed to hydrolyse ulvan.15, 37, 51, 63 In order to minimize these 
effects, innovative methods that combine mild acid hydrolysis with enzymatic 
degradation have been developed and allow an accurate insight into ulvan‟s sugar 
composition and the authentication of the presence of iduronic acid within its 
backbone.19, 55 
It is now generally agreed3, 23, 53, 61 that the backbone of ulvan is mostly composed of α- 
and β-(1→4)- linked sugar residues, namely of α-1,4- and α-1,2,4- linked L-rhamnose 
3-sulphate, with branching at O-2 of rhamnose, β-1,4- and terminally-linked D-
glucuronic acid and β-1,4-linked D-xylose, partially sulphated on O-2. The major 
structural units are the β-D-glucuronosyluronic acid-(1,4)-L-rhamnose 3-sulphate dimer 
(β-D-GlcpA-(1→4)-L-Rhap 3-sulphate) and α-L-IdopA-(1→4)-α-L-Rhap 3-sulphate, also 
known as ulvanobiuronic acid A and B, respectively.19, 23-24, 30, 53, 61, 64 The main 
difference between these aldobiuronic acids is the presence of glucuronic acid in A, 
which is replaced by iduronic acid in B.30 Variations in these main motifs can also be 
encountered.37, 61  
One remarkable feature of ulvan is the presence of rare sugars within its backbone, 
namely sulphated rhamnose and iduronic acid. Rhamnose is an unusual sugar, usually 
found in bacteria and rare in animals, and branching of O-2 of 1,4-linked α-L-rhamnose 
residue was found only on an exopolysaccharide synthesised by the Arthrobacter sp. 
bacterium.23 The presence of iduronic acid in ulvan‟s polysaccharidic chain represent 
another striking characteristic, as this sugar residue has never been identified in algal 
polysaccharides.19 
 
6. Enzymatic degradation 
Degradation of polysaccharides occurs through a sequence of abiotic and/or biological 
reactions. In order to get a sense on the biodegradation of ulvan, knowledge of its 
enzymatic cleavage becomes essential. In general, polysaccharide enzymatic 
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degradation is carried by polysaccharide hydrolases or polysaccharide lyases.57 
Polysaccharide lyases, in particular, degrade the polysaccharidic chain by β-elimination 
reactions and are usually isolated from bacteria, algae, gastropods and fungi.57, 65 
Despite this knowledge, only a few enzymes with ulvan lyase activity were identified so 
far and are summarized in Table 1.2. Generally, the discovery and isolation of novel 
polysaccharide enzymes is based on the need of enzymatic hydrolysis of 
polysaccharides as a tool for better understanding its structure.51  
In this regard and in order to try to elucidate the chemical structure of ulvan and 
understand the enzymatic degradation of this polysaccharide, an endo-ulvan lyase has 
been isolated from a marine Gram-negative bacterium.24 These bacteria were selected 
from slurry rich in decomposing green algae Ulva and their ulvanolytic activity requires 
the presence of calcium chloride and demonstrates optimum activity at pH 9.24 
Depolymerisation of ulvan is an endo-molecular process and ulvanobiouronic acid A 
motif (β-D-GlcpA-(1→4)-L-Rhap 3-sulphate) is cleaved resulting in different 
saccharides with 4-deoxy-L-threo-hex-4-enopyranosyluronic acid at the reducing 
end.24, 66 The isolation of this lyase permitted new insights on ulvan‟s chemical 
composition.  
The same objective was on the base of the work of Quemener and co-workers19 which 
were able to purify a β-glucuronidase from the snail Helix pomatia and used it to 
optimize studies on the different sugar composition of ulvans from various sources. 
Within their work, a chemo-enzymatic method was developed to optimize the release of 
stable monosaccharides after ulvan‟s degradation and β-glucuronidase was 
successively used to hydrolyse the resistant disaccharide aldobiuronic acid.  
The work of El Boutachfaiti and co-workers67 resulted on the successful isolation of an 
ulvan-lyase from a bacterium from the genus Ochrobactrum. This particular enzyme 
cleaves the osidic bond bridging ulvanobiuronic acid A and ulvanobiuronic B, through a 
β–elimination reaction.67 
Another enzyme with ulvan lyase activity was isolated from a fungus prevalent in soils, 
Trichoderma sp., and it was identified as a glucuronan lyase. It is dependent on the 
presence of some ions, including calcium and magnesium, and is sensitive to 
temperature. Ulvan‟s degradation by this fungal glucuronan lyase originates low 
molecular weight polysaccharides.68 
Due to the presence of uronic acids within ulvan‟s backbone, many authors19, 53, 69 have 
compared it with mammalian glycosaminoglycans, like chondroitin sulphate. In this 
sense, and in a biomedical application context, one can infer about the enzymatic 
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susceptibility of ulvan towards naturally occurring mammalian enzymes that degrade 
this type of molecules into sulphate residues and monosaccharides, such as β-
glucuronidase, hyaluronidase and aryl sulphate.70 Given the evolution of the knowledge 
of ulvan so far, it should be expected that some of the research focus should now shift 
towards the understanding of ulvan‟s enzymatic degradation and the nature of the 
released products. These studies are especially important when applications for 
instance in medicine, food or pharmaceutics are envisaged. In a particular example, 
within a context of tissue engineering and regenerative medicine, biodegradability 
(hydrolytic and/or enzymatic) in physiological conditions is one of the key and crucial 
properties of biomaterials.71 
 
Table 1. 2. Summary of identified enzymes with ulvanolytic activity, compiled from the 
references 19, 24, 66-68. 
7. Properties 
The particular composition and conformation of a given polysaccharide constitute the 
basis of its physicochemical and biological properties, as well as its particular function 
on the organism.72-74 These unique properties, which distinguish each polysaccharide, 
define the boundaries of their application development. Within this section some of the 
most studied properties of ulvan are reviewed, with special focus to its molecular 
weight distribution, ion bonding, ability to gel and cross-link in the presence of ions, as 
well as an overview of its biological properties. 
7.1. Molecular weight 
As molecular weight of a polysaccharide is strongly influenced by various factors, 
including extraction methodology26, 35, 43, seasonality34 or algae species and 
ecophysiology34, different molecular weights have been reported for ulvan 
polysaccharide. These may vary from 1.5x105 to 2x106 Da.31, 35, 44, 75 On the other hand, 
Enzyme Origin Activity References 
Endo-ulvan lyase 
Marine Gram-
negative 
bacterium 
Cleavage of (1→4) linkage between 
rhamnose 3-sulphate and glucuronic 
acid 
24, 66
 
β-Glucuronidase Land Snail 
Cleavage of (1→4) linkage between 
rhamnose 3-sulphate and uronic acid 
19
 
Ulvan lyase Bacteria 
Cleavage of the osidic bond between  
ulvanobiuronic acid A and 
ulvanobiuronic through β–elimination 
reaction 
67
 
Glucuronan lyase Filamentous fungi 
Acetylated and deacetylated 
glucuronans in general 
68
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ulvan exhibits an aggregation tendency, which can affect molecular weight 
determinations.75 Presence of contaminants, different molecular weight distributions or 
the occurrence of varying ulvan species with variable sugar content and distribution 
can also influence this property and may explain the polymolecular character of 
ulvan.37   
Nevertheless, it is agreed that ulvan is composed of two major macromolecular 
populations, identified as a high molecular weight fraction (5x105 to 8 x105 Da) and a 
medium molecular weight fraction (1.5x105 to 2x105 Da), being the high molecular 
weight fraction the most abundant and the one with higher viscosity.43, 55, 76 
7.2. Selective ion binding 
Green algae are well known for their ability to bind heavy metals, through covalent, 
electrostatic or redox reactions, removing them from contaminated waters.5, 77-78 This 
ability is reported to be associated with the anionic polysaccharide ulvan, present in the 
cellular walls of green algae, which is rich in functional groups with oxygen, including 
sulphate or hydroxyl groups, as potential metal binding sites.5, 77-80 In this regard, ulvan 
demonstrates different affinities towards various ions, such as Al > Cu > Pb > Zn > 
Cd=Mn > Sr > Mg=Ca.37 In the particular case of copper (II) ion, both ulvan‟s uronic 
acids and sulphate groups participate on the fixation of this ion.31, 75 
Besides the environmental impact related with this affinity to complex different ions81, 
this property can be directed and applied in a biomedical context. In this context, ulvan 
can be used as a chelating agent in therapies where the removal of these ions from the 
body is required or to warranty the presence of ions when they are needed. In this 
regard and due to this particular property, marine origin polysaccharides, like 
carrageenan82 and chitin or chitosan83, are often proposed as compounds with 
medicinal or pharmacological interest.  
7.3. Gel formation and ionic cross-linking 
An important characteristic to define future applications of a polysaccharide is its 
gelation mechanism. The use of ulvan as a gelling agent would increase its applicability 
range and encourage the exploitation of green algae.  
Ulvan is soluble in water and its solubility may be enhanced with temperature.84 
However, it cannot markedly thicken aqueous solutions and forms weak gels in 
deionized water, susceptible to pH and ions, with low intrinsic viscosity.9, 76, 85  
When in aqueous solution, ulvan tends to arrange in a bead-like structure, partially 
linked by filaments.76 This peculiar behaviour is explained by a localized hydrophobic 
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character present within this charged polysaccharide, mostly related with the presence 
of hydrophobic methyl groups of rhamnose.76 In this context, water can be considered 
as a poor solvent for this polysaccharide and may explain the low viscosities observed 
for ulvan aqueous solutions.26, 76 Decreasing the pH towards acidic moieties, forces 
ulvan beads to disperse into an isolated form.76 Increasing solution pH, promotes ionic 
interactions between carbonyl and sulphate groups, resulting in aggregation of ulvan 
beads.76 The same behaviour is observed in ulvan saline solutions or in the presence 
of boron or copper, where polysaccharide-self associations are enhanced.31, 75-76, 86  
In general, ulvan gels are formed in the presence of boric acid and divalent cations, or 
copper, at alkaline pH.9, 30-31, 37, 76, 86-87 An important research work of Lahaye and 
Axelos9 determined the gelation kinetis of ulvan in the presence of both boron and 
calcium ions, which lead to the conclusion that gelation of this polysaccharide is time 
and pH dependent. In an appropriate ionic milieu, this polysaccharide forms a gel and 
the reaction mechanism is thought to involve the cross-linking between ulvan and 
boron, mediated by calcium ions.9, 30, 87 These systems behave as viscoelastic solids, 
this is to say that they are true gels. A  mechanism of gelation of ulvan in the presence 
of boron and calcium was proposed to require the presence of free cis-hydroxyls, 
involving rhamnose or uronic acids.9 However, continuous research on this matter 
revealed that this scenario does not truly represent the gelation reaction mechanism. 
High sulphation degree of ulvan, mostly localized in rhamnose, may difficult cross-
linking which suggests that this particular sugar residue may not be involved in the gel 
formation through boron interactions.30 On the other hand, no borate complex was 
detected, neither involving glucuronic acid nor iduronic acid.30 In this scenario, the 
particular gelation mechanism of ulvan in the presence of boron is yet to be unveiled 
and may involve minor sugars also present within ulvan‟s backbone.30  
In agreement with the involvement of ulvan in the ability of green algae to bind metal 
ions, Paradossi and co-workers found an affinity of this polysaccharide towards copper 
(II) and Lahaye and co-workes were able to induced gelation of ulvan in the presence 
of copper, zinc, magnesium and calcium.31, 37  
The peculiar gelation behaviour of ulvan may result from the aggregation of ulvan 
bead-like structures through hydrophilic moieties present within this polysaccharide.76 
Nevertheless, viscosity of polysaccharide solutions and gel forming ability are highly 
dependent on the chemical composition of the polysaccharide itself.34 In the particular 
case of ulvan, high uronic acid content seems to affect the viscosity of ulvan solutions 
and the ability to form gel.44 In fact, gel formation depends on intra- and inter-molecular 
cross-links, which are hampered by highly negative groups, including carboxylic acids 
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(like uronic acids), sulphate groups and/or methyl groups (in rhamnose).86 An example 
of the striking effect of sulphation degree on the gelation ability of a polysaccharide is 
carrageenan. The three main types of carrageenan are kappa, iota and lambda and the 
main difference between these polysaccharides is their increasing sulphate content.88 
Both kappa and iota carrageenan adopt an ordered double helical structure and form 
thermoreversible gels through coil-helix conformational transition.88 However, the 
higher sulphation degree of lambda carrageenan impedes helix formation and 
consequently gel formation, possibly through steric hindrance or electrostatic 
repulsion.88 Despite the results and hypothesis gathered concerning ulvan‟s gelation, 
this is still an open field of research and the mechanisms of gelation are yet to be fully 
understood. 
7.4. Biological properties 
Marine algae constitute a rich and largely available source of sulphated 
polysaccharides with peculiar structures associated with different biological activities.56, 
74, 89 These biological activities have been the focus of intense research and different 
structure-function studies reveal that these are many times correlated with the 
sulphation degree of these polysaccharides.74, 89 
In general, polysaccharides are regarded as non cytotoxic nature origin polymers.32 
Ulvan in particular was already studied and its toxicological effects revealed.90 It was 
characterized in terms of its biological performance, evaluated by means of in vitro 
cytotoxicity assays, and demonstrated that this polysaccharide is cytocompatible and is 
considered non-toxic in the range of concentrations studied.90 Furthermore, its cellular 
effect was similar to hyaluronic acid, used as control on their studies.90 However, a 
change in the toxicity of this polysaccharide towards colonic epithelial cells was 
detected for modified ulvans, with low content or reduced uronic acids or desulphated 
ulvans.59 
Ulvan has been described as a heparinoid agent, this is to say that possesses 
biological activity similar to heparin being a potent anticoagulant.60, 91-92 It also has been 
found that this polysaccharide is a potent anti-viral, particularly against influenza virus, 
both human and avian, and herpes simplex virus 1.59-60 Furthermore, it presents 
antihyperlipidemic properties, and both ulvan and its low molecular weight 
oligosaccharides demonstrate an effect on lipid metabolism, limiting hyperlipidemy.5, 93-
95 Its antiperoxidative and antihyperlipidemic properties have shown to exert a 
protective effect over the liver of rats exposed to a hepatitis-inducing toxin.33, 95 
Antioxidant activity was additionally recognized in ulvan, namely scavenging activity 
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towards superoxide and hydroxyl radicals, metal chelating activity and reducing 
power.60, 96-100 This trait is influenced by the molecular weight of the polysaccharide and 
its oligosaccharides as well as by the sulphate content of ulvan and its derivatives.96-97, 
100 Chemical modifications of the natural polysaccharide, such as acetylation and 
benzoylation described by Qi and co-authors100-101 may enhance this ability. Another 
important feature of ulvan is its immunostimulating ability, comparable to other algal 
polysaccharides.69, 102-103 It has been reported to act as an inflammatory mediator, 
inducing respiratory burst in flatfish and mammalian phagocytes.69, 102-104 Phagocyte 
activation is a key process in the host defence against microorganisms and it is mostly 
related with the antioxidant properties already recognized in this polysaccharide.69, 102-
103, 105 This activity is strongly influenced by the presence of sulphate groups as well as 
by exposure time and concentration and may occur through interaction of the 
polysaccharide with cellular surface receptors.69, 102-103, 105 Ulvan can also mediate 
intestinal epithelial growth and take part on the repair of wounds by stabilizing and 
promoting binding of relevant growth factors to intestinal cells.84 It has demonstrated 
antiproliferative activities against human cancer cells, in a dose-dependent manner, 
particularly for breast adenocarcinoma cells.60 This may be correlated with its sulphate 
content and richness in uronic acids.60  
As mentioned before, many of ulvan‟s biological properties are strongly influenced by 
its sulphation degree. However, these can also be related to the ubiquitous presence of 
rhamnose within the backbone of this algal polysaccharide.106 In general, rhamnose-
rich polysaccharides possess anti-inflammatory properties, reduce bacterial adhesion 
to the skin, protect it from UV-induced and age-related damage and stimulate cell 
proliferation and collagen biosynthesis.106-107 In fact, skin keratinocytes and fibroblasts 
possess lectins that recognize rhamnose moieties present within a polysaccharide.106-
107 These peculiarities involve this type of polysaccharides with a unique interest for the 
treatment of skin pathologies, particularly the ones related with age and its effects.106-
107 
Marine origin polysaccharides are many times associated with important biological 
activities, which are affected by different factors, including molecular weight, chemical 
composition and chain conformation.56 Ulvan is no exception and, as it happens with 
many other polysaccharides, these properties justify the applicational interest on this 
green algal polysaccharide. 
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8. Applications 
The interest in marine algae, as sources of unique polysaccharides with novel 
structures and interesting biological activities for innovative potential applications, is 
increasing. These include food, pharmaceutical and medical industries as well as 
microbiology and biotechnology applications.5 However, few of the world‟s available 
algae species are used commercially. Among the three main divisions of macroalgae 
(Chlorophyta, Phaeophyta and Rhodophyta), green algae remain largely unexploited in 
this area. Gosselin and co-workers17 noticed, in the early 1960‟s, the discrepancy in 
knowledge of green algae‟s polysaccharides when compared to brown and red algae. 
Almost half a century later, this is still a quite valid consideration. Although the 
knowledge has evolved, green algae are still a rather underexploited biomass. Its 
polysaccharides remain in the field of possibilities, against, for instance alginate and 
carrageenan or agar. These are well established and worldwide accepted 
polysaccharides for diverse applications, ranging from food industry to biomedical 
field.5, 7, 108-109  
Ulvan from different sources is demonstrating ubiquitous potential to be successfully 
used in various applications. In this section, the applicability of ulvan as a 
polysaccharide will be discussed, although one should bear in mind that ulvan 
oligosaccharides also demonstrate interesting properties that may justify their research 
and future application development, particularly those related with their biological 
properties.93, 97, 110-111  
8.1. Active agent for pharmaceutical applications 
A review of algae applicability focused on pharmaceutical and medical applications was 
written by Albertus Smit, who enhances the ecological significance and potential of 
algae: “Phycologists may be surprised to discover how frequently seaweed natural 
products are discussed in medicine”.112 
In ancient times, green algae were used to treat different pathologies, including 
hyperlipidemia and urinary diseases.93 Nowadays the medicinal interest in green algae 
is centred in its polysaccharidic part, particularly ulvan, to be used as a therapeutic 
active agent. 
The presence of glucuronic and iduronic acids makes ulvan a very special 
polysaccharide. This fact gains importance as we think of this polysaccharide for 
pharmaceutical and biomedical applications. Both these sugar residues are important 
constituents of mammalian glycosaminoglycans, including heparin and chondroitin 
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sulphates.19, 53, 69 Another remarkable property of ulvan is its sulphation degree. 
Sulphate groups have long been associated with different biological activities.74 In fact, 
sulphated polysaccharides are abundant within animal cells and participate in cell 
recognition, adhesion or regulation of receptor functions.69, 94 
The use of ulvan as a strategic alternative to various synthetic or animal bioactive 
agents would take advantage of its algal origin, together with high availability and low 
expected production costs, low cytotoxicity and broad spectrum of biological activities. 
It could be applied as an antiviral59-60, antioxidant96-101, as an anticoagulant in 
alternative to heparin60, 91-92, antihyperlipidemic5, 33, 93-95 or make use of its 
antiproliferative activity towards cancer cells60  or on the therapy of diseases where the 
immune system is impaired69, 102-103. Furthermore, due to its similarity with mammalian 
glycosaminoglycans, it could be exploited as a pharmaceutical where the delivery of 
glycosaminoglycans is needed, such as for the treatment of musculoskeletal 
disorders.113-114 On the other hand, rhamnose moieties ubiquitous in ulvan‟s backbone, 
as mentioned above, may be the basis for its use for the treatment of skin pathologies, 
particularly the ones related with age and its effects.106-107 Massarelli and co-workers115 
have studied the interaction of ulvan with hepatocyte lectins and found that the 
presence of xylose within the backbone of this polysaccharide mediates the interaction 
with these membrane receptors. As ulvan is readily recognized by hepatocyte 
membrane receptors, it could be used as a biomaterial for diagnostic or therapeutic 
purposes.115 Moreover, and taking advantage of ulvan‟s ability to complex with metal 
ions37, it can find applications where the removal of these ions from the body is 
required or to warranty the presence of ions when they are needed. For example, it can 
be used in the therapy of metal poisoning or even be used as part of drugs relevant for 
targeted radioactive treatment of tumours, as already proposed for carrageenan.82 
Ulvan‟s biological activities and possible applicative scenario are summarized in Table 
1.3. 
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Table 1. 3. Summary of relevant biological activities associated with ulvan and its 
potential strategic application in a pharmaceutical context, according to diverse studies 
reported in the literature (5, 33, 59-60, 69, 91-103, 116-119). 
8.2. Medical devices 
Side by side with its biological properties and potential pharmaceutical relevance, one 
can think of ulvan for biomedical applications, in particular for the production of medical 
devices. In this regard, the technological development of ulvan is still in the field of 
possibilities and mainly focused on its applicability as a biomaterial for tissue 
engineering and regenerative medicine. Within a tissue engineering and regenerative 
medicine context the main objective is to guide cells into forming a functional living 
tissue.71 A common strategy involves the use of biodegradable scaffolds that provide 
structure and support cell adhesion, differentiation and proliferation.71 Depending on 
the target tissue one is trying to repair, regenerate or substitute, polysaccharide based 
systems can assume different forms, with different functionalities, ranging from nano-
particulate structures to complex 3D scaffolds, passing through smart systems. Natural 
origin materials present the additional advantage of possessing a variety of distinctive 
biochemical cues that may enhance and define their applicability in a biomedical 
context.71, 120-121 The promise that tissue engineering and regenerative medicine holds 
is becoming more realistic as significant milestones are achieved, particularly by the 
approval and commercialization of different developed systems based on natural 
polymers. Examples of commercial medical devices include CollaGuideTM and 
Novocart 3D Autologous Chondrocyte Transplantation, based on collagen, which are 
used for guided tissue regeneration and cartilage engineering, respectively, and 
alginate and chitosan wound dressings (Tegagen™ Alginate Dressing, Sorbsan® and 
ChitoFlex®). 
Biological Activity Strategic Possible Applications References 
Antiviral 
Treatment of viral infections, particularly influenza 
and HSV-1 
59-60, 119
 
Antioxidant 
Prevention of oxidative stress and be used as a 
protective drug for several pathologies, including 
age related or cancer 
96-101, 116-117
 
Anticoagulant Surrogate of heparin 
60, 91-92, 116-118
 
Antihyperlipidemic Regulation of lipid metabolism 
5, 33, 93-95, 116-
117
 
Immunostimulating 
Therapy of diseases where the immune system is 
impaired 
69, 102-103, 117
 
Antiproliferative towards 
cancer cells 
Agent for inhibition of cancer cells proliferation 
60
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In this area, as it happens in a general applicative overview, when one thinks about 
marine origin polysaccharides, both research and market are generally based on chitin 
and chitosan122-126, carrageenan123, 127-129 and alginate129-130.71, 121, 131-132 
The use of ulvan as a medical device, for applications such as tissue engineering and 
regenerative medicine, is at its early stage, particularly on what concerns 
polysaccharide modification and processing and biomaterial design. Nevertheless, 
diverse ulvan structures for different end applications have been so far developed and 
are already reported in the literature. These include nanofibres87, membranes133, 
particles134, hydrogels135 and 3D porous structures136. In order to produce these 
structures, ulvan has been functionalized by grafting with methacryloyl groups135 or by 
cross-linking with butanediol diglycidyl ether133, 136 and processed into hydrogels by 
photopolymerization135, membranes by solvent casting133, 3D porous structures by 
freeze drying136, particles by electrostatic interaction with a polycation134 and nanofibres 
by electrospinning87. An overview of these structures is presented in Table 1.4. 
Proposed applications include drug delivery, wound dressing or bone tissue 
engineering.87, 133-136 
 
Table 1. 4. Structures based on ulvan developed for biomedical applications, including 
tissue engineering and regenerative medicine, as reported in 87, 133-136. 
8.3. Personal care products 
The array of personal care products is quite broad and there is a tendency towards the 
use of natural origin products, including algae extracts.4, 137-138 The use of ulvan in this 
particular industry is poorly described, being mostly limited to patents that illustrate and 
claim the use of ulvan, or a water extract from green algae, in this field.139-141 However, 
it is easy to envision the potential applicability of this polysaccharide in personal care 
products, especially if one considers its described biological properties. First of all, 
ulvan presents similarities with glycosaminoglycans, like chondroitin and dermatan 
Structure Processing Methodology References 
Nanofibres 
Electrospinning of a blend solution based on ulvan and  
poly(vinyl alcohol) 
87
 
Membranes 
Modification of ulvan by chemical cross-linking with  
butanediol diglycidyl ether followed by solvent casting 
133
 
Particles 
Extrusion-dripping method to form ulvan particles by 
electrostatic interaction with a polycation (chitosan) 
134
 
Hydrogels 
Modification of ulvan with  methacryloyl groups followed by 
photopolymerization 
135
 
3D porous 
structures 
Freeze-drying of a solution prepared with ulvan cross-linked 
with  butanediol diglycidyl ether 
136
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sulphate, ubiquitous in skin tissue.19, 53, 69, 142 Furthermore, being a polysaccharide rich 
in rhamnose moieties, it may induce cell proliferation and collagen biosynthesis.106-107 
On the other hand, has proven antioxidant properties and high hydration ability.5, 96-101 
In fact, the presence of glucuronic acid within ulvan chain confers moisturizing 
properties to this polysaccharide, important in protecting skin and preventing damage 
by exposure to dry environments.138 These particularities reinforce ulvan‟s value for 
cosmetic applications.  
8.4. Food industry 
Green algae are present in the diet of humans since ancient times, as they are 
considered as food and an alternative and rich source of vegetables.5, 7, 21, 62 They are 
traditionally consumed in Asia and are also approved for consumption in Europe, 
namely in France.5, 21, 62, 93, 143 These algae are rich in soluble and insoluble dietary 
fibres and important minerals, as well as high potencies of vitamins, polysaccharides, 
chlorophyll and protein, and low lipid content.5, 62, 93, 144  In fact, nutritional interest in 
algae resides on their wealth on vitamins, oligoelements, minerals and dietary fibres.85, 
144 On the other hand, algae are considered as low energy food due to its low lipid 
content and due to the fact that their carbohydrates are resistant to digestion and 
fermentation.5-6, 28, 64, 145 Besides consumption of algae, one can make use of its 
constituents for food related applications. The majority of algal polysaccharides, 
including ulvan, are resistant to endogenous human digestive enzymes3, 6, 20 and for 
this reason, they can be considered and studied as good sources of dietary fibres. 5-6 
These fibres are present in algae in larger quantities than the ones found in land plants 
and can be divided into water soluble and insoluble fibres.6, 28, 62, 85 Ulvan is recognized 
as a soluble dietary fibre6, 28, 64 and it is resistant to hydrolysis by digestive enzymes. Its 
digestive fate has been proposed to be mostly related with depolimerization and 
fermentation by the large intestinal bacteria.3 However, ulvan demonstrates low 
fermentability and is poorly degraded by faecal bacteria.28, 64 This trait is strongly 
influenced by its characteristic chemical structure, with little influence of sulphate 
groups on the resistance of this polysaccharide to bacterial degradation.64 In fact, its 
resistance to degradation is maintained after the removal of sulphate groups or 
oxidation of uronic acid and can be associated with the absence of ulvan‟s specific 
depolymerases in colonic microflora.22, 146 This data is in accordance with the fact that 
different bacteria present in human flora do not use ulvan as a source of 
carbohydrates.147 Even though ulvan is poorly fermented, it induces positive effects on 
the metabolism of colonic microflora, including regulation of the activity of the enzymes 
β-glucuronidase and β-glucosidase28 and induction of intestinal mucin secretion148. 
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Interestingly, it appears that sulphate groups are not the main responsible for some of 
these effects.22, 64, 148 On the other hand, it is important to stress that consumption of 
Ulva sp. and its sulphated polysaccharide ulvan poses no threat to human health, 
contrasting with other types of algae which may induce toxicological and carcinogenic 
effects.28  
Dietary fibres possess many interesting properties which render them well established 
additives for food industry applications, as thickeners, stabilizers, emulsifiers or as 
bulking or gelling agents.5, 20 In general, algae dietary fibres, including ulvan, have 
remarkable hydration ability, form solutions with different viscosities, are able to interact 
with relevant biological molecules, including cholesterol, and provide bulk to faeces.5 
Furthermore, ulvan can be used in this particular industrial niche for its antioxidant 
properties, preventing food deterioration.89  
8.5. Other applications 
Besides pharmaceutical, biomedical or food related applications, ulvan has been 
studied and can be applied in many other areas, ranging from agriculture to more 
technical usages.  
Plant pathogens pose an important threat to agricultural production. In this regard, 
elicitors of plant defence mechanisms represent a powerful alternative to pesticides.149 
A good elicitor triggers defence responses and ensures protection to different diseases 
without disturbing the organism‟s primary metabolism.150  
Ulvan has demonstrated to activate signalling pathways of intracellular plant defence 
and exerted a protective effect against plant diseases, proving its potential applicability 
as an environmental friendly plant pathogens‟ control.150-155 In fact, pre-treatment of 
plants with ulvan induces plant resistance and reduces the impact and severity of 
fungal diseases; however and despite this effect on the plant itself, ulvan does not 
impede mycelia growth.151-152, 154 This activity may be associated with its sulphate 
content as well as with the presence of rhamnose and uronic acid in its composition, 
acting through the jasmonic acid pathway.153 In a more technical application of this 
polysaccharide, Castro and co-workers have used ulvan to purify a neutrophil fish 
mieloperoxidase.156 This particular application of ulvan is based on its anionic nature 
and on the fact that this polysaccharide resembles some glycosaminoglycans, enabling 
the binding of the enzyme via electrostatic interactions and its isolation and purification 
by affinity chromatography.156 Furthermore, being largely composed of rhamnose, 
ulvan can considered a good and cheap raw material to obtain this valuable 
monosaccharide.157 
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8.6. Relevant patents 
The increasing demand for novel polymers side by side with the sustainable 
exploitation of natural resources is forcing the focus of research towards natural origin 
polymers, particularly from marine origin. This mining of the ocean‟s resources is the 
basis of different emergent industries based on the unique properties of marine origin 
molecules. Examples of successful enterprises include Porifarma B. V. (The 
Netherlands), BioTechMarine (France) and Seanergy (Faroe Islands), among others. In 
the particular case of ulvan, the interest in this polysaccharide is being revealed by the 
increasing number of patents focused on the different possibilities of application 
development based on this polysaccharide, ranging from cosmetics, food, agricultural, 
pharmaceutical to more technical applications. A resume of this intellectual property is 
disclosed in Table 1.5. 
 
Table 1. 5. Summary of intellectual property related with ulvan or its derivatives, 
according to the following references: 116-119, 139-141, 155, 157-160. 
Product based 
on/including 
Application Priority Patent Number 
Water extract 
from green algae 
Source of L-rhamnose 1986 US4758283
157
 
Water extract 
from green algae 
Active agent for antiviral drugs 1987 EP0295956
119
 
Water extract 
from green algae 
General use for cosmetic, pharmaceutical, 
food or agricultural applications 
1989 WO1991/07946
140
 
Water extract 
from green algae 
Agent with anticoagulant activity 1990 EP0475383
118
 
Water extract 
from green algae 
Therapeutic agent for treatment of 
cardiovascular pathologies 
2004 US2007/0036821
117
 
Ulvan 
Elicitor of plant defence mechanisms for 
agricultural applications 
2004 US2007/0232494
155
 
Ulvan 
Use of ulvan as interspacing component to 
prepare an interspersed clay for cosmetic, 
pharmaceutical, food or packaging 
applications 
2004 WO2006/030075
141
 
Water extract 
from green algae 
Pharmacological agent for therapy of 
neuropathies associated with diabetes and 
preservation of renal function and 
vasculopathies 
2004 WO2004/103280
116
 
Ulvan 
Modification of ulvan and use of the 
resulting product as a surfactant 
2005 US2009/0299053
158
 
Ulvan 
Cosmetic composition – making-up or 
caring – for skin and lips 
2005 WO2007/007294
139
 
Ulvan 
Cleansing and detoxifying agent 
composed of alginate and ulvan 
2007 WO2009/027955
159
 
Water extract 
from green algae 
Agent for topical application for the 
treatment of hot flashes 
2008 WO2009/142745
160
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9. Outlook and perspectives 
The interest on marine origin molecules is not recent and has always attracted 
attention of visionary entrepreneurs for innovative industrial applications. Within this 
context, and given the evolution and advances of marine origin polysaccharides of 
different sources, it is surprising to see the limited evolution of green algae 
polysaccharides. This is particularly striking if one considers that the study of green 
algae polysaccharides is being documented since the beginning of the XX century. A 
possible justification for this impaired development may reside on the peculiar and 
complex structure of ulvan, only completely unravelled in 1997 with the definite 
confirmation of the presence of iduronic acid within ulvan‟s backbone.19 It was only in 
2009 that Robic and co-workers shed some light on the abnormal behaviour of this 
polysaccharide in aqueous solutions.76 This knowledge has strong impact on the future 
application development of this polysaccharide. Since the early 90‟s, research focused 
on ulvan has been increasing, with a particular focus on its structure and composition, 
as well as on its properties. Interest on the application development is far more recent. 
However, the potential of this green algae polysaccharide is such that intellectual 
property is being reported since mid 80‟s. When compared with other polysaccharides 
originated from red and brown algae, ulvan may be considered as a late bloomer. 
However, the limits of its potential applicability are being drawn and the knowledge 
generated during the past few years will drive research a step further towards the 
application development of this green algae polysaccharide. 
 
10. Final Remarks 
As the fundamental knowledge on ulvan increases, research on this polysaccharide 
tends to shift towards applied science. However, this evolution is naturally impaired by 
a lack of a standardized commercial form of this polysaccharide. In this regard, the 
design of a novel and effective extraction procedure, focused towards targeted 
applications, becomes crucial. This certainly will open the way to the possibility of 
scaling up. This is an important consideration, if continuous research on ulvan is 
intended. 
Literature is rich on reports highlighting the peculiar nature and diverse properties 
associated to this polysaccharide. In fact, a large portion of research efforts are 
focused on the study of ulvan‟s chemistry and properties. This knowledge constitutes 
the fundamental basis that supports applied studies in an attempt to position ulvan as a 
valid alternative to other polymers, in diverse areas of knowledge. In this sense, this 
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polysaccharide can find niches of application in areas like the pharmaceutical industry 
or the biomedical arena, for instance as a bioactive compound or as a medical device, 
or find applicability in the personal care products‟ market, or in the food industry or 
even in agriculture. However, it‟s the authors‟ belief that a practical understanding of 
ulvan‟s applicability is still a rather open field of research. This is of course enhanced 
by the particular demands of each niche of application. For example, if one considers 
ulvan in a biomedical context, to be used as a medical device for regenerative 
purposes, considerable research endeavour is still needed to accomplish clinical 
relevance based on ulvan. In this particular context, research strategies may be 
focused, for instance, on polysaccharide modification, processing and material design 
and/or material-cell interactivity in order to achieve successful development.  
Although the task of translating fundamental research on ulvan into practical 
achievements appears substantial, this polysaccharide holds great potential and 
versatility. Taking advantage of the knowledge gathered research can now be driven 
towards practical applications of ulvan, in an attempt to decrease the distance between 
scientific understanding and industrial awareness. The promise of success is feasible 
and for now, one can only say: “alea jacta est”. 
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Materials and methods 
More than a summarized description of the materials and methods employed 
throughout the herein presented work, this chapter intends to present in more detail the 
materials and techniques chosen to accomplish the proposed objectives. This allows 
for a deeper understanding of experimental and analytical tools utilised. 
 
1. Materials 
1.1. Ulva lactuca 
Ulvan was extracted from the green algae Ulva lactuca. Unless otherwise stated, these 
algae were supplied by Setalg (France) as dry flakes with a moisture content ≤15%. 
These algae are supplied with a certificate analysis report as follows (Table 2.1): 
 
Table 2. 1. Setalg‟s Ulva lactuca certificate analysis. 
Toxicological Analysis 
Mineral Arsenic (As) In conformity (Standard ≤ 3mg/kg) 
Cadmium (Cd) In conformity (Standard ≤ 0.5mg/kg) 
Mercury (Hg) In conformity (Standard ≤ 0.1mg/kg) 
Iodin (I) In conformity (Standard ≤ 2000mg/kg) 
Lead (Pb) In conformity (Standard ≤ 5mg/kg) 
Tin (Sn) In conformity (Standard ≤ 5mg/kg) 
Microbiological Analysis 
(Standards according to Conseil Supérieur d’Hygiène Publique de France) 
Total microorganisms obtained at 30ºC In conformity (Standard ≤ 100000 UFC/g) 
Thermotolerant coliforms In conformity (Standard ≤ 10 UFC/g) 
Anaerobic sulfito-reducing bacteria In conformity (Standard ≤ 100 UFC/g) 
Staphylocoques coagulase + In conformity (Standard ≤ 100 UFC/g) 
Clostridium perfringens In conformity (Standard ≤ 1 UFC/g) 
Salmonella In conformity (Standard Abs/25g) 
1.1.1.Ulvan  
Extracted ulvan has been characterized and some of its properties and composition 
can be summarized as follows (Table 2.2)1: 
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Table 2. 2. Properties and composition of ulvan extracted from the green algae Ulva 
lactuca.1 
Ulvan extracted from Ulva lactuca  
Molecular weight 790 kDa 
Protein 1.3% 
Sulphate 32.2% 
Sulphate free inorganic material 10.3% 
Rhamnose 22.4% 
Glucuronic Acid 22.5% 
Xylose 3.7% 
Iduronic Acid 3.1% 
Glucose 1% 
1.2. Hyaluronic acid (HA) 
Hyaluronic acid is a linear polysaccharide, member of a class of polymers known as 
glycosaminoglycans (GAG‟s). This polysaccharide is composed of β-(1→3) linked N-
acetyl-D-glucosamine and β-(1→4) linked D-glucuronic acid residues (Figure 2.1) and 
can be isolated from various animal tissues or obtained by bacterial fermentation.2 
This is a polysaccharide with ubiquitous usage in the biomedical and non-medical field, 
due to its remarkable physicochemical properties reinforced by its non-immunogenic 
nature.2-4 It is considered as a gold standard for many applications and for this reason it 
was chosen as a non-cytotoxic control in the study of ulvan‟s cytotoxicity (Chapter 4). 
Hyaluronic acid used in these studies was supplied by Sigma–Aldrich (Germany), as a 
white powder in the sodium salt form with 1% protein impurities and used without 
further modifications. 
 
Figure 2. 1. Hyaluronic acid disaccharide unit composed of N-acetyl-D-glucosamine 
and glucuronic acid. 
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1.3. 1,4- Butanediol diglycidyl ether (BDDE) 
Different cross-linking agents may be used to cross-link ulvan, including 1,4- butanediol 
diglycidyl ether. This is a homobifunctional epoxide reagent considered cytocompatible 
and is frequently employed in biomedical, pharmaceutical or cosmetic applications, 
where it is well established and widely accepted.5-9  
Both hydroxyl and carboxyl groups present within ulvan‟s backbone may be utilized for 
the cross-linking of this polysaccharide. Hydroxyl groups may be cross-linked via an 
ether linkage and carboxyl groups via an ester linkage. In acidic conditions labile ester 
bonds are formed, in alkaline media stable ether bonds are obtained and at neutral pH, 
a mixture of both is obtained.7, 9-11  
BDDE was supplied by Sigma–Aldrich (Germany) and used without further 
modifications, with a molecular weight of 202.25 g/mol and a purity grade ≥ 95%. The 
molecular structure of this reagent is presented in Figure 2.2. 
 
 
Figure 2. 2. 1,4- Butanediol diglycidyl ether structure. 
1.4. Poly-(D, L-lactic) acid (PDLLA) 
PDLLA is an amorphous derivative of poly-lactic acid, easily obtained from bacterial 
fermentation.12-14 This polyester is hydrophobic, biocompatible and bioresorbable, 
being believed to degrade in the body into non-toxic lactic acid residues.12, 14-15 It is this 
known degradability associated with various physical, thermal, mechanical and 
biological properties that justifies intense research and use of this polymer in human 
therapy.12, 15  
PDLLA was supplied by Purasorb (The Netherlands), in the form of white granules with 
an inherent viscosity of 1.87dL/g. It was used to produce porous scaffolds by a 
subcritical sintering technology (Chapter 7). Molecular representation of the repeating 
unit of PDLLA is depicted in Figure 2.3. 
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Figure 2. 3. Structural unit constituent of Poly-(D, L-lactic) acid. 
1.5. Chitosan 
Chitosan is the semi-synthetically N‐deacetylated polysaccharide, derived from chitin, a 
natural polymer present in different organisms including the exoskeleton of insects, 
crustaceans and fungi.16 This is a linear polysaccharide composed of 2-acetamido-2-
deoxy-D-glucopyranose and 2-amino-2-deoxy-D-glucopyranose units linked by β-
(1→4) glycosidic bonds (Figure 2.4).17 The cationic character of chitosan confers good 
complexing ability to this polysaccharide which can be used on conjugation studies with 
other polysaccharides, including ulvan.18 
Chitosan was purchased from Sigma-Aldrich (Germany) with medium molecular weight 
and purified through a re-precipitation method, described by Signini and Filho.17 Briefly, 
a solution of chitosan 1% (w/v) in 2% (v/v) aqueous acetic acid is prepared and filtered 
twice to remove any insoluble material. Chitosan is precipitated with 1M aqueous 
sodium hydroxide. Precipitate is recovered by filtration, extensively washed with 
distilled water, until a neutral pH is reached, and freeze dried. White flakes of this 
polysaccharide are obtained. 
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Figure 2. 4. Chitosan disaccharide unit composed 2-acetamido-2-deoxy-D-
glucopyranose and 2-amino-2-deoxy-D-glucopyranose units linked by β-(1→4) 
glycosidic bonds. 
 
2. Extraction of ulvan from green algae 
Nowadays, most of materials used for research in a biomedical context are 
commercially available. However, ulvan still needs to be extracted from green algae as 
it is not yet commercialized.  
In order to obtain this polysaccharide a novel extraction methodology has been 
developed. A detailed description of extraction methodologies employed on the 
extraction of ulvan from green algae was already given in Chapter 1. For this reason, 
the general procedure herein used to obtain ulvan will be briefly described in this 
section. 
As a natural product extract, the influence of several interfering substances has to be 
recognized and these have to be removed whenever and as efficiently as possible. In a 
first stage, dried Ulva sp was submitted to Soxhlet extraction with organic solvents in 
order to remove lipids and colouring matter. The choice of this technique relays on its 
recognition as one of the most efficient procedures to remove contaminants from a 
sample.19-20 
Following Soxhlet algae pre-treatment, polysaccharide per se was extracted from the 
residual off-white dried weed with hot water, in the range of 75-90ºC, based on ulvan‟s 
solubility in this particular solvent.21 These conditions allow the extraction of a high 
molecular weight polysaccharide with a suitable yield.22-24 Although several additives 
may be used to increase the yield of extraction23, 25-30, the choice of hot water as 
extraction solvent reduces introduction of contaminants during extraction.  
Obtained aqueous extracts are centrifuged, filtered and concentrated in a rotary 
evaporator. Resulting aqueous extract solution is further purified through enzymatic 
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hydrolysis with salivary α-amylase and proteinase K in order to remove starch and 
peptides, respectively, both typical contaminants which may be co-extracted with this 
polysaccharide. This methodology is frequently used and already proven effective.1, 22, 
31-33 Small molecular weight contaminants, including the ones responsible for odour and 
also colour can be removed with activated charcoal, through selective adsorption.20, 27, 
31 Finally, resulting solution is subjected to dialysis (salting-out), precipitated with 
ethanol and freeze dried.34 
A schematic summary of the overall extraction design is depicted in Figure 2.5. 
 
 
Figure 2. 5. Extraction methodology employed to obtain ulvan from the green algae 
Ulva. 
3. Polysaccharide characterization 
It is indeed a challenging endeavour to characterize a natural origin polysaccharide.  
After a concise understanding of extracted ulvan‟s structure and some of its chemical 
characteristics (work not included in the present thesis)1, a direct characterization was 
performed by focussing on particular characteristics regarded as important for the 
application development of this polysaccharide. 
3.1. Elemental analysis and protein quantification 
Elemental analysis, as a type of combustion analysis, is widely used for the 
determination of the percentage of different atoms within the sample. Samples are 
completely burned and the elemental composition (carbon - C, hydrogen - H, sulfur - S 
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and nitrogen - N) of the polysaccharide is determined by quantitative measurements of 
the combustion products, namely CO2, H2O, SO2 and N2. C, H, S and N contents 
present on ulvan samples were quantified by combustion of the sample, using a Carlo 
Erba CHNS-O EA 1108 apparatus.  
The percent composition of nitrogen present in the analysed ulvan allowed the 
determination of protein content, through Kjedhal analysis by using a conversion factor 
to convert the measured nitrogen content to a protein percent composition.35 This 
method is widely used as a standard and simple estimation of protein content in foods. 
However, it does not give a measure of the true protein content in a given sample, as it 
also accounts for non-protein nitrogen. Nevertheless, according to this method, it is 
possible to calculate the amount of crude protein (CP) in the sample by multiplying the 
percent nitrogen (N) by a conversion factor (6.25).  
           
3.2. Fourier transform infrared spectroscopy (FTIR) 
FTIR is often used due to the fact that it constitutes a quick and low-cost method. It is 
based on the vibrational excitation of covalently bonded atoms and groups present in 
molecules exposed to infrared radiation.36-37 FTIR spectrum is obtained through the 
determination of absorbed incident radiation at a given energy and corresponds to the 
frequencies of vibrations between the bonds of the atoms present within the 
molecule.37 In this sense, it represents a molecular ﬁngerprint of the analysed sample. 
In order to identify the fundamental and characteristic functional groups present in 
ulvan‟s structure, FTIR has been performed. Extracted polysaccharide powder was 
analyzed using an IR Prestige-21 apparatus (Shimadzu, Japan). Pre-dried powder was 
mixed with potassium bromide (KBr), in a mixing ratio of 1:10 of sample:KBr (w/w), and 
formed into a transparent pellet by manual uniaxial pressing. Transmission spectra 
were recorded using at least 32 scans with 4 cm-1 resolution in the spectral range of 
4000 – 400 cm-1. 
3.3. Nuclear magnetic resonance (NMR) 
Proton NMR spectroscopy is a fundamental tool when studying the chemistry of 
polysaccharides as it allows identification and the study of their structure. This 
technique exploits the properties of magnetic activated atomic nuclei possessing spin.38 
Polysaccharides are rich in 1H and 13C, which are considered as NMR-active nuclei.39 
These activated nuclei absorb electromagnetic radiation at a characteristic frequency 
and the transitions between energy levels are determined.38  
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At this point it is important to stress that due to the high number of possible 
disaccharide sequencings and distribution in addition to other possible structural 
irregularities or contaminants, obtained polysaccharides spectra are many times 
intricate, which enhances the complexity of analysing the signals.40-41 Despite the 
complexity of carbohydrate NMR spectra, information can be obtained about the 
chemical composition of the extracted polysaccharide.39-40 In this particular study, this 
technique was used to identify the presence of characteristic sugar moieties of ulvan.  
1H-NMR spectrum of pre-dried polysaccharide (10mg/ml) dissolved in a deuterated 
solvent (deuterium oxide) was recorded on a Varian Unity Plus (Varian, USA) 
spectrometer, at 25ºC. 
3.4. Thermogravimetric analysis (TGA) 
Thermogravimetric analysis provides a quantitative measurement of mass change in 
materials associated with dehydration, decomposition and oxidation of a sample with 
time and temperature.42 For TGA, a small amount (15-18 mg) of powder was taken for 
analysis in a Perkin Elmer TGA7 (Perkin Elmer, USA). The samples were heated from 
40 to 720°C at a rate of 10°C min-1 under a nitrogen atmosphere. 
3.5. Differential scanning calorimetry (DSC) 
DSC is another thermal analysis technique relevant in the characterization of the 
thermal properties and transitions of a polymer.42 Important and characteristic polymer 
thermal transitions analysed with DSC include glass transition temperature (Tg) or 
melting temperature (Tm).  
DSC experiments were carried out using TA-Q100 equipment (TA Instruments, USA), 
under a nitrogen atmosphere, on samples (5-10 mg) packed in aluminium pans. 
Samples were heated in two stages at a constant heating rate of 20 ºC/min from -20ºC 
up to 180ºC, then were left at this temperature for a period of 2 min and cooled at -
20ºC/min to the initial temperature. At this point a second heating run was conducted. 
An empty aluminium pan was used as reference. 
3.6. Dynamic mechanical analysis (DMA) 
Glass transition is one of the most important parameters in the characterization of a 
polymer. It occurs in amorphous materials or in the amorphous regions of a semi-
crystalline polymer and it is characterized by a relaxation of the polymeric chains. 
Bellow this temperature, the polymer assumes a rigid and brittle behaviour, being 
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elastic above this temperature. These changes impact their physical properties and 
processability.  
There are several techniques that can be employed for the study of this particular 
thermal transition, including DSC and DMA. In a typical DSC trace, a change on the 
heat capacity is detected upon glass transition; in DMA this transition is detected by a 
significant drop in the loss modulus or by a concurrent peak in tan delta (Tan δ).42   
In the present thesis, DMA (TRITEC 8000B DMA apparatus, Triton, UK) was used to 
investigate the in more detail some of the transitions detected in the DSC trace. 
Stainless steel pockets, provided by the DMA manufacturer, for these specific 
measurements (length = 15 mm, width = 7.5 mm, thickness = 1 mm) were used to fix 
the powder material into the DMA loading frame. Such pocket devices are especially 
useful to analyse powder materials and are frequently applied in pharmaceutics, for the 
study of active agents.43 The pockets filled with the sample were subjected to 
sinusoidal loading under Single Cantilever Bending mode conditions. The load was 
automatically adjusted in order to achieve an imposed displacement equal to 0.05 mm. 
The measurements were performed at frequencies of 1, 5, 7.5 and 10 Hz over the 
temperature range between 20 °C to 140 °C at 2 °C/min for each frequency. Note that 
the storage modulus that is given by the apparatus is basically resulting from the 
properties of the metallic component. However, any change in the viscoelastic 
properties of the sample will be detected in the tan δ trace. 
In order to confirm a glass transition temperature, both storage modulus and tan δ were 
recorded as a function of frequency, as well as temperature, and an Arrhenius equation 
was applied in order to determine the activation energy of a given thermal transition. 
         
  
   
  
where f is the applied frequency, A is a constant, R is the universal gas constant and T 
is the peak maximum temperature of the tan δ peak. The relationship between the 
observed changes in tan δ with frequency allows the computation of the activation 
energy.43 
3.7. X-ray diffraction (XRD) 
X-ray diffraction is another technique that can be employed for bulk characterization of 
polymers, particularly on the three-dimensional arrangement of molecules. XRD 
patterns were measured using a powder diffractometer Philips PW1710 apparatus 
(Philips, The Netherlands), with Cu-Kα radiation at 50 mA and 40 kV, operated in step 
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scan mode (1.542Å wavelength). The diffraction data was acquired at a rate of 0.02º 
2θ/s and over a Bragg angle range of 10º<2θ<50º. 
3.8. Biological assays 
Prior to any application development, every natural origin polysaccharide should 
undergo a screening stage of cytotoxicity testing. This procedure allows the detection 
of detrimental effects of the polymer towards cellular functions. 
An in vitro approach is economically and ethically favoured over animal tests, in 
compliance with the 3R‟s Principle (Reduction, Refinement and Replacement). Overall 
in vitro cytotoxicity procedures have proven to be effective in the screening of human 
chemical toxicity.44 In standard tests, the sample is incubated in direct contact with a 
layer of cells, usually from a cell line, for a period of at least 24 hours, together with 
positive and negative controls.45 This is considered the closest assay to evaluate and 
predict the cytotoxicity and the behaviour of a material in the body, since there is no 
barrier between the material in study and the cell layer.44 The effect of the presence of 
a foreign agent on cellular homeostasis may be detected by the disturbance of normal 
cellular biochemical functions; this knowledge is the foundation of many standard 
toxicologic studies (Figure 2.6).46-47 Cytotoxicity of extracted ulvan was evaluated 
according to ISO/EN 10993 part 5 guidelines for an exposure period of 24h.45 
 
Figure 2. 6. Animal cell basic scheme with the indication of some of the targets 
(biochemical parameters) usually employed on the study of cytotoxicity. 
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3.8.1. Cell lines 
For the present characterization work cell lines were used, namely mouse C3H/An 
connective tissue fibroblast-like cells (L929), obtained from the European Collection of 
Cell Cultures (ECCC, UK). The use of continuous cell lines possesses several 
advantages, such as their abundance, standardization of culture conditions and easy 
storage.48-49  
3.8.2. Cell culture 
Cells were cultured in tissue culture flasks at sub-confluent cell density in Dulbecco‟s 
modified eagle medium (DMEM) supplemented with sodium bicarbonate (44 mM) 
(Sigma–Aldrich, Germany), 10% fetal bovine serum (FBS – Alfagene, USA) and 1% of 
antibiotic-antimycotic solution (Gibco, UK). Cultures were maintained at 37°C, in a 
humidified tissue culture incubator with a 5 % CO2 atmosphere. Medium was renewed 
every 2-3 days. 
3.8.3. Polymer solutions preparation 
Cytotoxicity assays were performed using latex rubber and standard culture medium as 
positive and negative controls, respectively. Latex rubber is commonly used as a 
positive control for standard toxicological assays, as it is known to have a cytotoxic 
effect inducing cell death and lysis.50 Hyaluronic acid (HA), supplied by Sigma–Aldrich 
(Germany), was additionally used as a non-cytotoxic reference material. 
Ulvan and hyaluronic acid were dissolved in DMEM supplemented with sodium 
bicarbonate (44 mM), 10% FBS and 1% of antibiotic-antimycotic solution. Fresh stock 
solutions of ulvan and hyaluronic acid were prepared and diluted to the final test 
concentrations, in order to obtain polymer solutions with concentrations between 0 and 
15 mg/ml.  
3.8.4. Biochemical parameters applied in the study of the cytotoxicity of 
extracted polysaccharide 
Cell growth in normal culture conditions can be impaired by the presence of foreign 
compounds if one or more essential cellular functions, such as mitochondrial activity, 
DNA and protein synthesis or maintenance of membrane integrity, are affected.51 In 
fact, loss of viability, reduced proliferation rate or cell membrane rupture represent 
critical consequences that can result from exposure to a toxic biomaterial.52 Based on 
this, several methods can be used to evaluate cell viability and proliferation, like 
reduction of MTS and quantification of total protein or measurement of DNA synthesis 
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following the incorporation of radio-labelled molecules.52 Performed assays are based 
on metabolic activity given by mitochondrial activity through MTS assay, determination 
of nucleic acids through dsDNA quantification, and protein content through total protein 
quantification. 
 MTS assay 
MTS is commonly used for the analysis of cell metabolic activity and provides an 
indication of cell viability. This particular assay determines if cells exposed to the 
different polymers are metabolically active. It is based on reduction of the substrate, 3-
(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium 
(MTS) in a mitochondria-dependent reaction to yield a brown formazan product. This 
conversion is accomplished via NADPH or NADH produced by mitochondrial 
dehydrogenase enzymes in metabolically active cells. In this sense, only viable cells, 
undamaged by a foreign agent, can express this enzymatic activity.49 
In order to perform this assay, a CellTiter 96® AQueous One Solution Reagent 
(Promega, USA) was used. Briefly, cells were seeded onto 96-well plates at a 
concentration of 5x103 cells per well. After 24 h, medium and unattached cells were 
removed and polymer solutions were added. Culture medium without any 
polysaccharide was used as negative control and it is represented as 0 mg/ml. Cells 
were incubated in the presence of the different samples for an additional 24 h period. 
Three replicates were considered for each sample. After each time of exposure, 
medium was discarded from each well and the cell monolayer was washed twice with 
sterile phosphate buffered saline (PBS) solution. Cells were exposed to tetrazolium 
solution (MTS), following manufacturer‟s protocol, which allowed for viable cells to 
reduce the tetrazolium compound into a water soluble formazan product. Optical 
density at 490 nm was measured with a microplate reader (Synergie HT, Bio-Tek, 
USA). 
 Double stranded DNA (dsDNA) quantification 
Double stranded DNA quantification is based on fluorescence enhancement of a dye, 
PicoGreen, upon binding to dsDNA. The relative fluorescence units measured correlate 
with the total number of cells.47 In this sense, measurements of DNA synthesis are 
frequently taken to be representative and indicative of cell proliferation.53 
As for the MTS test, after cellular confluence culture medium was replaced by 
polysaccharide solutions. Three replicates were considered per sample. Culture 
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medium without any polysaccharide was used as negative control (represented as 0 
mg/ml). After 24h of incubation media was discarded from each well and the cell 
monolayer was washed twice with sterile PBS solution. Cell proliferation was measured 
by the total amount of double-stranded DNA and quantiﬁcation was performed using 
the PicoGreen dsDNA Assay Kit (InvitrogenTM, Molecular ProbesTM, USA), according to 
the manufacturer‟s instructions. In brief, cell monolayer was lysed by osmotic and 
thermal shock and the supernatant used for DNA quantiﬁcation. Fuorescence was 
measured at an excitation wavelength of 485/20 nm and at an emission wavelength of 
528/20 nm, in a microplate reader (Synergie HT, Bio-Tek, USA). DNA concentration for 
each sample was calculated using a standard curve of lambda DNA relating DNA 
concentration (ranging from 0 to 1.5 μg ml−1) and ﬂuorescence intensity. 
 Total protein quantification 
Total protein, measured through bicinchoninic acid (BCA) assay, combines the protein-
induced biuret reaction with the highly sensitive and selective colorimetric detection of 
the resulting cuprous cation (Cu1+) by BCA. The measured protein content corresponds 
directly to the cell number.47 
As for dsDNA quantification, after reaching confluence the culture medium was 
replaced by the polysaccharide solutions. Three replicates were considered per 
sample. Culture medium without any polysaccharide was used as negative control (0 
mg/ml). After 24h of incubation media was discarded from each well and the cell 
monolayer was washed twice with sterile PBS solution. From this point on, Micro 
BCATM Protein Assay Kit (Pierce Chemical, USA) was used, following manufacturer 
instructions. In summary, cells were exposed to a working solution containing 
bicinchoninic acid (BCA) as detection reagent for Cu+1, which is formed when Cu+2 is 
reduced by proteins, producing a purple reaction product. Optical density at 562 nm 
was measured using a microplate reader (Synergie HT, Bio-Tek, USA). A standard 
curve, using albumin as standard (0 to 200 µg/ml), was created and sample protein 
values were read off from the standard graph. Plotting the measured absorbance 
against albumin concentration allowed the calculation of protein concentration. 
 
4. Sample processing 
In order to understand the limits of processability of ulvan extracted from green algae, 
different polymer processing methodologies were attempted.  
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Ulvan is a polysaccharide that is soluble in water and prone to hydrolytic degradation in 
physiological conditions. This per se justifies the need for a modification step in order to 
render produced ulvan structures insoluble in water and stable at physiological 
conditions. Cross-linking was the chosen method to modify ulvan in order to produce 
both ulvan membranes and 3D porous structures. Among the different commercially 
available cross-linking agents we have chosen to work with 1,4- butanediol diglycidyl 
ether (BDDE) due to its ubiquitous applicability and acceptability in biomedical, 
pharmaceutical or cosmetic applications.5-8 As a practical example, this agent is widely 
used to cross-link hyaluronic acid to produce commercially available stable fillers for 
dermatological purposes.5 
There are several different processing techniques that can be employed in the 
processing of ulvan. Among these, solvent casting was performed to obtain ulvan 
membranes, freeze drying to obtain ulvan porous structures and extrusion-dripping 
method to produce ulvan particles. Each of these techniques will be further discussed. 
4.1. Cross-linking ulvan prior to membrane preparation 
Ulvan was mixed with BDDE (1:5 molar ratio), in an alkaline media (sodium hydroxide, 
40 mM). The cross-linking reaction was allowed to proceed for 180 min, at 50ºC. 
Cross-linked ulvan powder was exhaustively washed with water and acetone to remove 
any residual cross-linker. The obtained dried powder was further used to produce 
cross-linked ulvan membranes. 
4.1.1. Ulvan membranes produced by solvent casting 
Polymeric membranes were produced by solvent casting methodology. In this process, 
a homogeneous polymer solution is placed in an appropriate mould and the solvent is 
removed by evaporation. Membrane formation through solvent casting is affected by 
different physicochemical processes, namely diffusion, mass transfer, convection and 
precipitation.54 This is a solvent based technique that depends on polymer solubility 
and solvent volatility. Properties of the polymeric solution, including the polymer effect, 
solvent effect and a combined effect of both factors, play a decisive role within this 
process and on the final properties of the obtained membrane.54-55  
To prepare the polymeric membranes, cross-linked ulvan was dispersed in water (1% 
w/v) and the solution was homogenised with an UltraTurrax apparatus. Ulvan 
membranes were prepared by casting ulvan solution on Petri dishes, followed by 
solvent evaporation, at 50ºC, in a vacuum oven.  
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In the present study, dexamethasone, a steroid anti-inﬂammatory drug, was used as a 
model therapeutic agent. In this case, ulvan membranes impregnated with 
dexamethasone were prepared as described above, and dexamethasone was 
dissolved in acetone and added to ulvan solution, with a final concentration of 15% 
w/w, prior to solvent casting. The final appearance of ulvan membranes, loaded or not 
with dexamethasone, is a homogeneous and transparent yellowish film. 
4.2. Development of chemically cross-linked freeze-dried ulvan porous 
structures 
Freeze drying is often used to produce porous structures. A polymer solution is 
prepared, frozen and the solvent removed by lyophilisation under high vacuum.56 
Hence, this technique involves two stages, namely freezing the solvent which can be 
considered as a crystal nucleation process and sublimation of the resulting ice crystals 
leading to the formation of pores. This particular methodology makes use of ice crystals 
as porogens which results in a final porous architecture that is strongly influenced by 
solution properties as well as by polymer molecular arrangements. 
Prior to the processing of the structure per se, ulvan was cross-linked with BDDE. This 
chemical cross-linking was performed by simply mixing the polysaccharide with the 
cross-linking agent in an alkaline medium, to favour the formation of stable ether 
bonds.57 Ulvan (referred as UL) and cross-linker (referred as XL) concentrations are 
reported in Table 2.3. 
 
Table 2. 3. Different formulations based on ulvan (UL) and cross-linker (XL) used to 
prepare various ulvan porous structures. 
[UL] (% w/v) XL (w/w) 
4 0.20; 0.27; 0.53 
5 0.14; 0.50; 1.00; 1.50; 2.00 
6 0.13; 0.18; 0.36; 0.57 
8 0.25; 0.50; 0.75; 2.00 
The reaction was allowed to proceed for 180 minutes, at 50ºC. Afterwards, the solution 
is dialyzed against distilled water to remove any unreacted cross-linker, placed in an 
appropriate mould and freeze dried to allow the formation of porous structures. 
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4.3. Ulvan particles produced by extrusion-dripping method 
Extrusion-dripping method is a technique widely applied to produce polymer particles. 
These structures are prepared by adding a polysaccharide solution, in a dropwise 
manner, into a coagulation bath. The contact of droplets with the coagulation bath 
results in the instantaneous formation of gel-like particulate structures (Figure 2.7). 
Being a polyanion, ulvan is able to form insoluble complexes when in contact with 
water soluble polycationic molecules.58 
In order to produce the envisaged ulvan particles, an aqueous ulvan solution (6% w/v) 
was prepared and placed in a syringe to be added in a drop wise manner to a chitosan 
solution (1% w/v in 1% v/v acetic acid). This procedure was performed at room 
temperature and contact time of ulvan particles with chitosan solution was ~2h, as 
lower contact times resulted in unstable and rapidly dissolving particles. After 
stabilization, ulvan particles were collected, extensively washed and dried. 
Incorporation of dexamethasone was achieved by directly adding it  to ulvan solution at 
a concentration of 15% (w/w).59 
 
Figure 2. 7. Method to produce ulvan particles by addition of an ulvan solution in a 
drop wise manner to a coagulation bath composed of a polycation. 
Produced ulvan particles were afterwards incorporated into a polyester matrix, 
produced by subcritical sintering. 
4.3.1. Polyester matrix produced through subcritical sintering 
Subcritical sintering method uses carbon dioxide in a subcritical state to prepare highly 
porous and interconnected structures, under mild conditions.60 This methodology 
Materials and Methods 
63 
 
usually makes use of carbon dioxide which is considered environmentally benign, 
nontoxic, non-flammable, noncorrosive, readily available, inexpensive and an 
alternative to the use of organic solvents. The subcritical sintering technique, similarly 
to the supercritical fluid foaming, relies on the plasticizing effect of carbon dioxide 
which reduces the glass transition temperature of polymers. In the sintering process, 
the polymer is plasticized in mild conditions and the polymer particles are fused, 
creating a 3D scaffold with appropriate morphological properties for tissue engineering 
and regenerative medicine.61 This method eliminates the need of organic solvents and 
high temperatures generally needed to process synthetic polymers, with an additional 
advantage of allowing the enrichement with labile bioactive agents.60, 62-66 
Scaffolds were prepared by a subcritical fluid assisted sintering method at 50 bar and 
40 ºC. Approximately ~120 mg of a mixture of PDLLA and ulvan particles (empty or 
loaded with dexamethasone) were positioned in a mould, which was placed in a high 
pressure chamber. The chamber was heated by means of an electric thin band heater 
connected to a temperature controller. The sintering occurred within 30 minutes, which 
was the optimum contact time to allow the plasticization of the polyester; after this, the 
system was quickly depressurized. 
 
5. Sample characterization 
Various techniques are available to characterize the produced polymer structures 
assessing different parameters, including mechanical and thermal properties, 
morphology, chemical characterization and stability or biological activity. In this context, 
a strategic approach involves a multi-parameter characterization in order to acquire a 
realistic overview regarding the material‟s properties and functionality. 
5.1. Fourier transform infrared spectroscopy (FTIR) 
The bases of this technique are explained in more detail in section 3.2. Besides 
polysaccharide characterization, FTIR can also be used to study chemical 
modifications introduced by, for instance a cross-linking reaction, as part of structure‟s 
characterization.  
5.2. Scanning electron microscopy (SEM) 
Scanning electron microscopy is a valuable method frequently applied to study 
morphologic properties of polymeric structures.67 Nonconductive polymeric materials 
are normally coated with a thin, conductive material, such as gold or carbon by 
sputtering, in order to minimize negative charge build up from the electron beam.67 
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Developed structures were sputter-coated with gold, prior to SEM analysis (Leica 
Cambridge, model S360 (Leica Cambridge, England) or FEI Nova 200 (FEI, USA)).  
5.3. Micro-computed tomography (µ-CT) 
Micro-computed tomography makes use of X-rays to create an image/projection of a 
3D object used to construct a virtual model without destroying the original object.68-69 
The sample is defragmented into a series of 2D projections, that are exposed from the 
edges to X-rays, which are then used to build a 2D pixel map. Further analys with 
specific software generates a 3D model, representative of the analysed sample.69 In 
this context, it is able to provide both quantitative and qualitative information regarding 
the morphology of the sample. Micro-CT analysis includes information of porosity, 
mean pore size and pore size distribution, interconnectivity, anisotropy, etc.69-70 By 
applying this technique it is possible to scrutinize and visualize the intricate and 
complex 3D structure of the sample. 
Structures herein described were analyzed by micro-computerized tomography using a 
high-resolution micro-CT SkyScan 1072 scanner (Skyscan, Belgium) to characterize its 
morphological and morphometric properties. Each scaffold type was scanned in high-
resolution mode. Representative data sets of the analyzed sample were converted into 
binary images using a dynamic threshold to distinguish between polymer material and 
void space. Those operating parameters were maintained for each set of samples in 
each particular study. For morphometric analysis (CT Analyser®, SkyScan, Belgium), 
2D images were reconstructed using CT Analyzer software from the micro-CT scanner 
supplier (NRecon, SkyScan, Belgium). Different morphometric parameters were 
determined, including porosity, mean pore size and respective distribution and 
structure interconnectivity. 3D virtual models of representative regions in the bulk of the 
structures was also created, visualized and registered using the image processing 
software supplied by the manufacture. 
5.4. Mechanical characterization 
Mechanical properties of different polymeric structures can be characterized by their 
deformation behavior, resulting in a stress-strain response.67 These properties are 
associated with the molecular arrangements of the processed polymer and are crucial 
in evaluating the effectiveness of the processed structures to be selected for a 
particular biomedical application.67  
Mechanical characterization of produced ulvan structures was performed through 
quasi-static testing in tensile or compression mode, using a universal testing machine. 
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This technique allows the investigation of the mechanical behaviour of the produced 
structures under static loading. 
5.4.1. Tensile testing 
Ulvan membranes described in Chapter 5 were subjected to tensile tests to evaluate 
the effect of cross-linking over the mechanical properties and to determine the 
mechanical performance of these membranes. Membranes with 500μm in thickness 
were cut into 10-mm-long specimens and tensile tests, in dry state, were performed 
using a Universal Testing Machine (Instron 4505, Instron Int. Ltd., UK), with a load cell 
of 1 kN, gauge length of 10 mm and cross-head speed of 5mm/min was used up to 
rupture of the membrane. A minimum of five specimens were tested for each sample 
(the values reported are the average of those results). 
These tests allowed the determination of different mechanical properties, defined as 
follows and represented in Figure 2.8: 
 tangent modulus, defined as the slope of the straight line obtained by linear 
regression of the stress-strain curve in the near elastic region of the material 
(between 0 and 1.0 % strain);  
 the ultimate tensile strength, defined as the maximum tensile stress developed 
in the material during the tensile test; 
 strain at break point, defined as the maximum strain of the material, i.e. 
elongation at the failure point of the material. 
 
 
 
Figure 2. 8: Graphical representation of the tangent modulus at 1 % strain, ultimate 
tensile strength and strain at break point. 
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5.4.2. Compression testing 
3D structures developed in Chapters 6 and 7 were mechanically tested by compression 
experiments in an Instron 5543 universal testing machine (Instron Int. Ltd., UK) with a 
load cell of 1kN. Compression testing was carried out at a crosshead speed of 
2mm/min, until obtaining a maximum reduction in samples height of 60%. Compressive 
modulus was determined in the most linear region of the stress–strain graph using the 
tangent method. A minimum of five samples of each type/condition were tested. 
5.5. Water uptake and degradation tests 
Water uptake and degradation can be easily quantified by a mass based method. For 
water uptake, generally, samples are weighted out into screw-top plastic tubes, 
immersed in phosphate buffered saline (PBS) and allowed to swell at 37ºC, with gentle 
agitation (60 rpm) in a precision water bath. After each time point, the samples are 
brought to surface dryness, on a Whatman filter, and weighted.  
The content of water in the swollen scaffolds is then calculated by the following 
equation: 
                                  
where wi is the initial weight of the specimen before immersion and ws is the weight of 
the swollen structure.  
After each time period the samples are dried and weighted to determine the weight 
loss, which is calculated according to the equation: 
                                  
where wd is the final weight of the sample (dried) and wi is the initial weight of the 
sample. 
5.6. In vitro dexamethasone release profile 
In order to quantify the release of a drug from the produced structures, a simple 
methodology was employed. Drug-loaded structures were immersed in PBS (pH 7.4) 
and incubated at 37°C for a certain period of time. The release of dexamethasone was 
periodically monitored by extracting 500 µl aliquots. Retrieved aliquots were 
replenished with 500 µl of PBS. The concentration of dexamethasone was determined 
by UV–Vis spectroscopy at 242 nm (Shimadzu UV 1601, Japan). Drug concentration 
was calculated using a standard curve, relating the concentration of drug with the 
absorbance intensity.  
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5.6.1. Mathematical modeling of dexamethasone release from ulvan 
membranes 
Different methods have already been developed to try to model the release of a drug 
from a delivery system. The advantage of these studies relies on the fact that they help 
understand the mechanisms of mass transfer behind drug release and predict the 
effect of the matrix properties on this release kinetics.71 
In the present research work, and in order to understand the mechanisms of 
dexamethasone release from ulvan structures the power law was applied to the 
experimental data. This particular approach was chosen as it accounts for both drug 
diffusion and matrix swelling.71 Power law is a simple empirical equation, which 
describes a linear relationship between logarithm of the percentage of drug released 
and logarithm of time, up to 60% of the maximum drug released.  
  
  
     
Mt/M∞ is related with the fractional drug release, k is the kinetic constant, t refers to the 
release time and n is the diffusional exponent that is related to the drug transport 
mechanism. According to this law, the release mechanism is determined by the 
diffusional exponent (Table 2.4). It can be governed by a Fickian Transport, where the 
release occurs through molecular diﬀusion of the drug due to a concentration gradient; 
Case-II Transport, which is mostly associated with swelling, due to the relaxation of the 
macromolecules upon water uptake into the polymeric matrix or it can be governed by 
both drug diffusion (diffusional release) and polymer swelling (relaxation release), in a 
mechanism known as Anomalous Transport.63, 71 
 
Table 2. 4. Mechanisms behind drug release from polymeric devices, with various 
geometries, and exponent n of the power law equation. Adapted from Siepmann & 
Peppas, 2001.71 
 Film Cylinder Sphere Release Mechanism 
n 
0.5 0.45 0.43 
Fickian Transport 
(diffusional release) 
0.5<n<1.0 0.45<n<0.89 0.43<n<0.85 
Anomalous Transport 
(diffusional and relaxation release) 
1.0 0.89 0.85 
Case-II Transport 
(relaxation release) 
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5.7. Biological assays 
Systemic and physiological material‟s related toxicity events can be complex and 
difficult to evaluate, both in vivo and in vitro.53 For this reason, toxicity is generally 
evaluated at the cellular level – cytotoxicity.53 The basis of cytotoxicity studies 
employed on the study of biomaterials was already explained in more detail in section 
3.8. Briefly, the effect of a material over normal cellular function is evaluated by 
monitoring of some targeted cellular responses and mechanisms, like metabolism and 
viability, growth and/or survival, etc.53 
In the present work, the general guidelines of the ISO/EN 10993 part 5 were followed45, 
and cellular metabolic activity and/or proliferation were accessed. Different types of 
methodologies can be applied in order to access the toxicity of a developed polymer 
matrix, namely extract and direct and indirect contact assays, followed by the 
evaluation of different parameters, including cell damage, growth or metabolism.45 
5.7.1. Cell lines 
As for the evaluation of cytotoxicity of ulvan extracts, mouse C3H/An connective tissue 
fibroblast-like cells (L929), obtained from the European Collection of Cell Cultures 
(ECCC, UK), were used for cytotoxicity testing of produced structures.  
5.7.2. Cell culture 
Cells were cultured in tissue culture flasks at sub-confluent cell density in Dulbecco‟s 
modified eagle medium (DMEM) supplemented with sodium bicarbonate (44 mM) 
(Sigma–Aldrich, Germany), 10% fetal bovine serum (FBS – Alfagene, USA) and 1% of 
antibiotic-antimycotic solution (Gibco, UK). Cultures were maintained at 37°C, in a 
humidified tissue culture incubator with a 5 % CO2 atmosphere. Medium was renewed 
every 2-3 days. 
5.7.3. MEM extract and evaluation of cellular metabolic activity by MTS assay 
MEM extract test is widely employed in the study of cytotoxicity of leachables/soluble 
products of degradation from biomaterials. For this purpose cells are exposed to a 
prepared material extract (containing the material‟s leachables), after which the effect 
on the cells is measured (growth, metabolism, membrane damage, etc.).  
This particular test was performed to assess the cytotoxicity of PDLLA based 
structures; extracts of the materials were prepared and placed in contact with mouse 
L929 cells. Short-term cytotoxicity of leachables released from polymeric biomaterials 
towards L929 cells was evaluated through MTS assay. 
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In summary, 5x103cells.ml-1 were cultured in Dulbecco‟s modified Eagle‟s medium, 
supplemented with 10% fetal bovine serum and 1% antibiotic/antimycotic solution and 
allowed to grow until a desirable confluency was reached. At this time, culture media 
was replaced with material extracts, prepared in culture media. L929 cells viability was 
determined for each extract and compared to latex extracts, used as a positive control 
of cell death, and to cells growing in the absence material extracts (negative control, 
representing cell growth in culture media). After each time point (24, 48 and 72 h of 
incubation) MTS test was performed to assess cellular viability, following the 
manufacturer‟s instructions (details about this test can be found in section 3.8.4.). 
Optical density was measured at 490 nm, on a multi-well microplate reader (Synergy 
HT, Bio-Tek, USA).  
5.7.4. Direct contact: viability and proliferation of cells in the presence of ulvan 
3D porous structures 
The choice of a direct contact test in detriment of an extract assay to evaluate the 
cytotoxicity of these particular structures is largely related with the inherent properties 
of these structures, namely their water uptake ability (that can be as high as 2000%). 
This fact per se hampers the application of an easy and straightforward MEM extract 
test. The application of a direct contact test has the advantage of allowing the 
simultaneous evaluation cellular behaviour upon contact with the prepared structures. 
Briefly, confluent L929 cell at passages 20–26 were harvested for seeding onto ulvan 
samples at a density of 5.0x105 cells/scaffold.72 The constructs were cultured in 
standard medium for 1, 3, and 7 days. Cells seeded on standard tissue culture 
polystyrene were used as a negative control, representing cell normal growth in culture 
media. In this experiment cell adherent culture plates were chosen. Cells non-adherent 
to the samples were used, as a non standard method to screen possible toxicity of 
soluble components and other degradation products resulting from ulvan samples.  
The effect of the produced ulvan structures onto L929 cells was evaluated by assaying 
different parameters through MTS assay, dsDNA quantification and cell imaging. Both 
cell metabolic activity (MTS assay) and dsDNA quantification were performed on cells 
cultured on ulvan structures and on cells that end up growing in the culture plate. 
 MTS assay 
Details about this test can be found in section 3.8.4. In summary, cell viability for each 
culturing time was determined using the CellTiter 96 AQueous One Solution Cell 
Proliferation Assay (Promega, USA), following manufacturer instructions. Absorbance 
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of four samples per type of ulvan structure and time point was measured at 490 nm in a 
microplate reader (Synergie HT, Bio-Tek, USA). Cell proliferation was quantiﬁed by the 
total amount of double-stranded DNA (dsDNA), along the culturing time. 
 dsDNA quantification 
Details about this test can be found in section 3.8.4. Quantiﬁcation was performed 
using PicoGreen dsDNA Assay Kit (InvitrogenTM, Molecular ProbesTM, USA), according 
to the manufacturer‟s instructions.  Brieﬂy, cells were lysed by osmotic and thermal 
shock and the supernatant used for the DNA quantiﬁcation assay. Fluorescence was 
measured at an excitation wavelength of 485/20 nm and at an emission wavelength of 
528/20 nm, in a microplate reader (Synergie HT, Bio-Tek, USA). Quadruplicates were 
made for each sample and per culturing time. dsDNA concentration for each sample 
was calculated using a standard curve relating DNA concentration (ranging from 0.0 to 
1.5 mg/mL) and ﬂuorescence intensity. 
 Cell Imaging 
Viability, morphology and distribution of cells on ulvan structures were assessed, after 
1 and 3 days, by reflected/transmitted light microscope, following calcein-AM and 
propidium iodide staining, and by scanning electron microscopy (SEM).  
For reflected/transmitted light microscope visualization, ulvan structures were 
incubated in culture medium with calcein-AM and propidium iodide (InvitrogenTM, 
Molecular ProbesTM, USA). These fluorescent markers are used to label cells and allow 
visualization by selecting an appropriated wavelength.53 Calcein-AM is a non-
fluorescent permeable compound that once inside viable cells is converted by 
intracellular esterases into a fluorescent cell impermeable form, being used as a green 
fluorescent indicator of viable cells. This particular marker does not label dead cells, 
and is rapidly lost under conditions that cause cell lysis. In order to visualize dead cells, 
propidium iodide staining was performed. Propidium iodide is used as a red fluorescent 
marker of cells with compromised membranes, being used as an indicator of dead 
cells. The calcein-AM/propidium iodide stained samples were placed on a microscope 
slide and observed by reflected/transmitted light microscope (Zeiss, Axio Imager.Z1m, 
Germany).  
For SEM analysis (FEI Nova 200 SEM, FEI, USA), ulvan structures were ﬁxed with 
2.5% glutaraldehyde. This fixation step is necessary for stabilization of the overall 
structure (cells on the matrix), allowing the maintenance of the biological samples in 
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their natural state. Structures were further dehydrated in increasing ethanol 
concentrations, critical point dried and gold sputter coated prior to SEM observation 
(details about SEM are further reviewed in section 5.2.). 
 
6. Statistical analysis 
Statistical analysis was performed using the GraphPad Prism statistic software 
(Release version 5 for MS Windows). 
In a first approach, a Shapiro-Wilk test was used to ascertain about data normality.73 
As data failed to demonstrate a normal distribution, non-parametric tests were 
performed for further comparisons.  
Whenever two independent samples on one variable needed to be compared, a Mann-
Whitney test was applied.74 This particular test was employed for: 
 study of ulvan‟s polysaccharide cytotoxicity - direct comparisons between ulvan 
and hyaluronic acid (Chapter 4);  
 study of 3D porous structures produced by freeze drying - direct comparison 
between two structures with varying polysaccharide content (Chapter 6); 
 Study of the effect on mechanical performance of the presence of ulvan 
particles within a PDLLA matrix (Chapter 7).  
For the analysis of more than two independent groups of samples compared for one 
variable, a Kruskal-Wallis test was employed.75 When this test indicated significant 
differences between independent groups, different multiple comparison tests were 
performed to identify different groups. The Dunn's test is a specialized multiple 
comparison test that allows to compare a single control group to all other sample 
groups. These tests were generally applied to study the effect of the test samples 
(different polysaccharide concentrations, both of ulvan and hyaluronic acid, ulvan 
porous structures and PDLLA based matrix enriched with ulvan particles) over various 
cellular biochemical parameters, namely cellular metabolic activity and cellular number 
and proliferation. 
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Abstract 
During the last years, considerable attention has been given to different marine 
organisms, like algae, as potential sources of valuable materials. The continuous 
demand for novel materials and technologies is high and research on the 
underexploited marine green algae, including its polysaccharidic part - ulvan, has 
increased accordingly. In this research work, a novel method for extraction of ulvan 
from green algae is proposed and demonstrated successful. Different characterization 
techniques were employed to characterize the isolated algal polysaccharide, namely on 
what concerns its thermal trace and crystallinity. Upon heating, ulvan behaves as a 
non-meltable polysaccharide that is thermally stable before degradation at 220oC. 
Ulvan is semi-crystalline in nature and possesses high hygroscopic features, as 
revealed in this research work. Due to its properties, ulvan can be considered, pure or 
modified, as a versatile biodegradable polymer for different applications, including 
tissue engineering and regenerative medicine. 
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1. Introduction 
Natural polymers are becoming more and more important for technological and 
industrial related applications. These are believed to be a better alternative approach to 
the use of fully synthetic materials in different contexts.1 Nowadays, a lot of the 
research effort in the biomedical field, namely tissue engineering, is based on natural 
polymers.2-4 Among these, polysaccharides are at the centre of attention as they 
possess unique physical and chemical properties, being recognized not only for their 
important functional properties but also for their potential biological applications. The 
list of known natural carbohydrates is continuously growing, owing to new discoveries 
in animal and plant material.5 They can be used in their native form or after chemical 
modification, as is the case of chitin or cellulose, in order to render them suitable for the 
envisaged applications.6 
Over the last years, different marine organisms have been raising considerable interest 
as sources of valuable materials. Algae, for instance, has been target of special 
attention. The unique properties of polysaccharides that are found in these organisms 
are especially interesting, which emphasizes the importance of obtaining further 
knowledge in this area. In fact, the exploitation of algae for different applications and as 
a source of carbohydrate polymers is not a novelty as these polymers have long been 
used. Nevertheless, among the three main divisions of macroalgae (Chlorophyta, 
Phaeophyta and Rhodophyta), green algae remain largely unexploited. In the past 
decade, marine eutrophication has promoted the proliferation of algal biomasses, 
namely of Ulva sp. This is associated with an increase in human activity in coastal 
areas, which potentiates an increase in some nutrients in the aquatic environment, 
leading to growth of green algae, commonly known as algal blooms. As a 
consequence, the interest in exploiting such natural resource has increased 
significantly and, in particular, for its polysaccharidic part, ulvan.7 This designation is 
used to denote polysaccharides from members of the Ulvales algae, namely Ulva. 
Ulvan is mostly composed of rhamnose, glucuronic acid, iduronic acid, xylose, and 
sulphate.8 To extract ulvan from green algae, different methodologies have been 
employed9-12, based on the solubility of this polysaccharide in water. However, a 
special concern must be given to purification, as it will be of outmost importance to the 
final use of this polymer. In this context, a simple and novel extraction procedure is 
proposed. An important input and insight on ulvan‟s properties has been already given 
by many research works.8-10, 12-16 Still, many of its characteristics and properties remain 
unknown, namely on what concerns its thermal trace and crystallinity. The precise 
knowledge of thermal behaviour and crystallinity of this polysaccharide assumes a 
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crucial role on its characterization, as different properties, such as mechanical 
performance, solubility, among others, are expected to be directly influenced by these 
features. 
In this study, some of the functionalities of this polysaccharide are unveiled and a 
simple method of extraction of ulvan is proposed.  
 
2. Results 
2.1. Chemical characterization of the extracted polysaccharide 
A novel yet simple extraction procedure was defined in order to obtain a final extract 
suitable for different applications, including food and biomedical manufacturing 
processes. Extraction methodology was carried out as schematically represented in 
Figure 3.1. The yield of this procedure is c.a. 10-20%.  
 
 
Figure 3. 1. Scheme for the extraction of water soluble material, namely ulvan, from 
green algae. 
Elemental analysis, presented in Table 3.1, revealed the presence of proteins and 
sulphate. These results are in agreement with the fact that the polysaccharide ulvan is 
a sulphated polysaccharide present in the cell wall of green algae, in close association 
with proteins, as described by Lahaye and Robic.8, 17  
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Table 3. 1. Elemental analysis of ulvan extracted from green algae collected at the 
portuguese coast. 
 % N % C % H % S Protein (%) 
Ulvan a 1.50±0.01 20.55±0.09 3.23±0.01 9.07±0.58 9.37 
Ulvan b 1.58±0.01 20.20±0.13 3.29±0.06 6.98±1.95 9.87 
On the other hand, we have compared the chemical elements present in two different 
batches of ulvan, in order to account the possible variability associated with the 
extraction of natural compounds. In our study, despite the existence of variability we 
can observe that the two batches of ulvan are similar. The amount of chemical 
elements and molecules, like proteins and sulphate may vary for different reasons, 
namely methodological, ecophysiological and taxonomical reasons. Nonetheless, these 
results are in agreement with past findings on the elemental characterization of 
ulvan.11, 18 
In order to further characterize ulvan extracted from green algae and to identify the 
fundamental groups present in its structure, FTIR analysis was performed. The infrared 
spectrum of this polysaccharide is given in Figure 3.2. 
 
Figure 3. 2. Infrared spectrum of ulvan between 400 and 4000 cm-1. The main 
characteristic functional groups are depicted in the graph. 
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Stretching of polymeric hydroxyl groups is identified by a broad band in the range 
3500–3200 cm-1. The presence of a carboxylic acid is revealed by a band at ~ 1650 
cm-1. This carbonyl group probably is in the form of a salt (carboxylate).5 The 
asymmetric stretching of the ether glycosidic bridge (CH–O–CH) is shown by an 
intense band around 1130cm-1. The signals in the ranges of 1315–1220cm-1 and 1140 
–1050cm-1 are assigned to the symmetric and asymmetric stretching of an ether 
sulphate group (RO–SO-3).  
1H-NMR spectroscopy is a fundamental tool when studying the chemistry of 
polysaccharides. However, due to the high number of possible disaccharide 
sequencings and distribution in addition to other possible structural irregularities, 
obtained spectra are many times intricate, which enhances the complexity of analysing 
the signals.8, 19 However if one is not intending quantification this technique can be 
used to identify the presence of sugar moieties, like iduronic acid. The choice of this 
technique over others relies on some of the relative advantages of NMR, especially on 
what concerns simplicity of sample preparation, easier calibration of the equipment, 
faster optimization of experimental protocols and less time required for experimental 
results. Despite the complexity of carbohydrate NMR spectra, information can be 
obtained about the chemical composition of the extracted polysaccharide.19-20 Proton 
NMR spectrum of extracted water soluble polysaccharide is represented in Figure 3.3.  
 
Figure 3. 3. 1H-NMR spectrum of ulvan, at 25ºC. 
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Proton signals were assigned taking into account the chemical shifts of mono and 
oligosaccharides of ulvan21 and methylation analysis14, 22 information. Table 3.2 shows 
the proton chemical shifts associated to each carbon atom present in the molecule.  
Accordingly, anomeric proton chemical shifts of iduronic acid and rhamnose 3-sulphate 
linked to iduronic acid are 5.00 and 4.92, respectively. The proton chemical shifts 
attributed to rhamnose are 4.86, 4.30, 4.52, 3.60, 4.12 and 1.30. Characteristic 
glucuronic acid chemical shifts are 4.73, 3.47, 3.72, 3.72 and 3.80. Iduronic acid proton 
chemical shifts are 5.02, 3.72, 3.82, 4.09 and 4.66.  
 
Table 3. 2. Ulvan proton chemical shifts assignments obtained through the analysis of 
1H-NMR spectrum. 
 C1 C2 C3 C4 C5 C6 
Rhamnose 4.86 4.30 4.52 3.60 4.12 1.30 
Glucuronic Acid 4.73 3.47 3.72 3.72 3.80 - 
Iduronic Acid 5.02 3.72 3.82 4.09 4.66 - 
2.2. Physical properties of extracted ulvan 
The thermal properties of ulvan extracted from green algae were investigated by 
means of thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) 
and dynamic mechanical analysis (DMA). 
Thermogravimetric analysis provides a quantitative measurement of mass change in 
materials associated with dehydration, decomposition and oxidation of a sample with 
time and temperature. Ulvan characteristic thermogravimetric curve is presented in 
Figure 3.4. 
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Figure 3. 4. Characteristic thermogravimetric curve of ulvan, recording mass loss 
versus increasing temperature, with its ﬁrst derivative. 
The initial mass loss is related to the volatilization of moisture, as hydrogen bound 
water, present in the sample, associated with desorption of bound water and 
dehydration reactions. Moisture associated with ulvan is around 20%. The first 
polysaccharidic decomposition step starts at around 220ºC. The second decomposition 
step at ~700ºC can be attributed to inorganic material present in the sample. The total 
content of ash is estimated around 20% of the initial weight of the sample. This high 
amount of ash can be attributed to counterions associated with sulphate groups and 
uronic acids of ulvan.14, 23 On the other hand, TGA is primarily used for determination of 
thermal stability of a sample. In this case, one can ascertain ulvan‟s thermal stability 
until c.a. 200oC.  
In order to identify thermal transitions of ulvan, differential scanning calorimetry was 
employed. The thermal performance of this polysaccharide is depicted in Figure 3.5.  
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Figure 3. 5. Thermogram of ulvan, on heating: ﬁrst heating scan (straight line) and 
second heating scan (dash line) (Endo up). 
Two transitions were detected in the samples scanned in a temperature range of -20oC 
to 180oC. The major transition is associated with a large endothermic peak detected at 
about 120ºC. This peak is not detected in the second run and therefore can be 
attributed to absorbed moisture (water), which is in agreement with the data recorded 
in TGA. The observation of this endothermic peak has already been reported by 
different authors for various polysaccharides.24-25 
A less pronounced thermal transition is observed at 5ºC. This shoulder in the DSC 
trace is still detected in the second run and the nature of this low temperature transition 
is still not understood. It may be associated with a small quantity of ice, which is in 
agreement with the presence of bound water. As in many unmodified polysaccharides, 
like chitosan26, ulvan undergoes thermal degradation prior to melting, as observed in a 
melting point meter (data not shown). 
The presence of the glass transition in ulvan is not clear or not observed in this DSC 
study. In some cases, differential scanning calorimetry may not be sensitive enough to 
detect the relaxation temperature of semi-crystalline polysaccharides. Consequently 
and in order to further understand the thermal transitions detected in DSC experiments, 
dynamic mechanical analysis was performed. Until recently, DMA was only used to 
study self-supporting materials. However, it is now possible to apply this technique in 
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the study of powders27 and in order to effectively detect their thermal transitions, like 
glass transition. Figure 3.6 shows the resulting thermogram for ulvan at 1Hz. 
 
 
Figure 3. 6. Ulvan thermogram obtained from DMA, at 1Hz: tan δ (straight line) and 
storage modulus (dashed line). 
It can be observed a peak for tan δ at around 30ºC and it may be related with the low-
temperature transition, previously identified by DSC (around 5ºC). As DSC and DMA 
measure different processes, the difference in readings can be of as much as 25ºC in 
data. Another thermal transition was also detected at around 130ºC. We believe that 
this is associated with water loss and it is in agreement with previous findings reported 
by the TGA and DSC studies.  
XRD analysis was applied to determine the crystallinity degree of extracted ulvan. The 
XRD pattern of this polysaccharide, presented in Figure 7, is typical for a semi-
crystalline polymer and shows five major crystalline reflections at 13.1o, 23.2o, 26.4o, 
32.6o and 39.4o. 
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Figure 3. 7. X-ray diffractogram of ulvan powder. 
 
3. Discussion 
A novel procedure was studied and applied to extract water soluble ulvan from green 
algae. Different procedures were described in the literature for the extraction of 
sulphated polysaccharides from green algae.7, 12-13, 17, 28 According to the intended 
application of the final extracted polysaccharide, different processes must be used 
depending on the envisaged purity degree of the polymer, which is especially relevant 
in the case of human related applications. Chemical characterization by chemical 
analysis, infrared and 1H-NMR spectroscopy indicate that the structure of the obtained 
acidic sulphated polysaccharide is similar to that of ulvan already reported in the 
literature. The extracted water soluble polysaccharide IR spectrum (Figure 3.2) is 
comparable with the obtained spectra of ulvan.14, 29 This fact demonstrates that the 
proposed extraction process is able to maintain ulvan structure and provides a good 
indication that its intrinsic properties are also preserved. FTIR (Figure 3.2) and 1H-NMR 
(Figure 3.3) results also reveal the polysaccharidic nature of the obtained water soluble 
ulvan, as well as the presence of rhamnose and uronic acids, with sulphate groups, as 
previously found for ulvan. The molecular structure of the extracted polysaccharide can 
therefore be inferred as the one already proposed for ulvan and it is depicted in Figure 
3.8.21 
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On the other hand, and accounting with the variability associated to the extraction of 
natural origin molecules, we can observe similarity within different ulvan batches 
extracted with the method proposed in the present study. 
 
Figure 3. 8. Molecular structural motif constituent of ulvan. 
Besides chemical characterization, physical properties are relevant to establish the 
processability of a polymeric material and their potential use in consumer oriented 
applications. For example, in many preparation and processing methodologies, 
polysaccharides must be submitted to high temperatures. In this context, thermal 
characterization is an important step for the study of thermal transitions, which may 
reveal important information concerning the adequate temperature intervals compatible 
with the processing of materials based on ulvan. Up to date, there are no reported 
results focusing the thermal events occurring in this polysaccharide. 
Thermogravimetric analysis is a simple and accurate method for studying the 
decomposition pattern and the thermal stability of polymers. Parikh described, in 2006, 
thermal degradation of polysaccharide as a four step process:  
(1) Desorption of physically absorbed water;  
(2) Removal of structural water (dehydration reactions);  
(3) Depolymerisation accompanied by the rupture of C-O and C-C bonds in the ring 
units resulting in the evolution of CO, CO2 and H2O;  
(4) Formation of polynuclear aromatic and graphitic carbon structures.30 
According to the thermogravimetric present results (Figure 3.4), ulvan undergoes 
thermal degradation in a very typical manner. On the other hand, ulvan is thermally 
stable until c.a. 200ºC. Villetti and co-workers studied the thermal degradation 
mechanisms of different natural polymers and observed that polyanions, like sodium 
hyaluronate and xanthan, possess low thermal stability in comparison with neutral 
polysaccharides, like methylcellulose.31 
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To further understand the thermal behaviour and transitions occurring in ulvan, DSC 
was performed. Ulvan thermogram in Figure 3.5 exhibits a major transition around 
120ºC. A peak in tan δ was also detected by DMA in this temperature range, at around 
130ºC (Figure 3.6). This transition could be associated with loss of water, being 
consistent with the hydrophilic nature of ulvan functional groups; the presence of this 
peak can also reveal the existence of bound water.32-33 Morelli and co-workers have 
identified this event as the glass transition of ulvan.34 However, in the present case, a 
vitreous transition should have been observed during a second heating run, which does 
not occur. Based on these findings, such event will not be regarded as a glass 
transition.  
A less pronounced thermal transition is observed at 5ºC by DSC (Figure 3.5) that could 
also be associated to the process detected by DMA at 30ºC (Figure 3.6). In order to 
better understand this thermal event, the Arrhenius equation was applied to calculate 
its activation energy. 
         
  
   
  
f is the applied frequency, A is a constant, R is the universal gas constant and T is the 
peak maximum temperature of the tan δ peak. Plotting the natural logarithm of the 
frequency against the inverse of the observed peak temperature gave a linear 
relationship with a regression coefficient of 0.98 (data not shown) and an activation 
energy of 248 kJ/mol. Such value is in the order of the activation energy found for the 
glass transition of polymeric systems.35 However, the low intensity of the tan δ peak 
suggests that this process should occur in a small fraction of the analysed polymeric 
system, for example, due to the presence of some impurities in the sample, and may 
not be related to the polysaccharide itself. In light of the present results, both DSC and 
DMA experiments did not allow the identification of a clear occurrence of a glass 
transition in ulvan in the temperature interval analysed. Many times, the direct 
identification of a glass transition temperature in polysaccharides can be a delicate 
task, mostly because the temperature range at which the main relaxation occurs is 
close to the degradation temperature of the material, as is the case of amorphous 
cellulose.36 Other factors as water-polysaccharide interactions can also increase 
complexity in identifying glass transition in polysaccharides. Nonetheless, thermal 
behaviour and the associated reactions occurring over specific temperature ranges and 
heating rates represent a unique sequence for each material. The distinctive 
characteristics unveiled in this work represent ulvan thermal performance, which are 
believed to be intimately related to its molecular structure. 
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From the the x-ray diffractogram of ulvan (Figure 3.7), the semi-cristalline nature of this 
polysaccharide was revealed. This indicates that the amorphous component of ulvan 
dominates over the crystalline organized one. This structural arrangement directly 
affects different properties such as tensile strength, flexibility, solubility, swelling or 
opaqueness of the bulk polymer, as physical properties are dependent on the degree 
of order within the material.36 
Ulvan is water soluble and hygroscopic hydrocolloid, as seen by the presence of bound 
water and due to the hydrophilic nature of some of its functional groups. This property 
is also related with the semi-crystalline nature of this polysaccharide. In fact, the 
crystalline structure includes a fixed number of water molecules, while the amorphous 
zones accommodates an increasing amount of moisture depending on the water 
activity of the atmosphere where the samples are being equilibrated.37 This particular 
feature is an important character for many consumer oriented applications, as in food 
industry, or to improve polymer processing. 
A table summarizing ulvan‟s properties is depicted in Table 3.3. 
 
Table 3. 3. General properties of ulvan extracted from green algae. 
Properties 
Functional Groups -COO(H), -OH, -OSO(4) 
Colour White 
Protein cc. 9 – 10% 
Sulphate cc. 9 – 10% 
Moisture cc. 20% 
Ash cc. 20% 
Solubility Water Soluble 
Hygroscopy Hygroscopic 
Thermal Stability Until cc. 220
o
C 
Melting Temperature Non-meltable 
Glass Transition Not detected 
Crystallinity Semi-crystalline 
Ulvan can be considered for itself as a versatile and promising biodegradable polymer 
to be used in different areas, ranging from health care to different industrial 
applications. Its functional properties are expected to be improved by physical or 
chemical modifications, like complexation with other polymeric materials, chemicals or 
salts or modifications introduced in the polysaccharidic chain.  
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4. Conclusions 
The scope of this paper was twofold. First, the main goal was to establish a new and 
simple method of extracting ulvan from green algae. Secondly, the work herein 
presented was carried out in order to gain a better understanding on the extracted 
polysaccharide ulvan, in order to define its potential applications. However, apart from 
the relevance of any fundamental study of polysaccharides, this study contributes to 
unravel the physical properties of ulvan and its technical use. Up to date, there are no 
reported results regarding the thermal transitions occurring in the polysaccharide ulvan 
and information related with its crystallinity. In the present study, it was possible to 
conclude that ulvan is a non-meltable semi-crystalline polysaccharide, which is 
thermally stable before degradation at 220 ºC. 
 
5. Materials and methods 
5.1. Extraction of ulvan polysaccharide 
Soxhlet extraction of dried Ulva sp. with organic solvents removed most of the lipids 
and colouring matter which otherwise would contaminate the water extract. The 
residual off-white weed was dried and subjected to three hot water extractions, each 
with c.a. 0.5l, for a total of 8h at 75-85ºC, on a boiling-water bath, under continuous 
stirring. After filtration through a cotton cloth, the aqueous extracts were centrifuged, 
and the liquid supernatant was filtered. The water extract was concentrated until 10-
20% of its initial value, in a rotary evaporator. The derived solution was then 
deproteinized by proteinase digestion, with proteinase K. Afterwards, the solution was 
decolorized and deodorized by adsorption on activated charcoal. The water extract was 
centrifuged, filtered and precipitated with 4 vol. of absolute ethanol. Finally, the 
recovered precipitate was freeze dried. Yield of a white polysaccharide resulting from 
this extraction methodology is c.a. 10 – 20%. 
5.2. General methods 
Elemental analysis (% C, H, N and S content) was performed by combustion to 
evaluate the content of the major components present in the extracted analyte. A Carlo 
Erba CHNS-O EA 1108 apparatus was used.  
Proteins were measured as nitrogen content through Kjedhal analysis.38 According with 
this method, it is possible to calculate the amount of crude protein (CP) in the sample 
by multiplying the percent nitrogen (N) by a conversion factor (6.25), through the 
following equation. 
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To assess the chemical constituents of the extracted polysaccharide, powder was 
analyzed by infrared spectroscopy (FTIR) in transmission mode using a IR Prestige-21 
apparatus (Shimadzu, Japan). Pre-dried powder was mixed with KBr and then formed 
into a disc by manual pressing. Transmission spectra were recorded using at least 32 
scans with 4 cm-1 resolution in the spectral range of 4,000 – 400 cm-1. 
1H-NMR spectrum of pre-dried polysaccharide dissolved in D2O was recorded on a 
Varian Unity Plus spectrometer (Varian, USA), at 25ºC. 
For TGA, a small amount (15-18mg) of powder was taken for analysis in a Perkin 
Elmer TGA7 (Perkin Elmer, USA). The samples were heated from 40 to 720°C at a rate 
of 10°C min-1 in nitrogen atmosphere.  
DSC experiments were carried out using TA-Q100 equipment (TA Instruments, USA). 
The experiments were conducted, under a nitrogen atmosphere, on samples (5-10mg) 
packed in aluminium pans. The samples were heated in two stages at a constant 
heating rate of 20ºC/min from -20oC up to 180ºC, then were left at this temperature for 
a period of 2 min and cooled at -20ºC/min to the initial temperature. At this point a 
second heating run was conducted. An empty aluminium pan was used as reference. 
In the present work, DMA (TRITEC 8000B DMA apparatus, Triton, UK) was used to 
investigate the viscoelastic properties of the analyte. Stainless steel pockets, provided 
by the DMA manufacturer, for these specific measurements (length = 15mm, 
width = 7.5mm, thickness = 1 mm) were used to fix the powder material into the DMA 
loading frame. Such pocket devices are especially useful to analyse powder materials 
and more details about the protocols for their use can be found elsewhere.27 The 
pockets filled with the sample were subjected to sinusoidal loading under Single 
Cantilever Bending mode conditions. The load was automatically adjusted in order to 
achieve an imposed displacement equal to 0.05mm. The measurements were 
performed at frequencies of 1, 5, 7.5 and 10Hz over the temperature range between 
20°C to 140°C at 2°C/min at each frequency. Note that the storage modulus that is 
given by the apparatus is basically resulting from the properties of the metallic 
component. However, any change in the viscoelastic properties of the sample will be 
detected in the tan δ trace. 
X-ray diffraction (XRD) patterns were measured using a powder diffractometer Philips 
PW1710 apparatus (Philips, The Netherlands) operated in step scan mode (1.542Å 
wavelength). The diffraction data was acquired at a rate of 0.02º 2/s and over a Bragg 
angle range of 10º<2<50º.  
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In vitro cytotoxicity assessment of ulvan, a polysaccharide 
extracted from green algae 
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Abstract 
Sustainable exploitation and valorisation of natural marine resources represents a 
highly interesting platform for the development of novel biomaterials, with both 
economic and environmental benefits. In this context, toxicity data is regarded as a 
crucial and fundamental knowledge prior to any advances in the application 
development of natural derived polymers. In the present work, cytotoxicity of ulvan 
extracted from green algae Ulva lactuca was assessed by means of standard in vitro 
cytotoxicity assays. Fibroblast-like cells were incubated in the presence of this green 
algae‟s polysaccharide and cell viability was assayed through 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) test. In 
addition double stranded DNA and total protein were quantified in order to assess cell 
number. In order to establish ulvan‟s non-cytotoxic behaviour, the effect of this 
polysaccharide on cellular metabolic activity and cell number was directly compared to 
hyaluronic acid, used as a non-cytotoxic control material. In this study, ulvan 
demonstrated promising results in terms of cytotoxicity, comparable to the currently 
used hyaluronic acid, which suggests that ulvan can be considered as non-toxic in the 
range of concentrations studied.  
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1. Introduction 
Living organisms are rich in carbohydrates. The wide chemical and functional diversity 
of these molecules is related with a rather large source base, which ranges from 
microbial to animal origin. Carbohydrates that form the structural basis of algae 
represent a unique group of gel-forming and viscous polymers, which are neither found 
in higher plants nor digestible by non-ruminant animals.1 Industrial and technological 
applications of these marine carbohydrates include, among others, food industry, 
aesthetics or biomedical devices. In fact, the use of natural origin polymers on the 
development of novel biomaterials has already proven its feasibility and applicability, 
particularly in medical related areas, including tissue engineering applications.2-6 
Being largely unexploited, green algae possess remarkable potential for 
biotechnological development. Ulvan is a sulphated polysaccharide present in the cell 
wall of these algae and it is mostly composed of rhamnose, glucuronic acid, iduronic 
acid and xylose.7-9 Regardless of the properties of this polysaccharide10-15, the lack of 
adequate data on the safety of ulvan, as that derived from standard toxicological 
studies, limits its applicability as a consumer oriented product. This is especially 
relevant when biomedical applications are envisioned, such as the use of ulvan as a 
biomaterial for tissue engineering and regenerative medicine purposes. Furthermore, 
and apart the study of physicochemical features, evaluation of the cytotoxic 
performance of any emergent polysaccharide extracted from a natural resource 
represents a crucial step in its research and development. In this context, 
biocompatibility assessment must be performed in order to attain information on ulvan‟s 
cytotoxicity and appraise its application potential in sectors where consumer oriented 
applications are envisaged. This is especially important, as ulvan‟s intrinsic properties 
may justify its application, in some industrial areas, without high levels of manipulation 
or significant modification of its native structure. One notable characteristic of ulvan is 
the presence of rare sugars within its backbone, namely sulphated rhamnose and 
iduronic acid. The presence of iduronic acid is unusual as this sugar residue has never 
been identified in algal polysaccharides and it is an important constituent of mammalian 
glycosaminoglycans, including heparin and chondroitin sulphate.16-17 Furthermore, the 
presence of sulphate groups and the unusual chemical composition and structure of 
ulvan grants different biological properties to this green algae‟s polysaccharide.11, 18-26 
In this context, it is easy to envisage the use of this polysaccharide in areas such as 
the pharmaceutical or the biomedical one. 
In vitro cytotoxicity procedures have proven to be effective in the screening of human 
chemical toxicity.27 In standard cytotoxicity tests, the sample is incubated in direct 
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contact with a layer of cells, usually from a cell line, for a period of at least 24 hours, 
side by side with positive and negative controls.28 This is considered an effective 
method to evaluate and predict the cytotoxicity and the behaviour of a material in the 
body, since there is no barrier between the material in study and the cell layer.27 The 
effect of the presence of a foreign agent on cellular homeostasis may be detected by 
the disturbance of normal cellular biochemical functions; this knowledge is the basis of 
many standard toxicological studies.29-30 In this regard, available commercial assays 
are based on the measurement of different biochemical functions like the double-
stranded DNA quantification (dsDNA), and protein content, through total protein 
quantification, in order to quantify cellular proliferation; metabolic viability can be 
determined by mitochondrial activity, through MTS assay, and membrane integrity, 
assayed through lactate dehydrogenase assay.30 Loss of viability, reduced proliferation 
rate or cell membrane rupture represents critical consequences generated by a toxic 
biomaterial.31  
In order to assess the intrinsic cytotoxic behaviour of ulvan extracts, different standard 
cytotoxic strategies were followed, including the evaluation of cellular viability by MTS 
test and number, through dsDNA and total protein quantification. Furthermore, 
biological performance of ulvan is evaluated and compared to hyaluronic acid. This 
polysaccharide is used as a non-cytotoxic control material and it is a well established 
polysaccharide used in diverse industrial applications, including the biomedical field.32 
 
2. Materials and methods 
2.1. Materials 
Unless otherwise stated, all reagents were purchased from Sigma-Aldrich (Germany). 
Ulvan was extracted from the green algae Ulva lactuca. Unless otherwise stated, these 
algae were supplied by Setalg (France) as dry flakes with a moisture content ≤15%. 
Uvan was obtained by extraction from Ulva lactuca using a procedure described by the 
authors elsewhere.33 In summary, Soxhlet extraction of dried Ulva lactuca removed 
most of the lipids and colouring matter. The residual off-white weed was dried and 
subjected to three hot-water extractions, between 75-85ºC. After filtration through a 
cotton cloth, the aqueous extracts were centrifuged, and the liquid supernatant was 
filtered. The water extract was concentrated until 10-20% of its initial value, in a rotary 
evaporator. Starch and proteins were removed by enzymatic digestion. Afterwards, the 
solution was decolorized and deodorized by adsorption on activated charcoal. The 
water extract was centrifuged, filtered and precipitated with 4 vol. of absolute ethanol. 
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Finally, the recovered precipitate was freeze dried. Yield of a white polysaccharide 
resulting from this extraction methodology is c.a. 10 – 20%. 
Characterization of the extracted polysaccharide revealed different physicochemical 
properties which are summarized in Table 4.1.34 
 
Table 4. 1. According to Costa and co-authors34, properties and composition of ulvan 
extracted from the green algae Ulva lactuca can be summarized as follows. 
Ulvan extracted from Ulva lactuca  
Molecular weight 790 kDa 
Protein 1.3% 
Sulphate 32.2% 
Sulphate free inorganic material 10.3% 
Rhamnose 22.4% 
Glucuronic Acid 22.5% 
Xylose 3.7% 
Iduronic Acid 3.1% 
Glucose 1% 
2.2. Fourier transform infrared spectroscopy (FTIR) 
Extracted polysaccharide powder was analyzed using an IR Prestige-21 apparatus 
(Shimadzu, Japan). Pre-dried powder was mixed with potassium bromide (KBr), in a 
mixing ratio of 1:10 of sample:KBr (w/w), and formed into a transparent pellet by 
manual uniaxial pressing. Transmission spectra were recorded using at least 32 scans 
with 4 cm-1 resolution in the spectral range of 4000 – 400 cm-1. 
2.3. Cell line 
Mouse C3H/An connective tissue fibroblast-like cells (L929) were obtained from the 
European Collection of Cell Cultures (ECCC, UK). L929 cells between passages 8 and 
10 were used to perform the biological studies. 
2.4. Cell culture 
Cells were cultured in tissue culture flasks at sub-confluent cell density in Dulbecco‟s 
modified eagle medium (DMEM) supplemented with sodium bicarbonate (44 mM) 
(Sigma–Aldrich, Germany), 10% fetal bovine serum (Alfagene, USA) and 1% of 
antibiotic-antimycotic solution (Gibco, UK). Cultures were maintained at 37°C, in a 
humidified tissue culture incubator with a 5 % CO2 atmosphere. Medium was renewed 
every 2-3 days. 
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2.5. Polymer solutions preparation 
Cytotoxicity of extracted ulvan was evaluated according to ISO/EN 10993 part 5 
guidelines28 for an exposure period of 24h. Cytotoxicity assays were performed using 
latex rubber and standard culture medium as positive and negative controls, 
respectively. Latex rubber is commonly used as a positive control for standard 
toxicological assays, as it is known to have a cytotoxic effect inducing cell death and 
lysis.35 Hyaluronic acid (HA), was additionally used as a non-cytotoxic reference 
material. 
Ulvan and hyaluronic acid were dissolved in DMEM supplemented with sodium 
bicarbonate (44 mM), 10% FBS and 1% of antibiotic-antimycotic solution. Fresh stock 
solutions of ulvan and hyaluronic acid were prepared and diluted to the final test 
concentrations, in order to obtain polymer solutions with concentrations between 0 and 
15 mg/ml.  
2.6. MTS assay 
The effect on cell viability of exposure to different polymer solutions for a period of 24 h 
was determined by colorimetric MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay, using CellTiter 96® 
AQueous One Solution Reagent (Promega, USA). Briefly, cells were seeded onto 96-well 
plates at a concentration of 5x103 cells per well. After 24 h, medium and unattached 
cells were removed and polymer solutions were added. Culture medium without any 
polysaccharide was used as negative control and it is represented as 0 mg/ml. Cells 
were incubated in the presence of the different samples for an additional 24 h period. 
Three replicates were considered for each sample. After the defined time of exposure, 
medium was discarded from each well and the cell monolayer was washed twice with 
sterile phosphate buffered saline (PBS) solution. Cells were exposed to tetrazolium 
solution (MTS), following manufacturer‟s protocol, which allowed for viable cells to 
reduce the tetrazolium compound into a water soluble formazan product. Optical 
density at 490 nm was measured with a microplate reader (Synergie HT, Bio-Tek, 
USA).  
2.7. dsDNA quantification 
As for the MTS test, after cellular confluence the culture medium was replaced by 
polysaccharide solutions. Three replicates were considered per sample. Culture 
medium without any polysaccharide was used as negative control (represented as 0 
mg/ml). After 24h of incubation media was discarded from each well and the cell 
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monolayer was washed twice with sterile PBS solution. Cell proliferation was measured 
by the total amount of double-stranded DNA and quantiﬁcation was performed using 
the PicoGreen dsDNA Assay Kit (InvitrogenTM, Molecular ProbesTM, USA), according to 
the manufacturer‟s instructions. In brief, cell monolayer was lysed by osmotic and 
thermal shock and the supernatant used for DNA quantiﬁcation. Fluorescence was 
measured at an excitation wavelength of 485/20 nm and at an emission wavelength of 
528/20 nm, in a microplate reader (Synergie HT, Bio-Tek, USA). DNA concentration for 
each sample was calculated using a standard curve of lambda DNA relating DNA 
concentration (ranging from 0 to 1.5 μg ml−1) and ﬂuorescence intensity. 
2.8. Total protein quantification 
As for the dsDNA quantification, after reaching confluence the culture medium was 
replaced by the polysaccharide solutions. Three replicates were considered per 
sample. Culture medium without any polysaccharide was used as negative control (0 
mg/ml). After 24h of incubation media was discarded from each well and the cell 
monolayer was washed twice with sterile PBS solution. From this point on, Micro 
BCATM Protein Assay Kit (Pierce Chemical, USA) was used, following manufacturer 
instructions. In summary, cells were exposed to a working solution containing 
bicinchoninic acid (BCA) as detection reagent for Cu+1, which is formed when Cu+2 is 
reduced by proteins, producing a purple reaction product. Optical density at 562 nm 
was measured using a microplate reader (Synergie HT, Bio-Tek, USA). A standard 
curve was created and sample protein values were read off from the standard graph. 
Albumin solutions were used as standards (0 to 200 µg/ml). Plotting the measured 
absorbance against albumin concentration allowed the calculation of protein 
concentration.  
2.9. Statistical analysis 
Statistical analysis was performed using the GraphPad Prism statistic software 
(Release version 5 for Windows). Initial statistical results indicated that nonparametric 
tests should be used for all comparisons. Therefore, the effect of the test 
polysaccharides over L929 metabolic activity and cell number was evaluated by 
Kruskal–Wallis test followed by Dunn‟s test for multiple comparisons. Direct 
comparisons between polysaccharides were made by Mann-Whitney test. Statistical 
significance was defined as p<0.05. 
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3. Results 
Ulvan is a high molecular weight sulphated polysaccharide composed of rhamnose, 
glucuronic acid, xylose, iduronic acid and glucose. Ulvan is present in the cell wall of 
green algae, in close association with proteins and methods of extraction and 
purification, with a specific deproteinization protocol are not completely effective, as the 
presence of proteins are still detected.33-34 
FTIR characterization confirmed the presence of the constituent functional 
characteristic if this polysaccharide. 
 
Figure 4. 1. Infrared spectrum of ulvan between 400 and 4000 cm-1. 
Figure 4.1 demonstrates a typical infrared spectrum of ulvan, characterized by signals 
with different intensities corresponding to 3500, 1650, 1400, 1250 and 1070 cm-1.36-37 
Stretching of polymeric hydroxyl groups ubiquitous within ulvan‟s backbone is identiﬁed 
by a broad band in the range of 3500 – 3200 cm-1. Carboxylate groups are revealed by 
asymmetrical stretching band at 1650 cm−1 and symmetric stretching band at 1400 
cm−1.33, 37 The region corresponding to 1200 – 1000 cm−1 is characteristic of 
polysaccharides and corresponds to sugar ring vibrations, stretching of C–OH and 
vibration of the ether glycosidic bridge (CH–O–CH).37 Stretching of ether sulfate groups 
(RO–SO-3) is represented by a band at about 1250 cm−1.36 
The main objective of the present study is focused on the evaluation of the cytotoxic 
behaviour of ulvan, reinforced by direct comparison with hyaluronic acid. 
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In the present research work, cells were cultured in the presence of ulvan, in different 
concentrations, and subsequently submitted to different assays in order to ascertain on 
the cytotoxicity of this polysaccharide. Cellular metabolic activity and number were 
chosen to assess the cytotoxicity of different ulvan solutions with increasing 
concentrations. Cell metabolic activity is commonly assessed through MTS assay and 
cell number and proliferation by dsDNA and/or total protein quantification. The result of 
these assays represents a good indicator of cytotoxicity of a material, as they 
characterize metabolism and growth of a cell population.  
In order to assess and understand ulvan‟s cytotoxicity, its cytocompatibility was 
evaluated and compared with hylauronic acid. Taking into account the non-cytotoxic 
character of hyaluronic acid, this study aimed at comparatively assessing in vitro 
performance of ulvan and authenticating its non-cytotoxic behaviour. 
Cellular viability upon exposure to different concentrations of ulvan, evaluated as 
metabolic activity (Figure 4.2), indicates that this natural origin polysaccharide does not 
induce a detrimental effect on the metabolic activity of cells. As expected, the same 
result is observed for hyaluronic acid. However, it appears to be an effect related with 
concentration for both these polysaccharides. Cells cultured in the presence of different 
concentrations of these polysaccharides demonstrate equal or higher metabolic activity 
when compared with negative control (culture medium without the addition of the test 
sample). In the particular case of ulvan, lower concentrations (0.25, 0.5 and 0.75 
mg/ml) induce a significant increase in metabolic activity, which is not observed for 
higher concentrations (1, 1.25 and 1.5 mg/ml). This increase in metabolic activity of 
L929 cells exposed to ulvan results in a significant difference on the metabolism of 
these cells towards the ones exposed to hyaluronic acid, particularly for ulvan 
concentrations ranging from 0.25 to 1 mg/ml. For hyaluronic acid, this stimulating effect 
is observed for all test concentrations.  
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Figure 4. 2. Box plot of L929 metabolic activity exposed to two polysaccharides, ulvan 
and hyaluronic acid. Data were analyzed by nonparametric Mann Whitney and Kruskall 
Wallis tests: §) denotes significant differences compared with the negative control 
(0mg/ml) and #) denotes significant differences compared with hyaluronic acid with the 
same concentration. 
Increased metabolic activity observed for cells exposed to ulvan correlates well with the 
number of cells evaluated through dsDNA quantification (Figure 4.3), which is 
significantly higher than the one observed in the negative control (for concentrations 
0.25, 0.5, 0.75 and 1mg/ml). In the particular case of hyaluronic acid, increased 
metabolic activity observed in MTS results, is not associated with an increase in the 
number of cells exposed to different concentrations of this polysaccharide, except for 
concentration 0.75mg/ml. Some of the differences observed between the metabolic 
activity of cells exposed to ulvan with the one observed for hyaluronic acid can be 
correlated with cellular number, which is higher for ulvan than for hyaluronic acid, for 1 
and 1.5 mg/l. 
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Figure 4. 3. Box plot of L929 dsDNA concentration exposed to two polysaccharides, 
ulvan and hyaluronic acid. Data were analyzed by nonparametric Mann Whitney and 
Kruskall Wallis tests: §) denotes significant differences compared with the negative 
control (0mg/ml) and #) denotes significant differences compared with hyaluronic acid 
with the same concentration. 
Despite the differences observed in cellular number, quantified as dsDNA 
concentration, for various ulvan concentrations in relation to the control, these are not 
reflected in protein content (Figure 4.4).  
Although differences between both polysaccharides relative to protein content are also 
detected, in this particular case, the majority of the observed significant differences are 
related with higher protein content in cells exposed to hyaluronic acid (0.75, 1, 1.25 and 
1.5 mg/ml). 
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Figure 4. 4. Box plot of L929 protein concentration exposed to two polysaccharides, 
ulvan and hyaluronic acid. Data were analyzed by nonparametric Mann Whitney and 
Kruskall Wallis tests: §) denotes significant differences compared with the negative 
control (0mg/ml) and #) denotes significant differences compared with hyaluronic acid 
with the same concentration. 
 
4. Discussion 
Nowadays, polysaccharides are the focus of attention in many areas of knowledge. 
Among these, marine origin polysaccharides are playing a central role, as the marine 
environment represents an open source of attractive molecules with potential 
applicability in many fields of interest. Examples of these are chitin and its derivative 
chitosan, alginate, carrageenan, agar, collagen, among others.38-43 However, prior to 
any development towards specific applications, polysaccharides should undergo 
cytotoxicity screening. 
When consumer oriented applications, like food, pharmaceutical and biomedical, are 
envisaged, evaluation of the cytotoxicity of a polymer assumes a crucial importance, 
especially when the polymer in focus is a natural extract. In this sense, ulvan 
cytotoxicity was evaluated and validated by comparison with hyaluronic acid. Applying 
MTS test, L929 cells produced large amounts of a brown formazan product upon 
incubation with different concentrations of ulvan, which indicates normal cell 
metabolism and normal mitochondrial integrity and activity that can be interpreted as a 
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direct measure of cell viability. In this regard, observed increased metabolic activity 
induced by low concentrations of ulvan can only mean one of two things – proliferation 
or an increase in metabolic activity without cell proliferation.44 In the particular case of 
ulvan, it is observed an increase in metabolism of L929 cells with significant changes in 
cellular number (indicated by significant increases on dsDNA concentration), with 
influence of polysaccharide concentration. In the case of hyaluronic acid, the same 
observations are valid; only in this case, the majority of differences observed in cell 
number are detected with protein content. This is to say that cells are metabolic active 
and viable and are also able to grow in the presence of both polysaccharides. As 
mentioned before, dsDNA and protein quantification assays can be correlated to the 
number of cells and provide an indication on cellular proliferation.45-46 However, in the 
present study, both assays result in different effects. A possible explanation for these 
results may lay on the nature of each test; nevertheless both these tests point to a non-
cytotoxic behaviour of both polysaccharides, as already observed with MTS results. In 
this regard, cells appear to retain normal metabolism and growth after exposure to a 
range of both polysaccharides‟ concentrations and there appears to be a dose-
dependent effect. In fact, a significant increase in the number of cells exposed to some 
concentrations of ulvan and hyaluronic acid, correlated with an increase in metabolic 
activity, can be observed by comparison with the negative control. This may indicate 
that both these polysaccharides may exert an estimulating effect on cellular 
proliferation. The basis for these observations is beyond the scope of this study; 
however one could infer about the correlation of this effect with the inherent biological 
properties associated with each polysaccharide. In the particular case of hyaluronic 
acid, a stimulatory effect towards cellular proliferation has already been noticed in 
different studies.47-48 For example, Ehlers and co-workers found that hyaluronic acid 
added to culture medium induced a dose-dependent effect on the growth and 
differentiation of human chondrocytes in culture.48  
In the present study, an assessment of ulvan‟s cytotoxicity was performed and results 
indicate that cellular viability is not impaired by the presence of ulvan, although a dose-
dependent effect on cellular metabolism is observed. The same results are observed 
for hyaluronic acid. In this context, it is possible to infer on ulvan‟s non-toxic behaviour. 
Unravelling the non-cytotoxic nature of ulvan extracted from green algae will favour the 
exploitation and development of this natural polysaccharide, particularly for consumer 
oriented applications. The interest in algae origin polysaccharides with novel structures 
and interesting biological effects for innovative applications is increasing. However, 
green algae remain largely unexploited in these areas, in comparison with other algae 
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polysaccharides, including alginate, agar and carrageenan. These are recognized and 
worldwide accepted polysaccharides for diverse applications, including food and 
biomedical uses.1, 6, 42, 49-51 Nevertheless, ulvan is revealing noteworthy potential to be 
effectively applied in these highly demanding fields.  
 
5. Conclusions 
Based on data herein reported, ulvan extracted from green algae proved to be 
cytocompatible, within the test conditions. Our results also reinforce the effectiveness 
of the applied extraction procedure, yielding a polysaccharide with good biological 
performance. These findings are further validated by the comparison with hyaluronic 
acid. Ulvan demonstrates its merit as a promising polysaccharide candidate for 
biomedical related applications. Data justifies further research on the intrinsic 
characterization and performance evaluation of this polysaccharide. 
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SECTION IV – PROCESSING OF ULVAN EXTRACTED FROM 
GREEN ALGAE INTO DIFFERENT STRUCTURES SUITABLE FOR 
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Processing ulvan into 2D structures: cross-linked ulvan 
membranes as new biomaterials for drug delivery applications 
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Abstract 
The polysaccharide ulvan, composed of sulphated rhamnose, glucoronic and iduronic 
acids was used to produce polymeric membranes by solvent casting. As ulvan is 
soluble in water, a cross-linking step was necessary to render the membrane insoluble 
in water and stable at physiological conditions. Cross-linked ulvan membranes were 
characterized by Fourier transform infrared spectroscopy, scanning electron 
microscopy, swelling behaviour was investigated and the mechanical performance 
assessed by quasi-static tensile testing. Furthermore, the ability and mechanism of 
sustained release of a model drug from ulvan membranes was investigated. Produced 
membranes revealed remarkable ability to uptake water (up to ~1800% of its initial dry 
weight) and increased mechanical performance (1.76MPa) related with cross-linking. 
On the other hand, medicated ulvan dressings demonstrate the potential as drug 
delivery devices. Using a model drug we have observed an initial steady release of the 
drug - of nearly 49% - followed by slower and sustained release up to 14 days.  The 
properties of ulvan membranes herein revealed suggest a great potential of this natural 
sulphated polysaccharide as a wound dressing.   
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1. Introduction 
Wound dressings are widely applied for the treatment of different wounds such as 
burns, trauma and diabetic ulcers among others.1-2 Currently commercial available 
wound dressings can be made of a wide range of materials including polyurethane (Ex: 
PolyMem®) or gelable polysaccharides, such as starch (Ex: Iodosorb®) and 
carboxymethylcellulose (Ex: Aquacel®).1-4 The abundance of available dressings is 
largely related with the demand of an effective management of the different types of 
wounds. Furthermore, the complexity of the wound healing process per se may require 
the use of several types of dressings, including medicated dressings.1 These in 
particular are meant to provide a sustained delivery of a therapeutic agent for a desired 
period of time providing aid in the treatment, management (including pain) and 
eventual healing of a wound.1  
Different materials are chosen to produce these systems, ranging from natural to purely 
synthetic polymers. In this context, natural origin materials may offer advantages with 
respect to biodegradability, biocompatibility and wide availability.5 Among the diversity 
of proposed nature origin biomaterials, marine derived polysaccharides are already 
being investigated for wound dressing applications, namely chitosan and/or alginate.6-8 
In the present study, we have focused our research on ulvan. This rather unexploited 
polysaccharide is anionic, water soluble, sulphated and semi-crystalline.9 Green algae, 
namely Ulva the common sea lettuce, are frequently involved in algal proliferation in 
eutrophicated coastal and lagoon waters.10 This biomass has diminished associated 
value and is either employed into compost production or simply dumped.11 Ways to use 
and add value to this biomass could be based on specific properties of their cell-wall 
polysaccharides and their application in high technological areas of knowledge, 
including the biomedical field. The exploitation of ulvan as an alternative to different 
synthetic or animal origin polymers would benefit of its algal origin, bioavailability and 
low expected production costs as well as associated biological activities. In fact, 
unmodiﬁed ulvan possesses interesting properties that can be directed towards highly 
demanding application areas like the pharmaceutical or food industry.12-14 However, 
some degree of modification of polysaccharides is many times required in order to 
control and fine tune its final properties to particular applications.15-17 Obtained 
polysaccharide derivatives may possess desirable properties that can widen their array 
of applications. In the particular case of ulvan, the study of polysaccharide modification 
is largely related with the production of biomaterials and reported work in this area 
relates to functionalization of this polysaccharide.18 In this pioneer work, Morelli and 
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Chiellini report the modification of ulvan by grafting with methacryloyl groups in order to 
produce stable and biodegradable hydrogels aimed for biomedical applications.18  
Nevertheless, application studies based on ulvan are scarce, especially concerning 
polysaccharide modification, processing and biomaterial design. Given the peculiar 
nature of this polysaccharide and its inherent biological effects, it is easy to envisage 
focused applications based on these properties. Ulvan‟s biological properties can be 
related to its sulphation degree, but also with its particular sugar composition.19-20 For 
instance, the ubiquitous occurrence of rhamnose in this algal polysaccharide can be 
considered as an advantageous characteristic, particularly for the treatment of skin 
pathologies.21-22 In general, rhamnose-rich polysaccharides demonstrate anti-
inflammatory properties, diminish skin bacterial adhesion, protect it from UV-induced 
and age-related injure and stimulate cellular proliferation and collagen biosynthesis.21-22 
Furthermore, ulvan has been described as a heparinoid agent.23-25 This heparin-like 
character positions ulvan as a strategic choice for wound management applications, as 
heparin, heparin derivatives and heparin-like compounds are known to exert positive 
effects on chronic wounds.26 In fact, heparin is often applied in the treatment of 
wounds, as this sulphated polysaccharide plays a pivotal role in the wound healing 
process, either by promoting fibroblast proliferation, inhibition of thrombin generation, 
improvement of fibrinolytic functions, or stimulation of heparin sulphate synthesis.26-29 
Within this context, the sulphated polysaccharide ulvan can be considered for 
applications in wound management, particularly as a wound dressing. Preparation of 
polymeric membranes to be applied as wound dressings can be performed by solvent 
casting, as this is a widespread method to process polymers into membranes.7-8 
Besides ease of preparation and low costs associated with this manufacturing method, 
it can be an effective way to incorporate a therapeutic agent into the membrane, by 
mixing it with the polymer prior to casting.30 After evaporation of the solvent, a 
combined polymer-drug membrane (medicated dressing) is obtained.31  
As the fundamental knowledge about ulvan evolves, the development of various 
modification and processing routes becomes decisive to its progress towards highly 
demanding areas. Hence the main objective of the present research work is to evaluate 
the feasibility of ulvan membranes to be applied as a wound dressing, especially as a 
drug delivery system.  
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2. Experimental procedure 
2.1. Materials 
Ulvan was extracted from green algae as described elsewhere.9 1,4-Butanediol 
diglycidyl ether (BDDE) and dexamethasone were provided by Sigma–Aldrich 
(Germany). 
2.2. Cross-linking ulvan 
Ulvan was mixed with BDDE (1:5 molar ratio), in an alkaline media (sodium hydroxide, 
40mM). The cross-linking reaction was allowed to proceed for 180min, at 50ºC. Cross-
linked ulvan powder was exhaustively washed with water and acetone to remove any 
residual cross-linker. The obtained dried powder was further used to produce cross-
linked ulvan membranes. 
2.3. Membrane preparation 
To prepare the polymeric membranes, cross-linked ulvan was dispersed in water (1% 
w/v) and the solution was homogenised with an UltraTurrax apparatus. Ulvan 
membranes were prepared by casting ulvan solution on Petri dishes, followed by 
solvent evaporation, at 50ºC, in a vacuum oven.  
Ulvan membranes impregnated with dexamethasone were prepared as described 
above, except that dexamethasone was dissolved in acetone and added to ulvan 
solution, with a final concentration of 15% w/w, prior to solvent casting. In the present 
study, dexamethasone, a steroid anti-inﬂammatory drug, was used as a model 
therapeutic agent. Non cross-linked ulvan membranes were prepared as described to 
study the cross-linking mechanism and the influence of cross-linking on the overall 
mechanical performance. The final appearance of ulvan membranes, loaded or not 
with dexamethasone, is a homogeneous and transparent yellowish film. 
2.4. Fourier transform infrared spectroscopy (FTIR) 
Chemical modifications introduced by the cross-linking reaction were investigated by 
FTIR. The infrared spectra were recorded on a spectrophotometer (IR-Prestige-21, 
Shimadzu, Japan), controlled by IRsolution software. All spectra were averaged on 32 
scans in the range of 600–4400 cm-1 with a resolution of 4 cm-1.  
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2.5. Scanning electron microscopy (SEM) 
Surface morphology of the produced membranes was analyzed using a Leica 
Cambridge S-360 scanning electron microscope (SEM) (Leica Cambridge, England). 
All specimens were pre-coated with a conductive layer of sputtered gold. 
2.6. Mechanical properties testing 
Ulvan membranes were subjected to tensile tests to evaluate the effect of cross-linking 
over the mechanical properties and to determine the mechanical performance of these 
membranes. Membranes with 500μm in thickness were cut into 10-mm-long specimens 
and tensile tests, in dry state, were performed using a Universal Testing Machine 
(Instron 4505, UK), with a load cell of 1 kN, gauge length of 10 mm and cross-head 
speed of 5mm/min was used up to rupture of the membrane. A minimum of five 
specimens were tested for each sample (the values reported are the average of those 
results). These tests allowed the determination of different mechanical properties 
defined as follows: tensile modulus defined as the slope of the straight line obtained by 
linear regression of the stress-strain curve in the near elastic region of the material 
(between 0 and 1.0 % strain); ultimate tensile strength (referred as tensile strength), 
defined as the maximum tensile stress developed in the material during the tensile test 
and strain at break point (referred as tensile strain), defined as the maximum strain of 
the material, i.e. elongation at the failure point of the material.  
2.7. Water uptake study 
The hydration degree of ulvan polymeric membranes was assessed over a period of 14 
days. Five specimens (previously weighed) were immersed in phosphate buffered 
saline (PBS, pH 7.4) and incubated at 37°C for 1, 3, 7 and 14 days. After each defined 
period of time, the specimens were removed from the PBS solution, gently blotted with 
a paper filter and the weight was again measured. The water uptake was calculated by 
the following equation: 
                                
where wi is the initial weight of the specimen before immersion and ws is the wet mass 
of the specimen at time t (days) after being removed from the solution. 
2.8. In vitro dexamethasone release profile 
Five specimens of ulvan cross-linked membranes loaded with dexamethasone were 
immersed in PBS (pH 7.4) and incubated at 37°C for a period of 14 days. The release 
of dexamethasone was periodically monitored by extracting 500µl aliquots and 
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replenishing with 500µl of PBS, in predetermined time intervals. The concentration of 
dexamethasone was determined by UV–Vis spectroscopy at 242nm (Shimadzu UV 
1601, Japan). The results presented are an average of five measurements.  
2.9. Mathematical modeling of dexamethasone release from ulvan membranes 
To better understand the mechanisms of dexamethasone release from ulvan 
membranes the power law (or Peppas equation) was applied to the experimental 
data.32-33 This particular model was chosen as it accounts for both drug diffusion and 
matrix swelling. Power law is a simple empirical equation, which describes a linear 
relationship between logarithm of the amount of drug released and logarithm of time, 
up to 60% of the maximum drug released: 
  
  
     
Mt/M∞ is related with the fractional drug release, k is the kinetic constant, t refers to the 
release time and n is the diffusional exponent that is related to the drug transport 
mechanism. For a thin polymeric membrane, the drug release mechanism is Fickian 
diffusion when n=0.5, n=1 Case II transport occurs leading to zero-order release and if 
the value of n is between 0.5 and 1, anomalous transport is observed.32-34 
 
3. Results and Discussion 
In the present research work, the development of cross-linked ulvan membranes is 
described and their use for local delivery of drugs, as medicated dressings, is 
proposed. In this type of applications, stability in physiological conditions constitutes a 
desired property. As unmodified ulvan is readily dissolved in water cross-linking plays a 
decisive role in tuning the properties of the final polymeric matrix.  
BDDE is one of the most frequently used homobifunctional epoxide reagent to cross-
link polysaccharides. It is considered cytocompatible which is of extreme importance 
when we are focusing on biomedical applications.35 The epoxide functionalities of 
BDDE are able to react with different groups like hydroxyls, amines or thiol groups.36-37 
Polyexpoxide compounds have already been successfully used to cross-link collagen, 
gelatine and hyaluronic acid.35-36 In fact BDDE is the cross-linking agent used to cross-
link many commercially available products, namely in aesthetics, such as dermal fillers 
like Juvederm® or Restylane®.38  
For all the above reasons, chemical modification of ulvan was performed via cross-
linking with BDDE. In order to try to identify the bonds responsible for the cross-linking 
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of ulvan with BDDE and understand the mechanism of reaction, FTIR spectroscopy 
was performed on the processed membranes, with and without cross-linking. By 
analyzing the FTIR spectra of Figure 5.1, it is possible to identify different characteristic 
peaks of ulvan: stretching (st) vibration of polymeric hydroxyl groups at 3500-3200cm-1; 
it is also possible to detect the presence of carboxyl groups by a band at 1650cm-1, the 
asymmetric stretching of the ether glycoside bridge and the symmetric and asymmetric 
stretching of the ether sulphate group in the range of 1315–1220cm-1 and 1140–
1050cm-1.9 By comparing FTIR results before and after cross-linking, it is not possible 
to detect the formation of novel bonds, which could have been introduced during the 
cross-linking reaction. There are several groups present in the region of 900–1250cm-1 
(highlighted in Figure 5.1), characteristic of native ulvan. However, after cross-linking, 
the signal around 1090cm-1 is markedly decreased. The disappearance of this signal 
may be due to the consumption of –OH needed for the cross-linking reaction to occur, 
as this band can be attributed to CH – OH (st). 
 
 
Figure 5. 1. FTIR spectra (Straight line: ulvan; Dash line: cross-linked ulvan). 
Epoxide groups are able to react with different nucleophiles, including amines, thyols 
and hydroxyl groups, present within the polymer backbone, yielding stable covalent 
bonds.37, 39-40 Reaction with different nucleophyles, in appropriate experimental 
conditions, will result in different end bonds. For example, efficient coupling of epoxide 
moieties with hydroxyls will occur in an alkaline media, at high pH, yielding stable ether 
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bonds; primary amine groups react with epoxide groups at moderate alkaline pH, 
resulting in secondary amines or sulphydryl groups yield thioether bonds in a reaction 
with epoxides at close to neutral pH.39 In this scheme, given that reaction of ulvan with 
BDDE occurs in an alkaline moiety, at high pH, and considering the apparent 
consumption of hydroxyl groups, as demonstrated by FTIR, ether bonds are expected 
to be formed. 
A reaction mechanism is proposed and illustrated in Figure 5.2. Reaction is thought to 
occur via ulvan‟s hydroxyl groups that are able to react with the epoxide moiety of 
BDDE in alkaline media, yielding a stable ether bond. Cross-linking may be complete, 
bringing together two polysaccharidic chains via ether bonds, or incomplete, with 
epoxide pendant groups.36 Given the bifunctional nature of BDDE, pendant epoxide 
groups may be expected, due to limited reagent concentration or due to absence of 
vicinal functional groups available to react with the epoxide.36  
 
 
Figure 5. 2. Proposed cross-linking mechanism of ulvan polysaccharide with BDDE.  
Surface studies by SEM revealed that ulvan membranes are non porous and their 
surface is homogeneous, presenting some degree of roughness (Table 5.1).  
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Table 5. 1. Surface topography of produced ulvan membranes. 
Surface topography 
 
SEM micrograph of the surface of cross-linked 
ulvan membrane (Magnification 3000x) 
As ulvan membranes are envisaged for applications as dressings, they are required to 
be resilient and stress resistant to be able to cope with the stresses exerted during 
manual manipulation or by surrounding tissue, and this endorses the importance of 
mechanical behaviour on this particular applications.1 To better understand the 
influence of cross-linking on the mechanical performance of the designed membranes, 
a comparison between non cross-linked membranes and cross-linked membranes was 
performed. When comparing the results obtained for both types of ulvan membranes, it 
is notorious the striking effect of cross-linking on the mechanical performance of ulvan 
membranes; in general, these properties can be improved by cross-linking.41-42 Tensile 
strength and modulus were significantly improved by the cross-linking reaction (Table 
5.2). Membranes without cross-linking have a tensile strength of 4.7kPa and a tensile 
modulus of 580kPa. Cross-linking ulvan yielded membranes with increased tensile 
strength and tensile modulus, causing the tensile strength to increase to 44kPa and the 
tensile modulus to increase by 203%. However, this made ulvan membranes less 
ductile, as it can be seen by the decrease in tensile strain.  
 
Table 5. 2. The mechanical properties obtained from the tensile curves are presented 
in the following table. 
Ulvan Membrane 
Tensile Modulus 
(kPa) 
Tensile Strength 
(kPa) 
Tensile Strain 
(%) 
Without cross-
linking 
580.0 ± 213.00 4.7 ± 1.89 26.4 ± 10.01 
With cross-linking 1760.0 ± 284.00 44.0 ± 12.00 15.2 ± 7.66 
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In order to evaluate the swelling behavior of ulvan membranes they were placed in a 
buffer solution, at 37ºC. Figure 5.3 presents the proﬁle of the water-uptake capability of 
cross-linked ulvan membranes as a function of time and demonstrates that ulvan 
membranes possess significant water uptake ability, showing a maximum peak after 14 
days in PBS (~1800%). The ability to uptake water must be one of the most remarkable 
and defining properties of the produced ulvan membranes. Maintenance of moisture in 
a wound is considered a critical aspect of wound management as a moist environment 
may favor the healing process through prevention of desiccation and cell death, 
stimulation of cell migration, angiogenesis, connective tissue generation and 
autolysis.1, 43 Furthermore, if high water absorption from exudate wounds is desired, 
ulvan membranes‟ hydration ability assumes a pivotal role.1 In this context, the water 
uptake demonstrated by ulvan membranes becomes relevant and supports their 
feasibility to be applied as wound dressings. 
On the other hand, this knowledge becomes relevant particularly when these 
membranes are aimed for drug delivery applications. 
 
Figure 5. 3. Percentage of water uptake by cross-linked ulvan membranes along time. 
In the present study, cross-linked ulvan membranes were loaded with a therapeutic 
model drug, dexamethasone, so as to evaluate their ability to be further used as 
medicated wound dressings. From Figures 5.4, and in more detail in Figure 5.5, a 
steady release of dexamethasone is observed for 8 hours. At this point, 49% of drug 
has been release from the prepared membranes. Afterwards, a slower release of the 
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drug is detected and at day 14 around 72% of dexamethasone has been released from 
ulvan membranes. 
 
Figure 5. 4. Dexamethasone concentration and percentage of drug released from 
ulvan membranes (SD for n=5). 
 
Figure 5. 5. Detail of dexamethasone concentration release profile from ulvan 
membranes (SD for n=5). 
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There are several factors that influence the release of a drug from a matrix, including 
diffusion of the drug out of the matrix and the water uptake by the polymeric matrix.34 
One factor is mostly related with the drug itself and the other is related with the polymer 
and the polymer network. Given the water uptake ability of ulvan membranes, we can 
hypothesize that the influence of ulvan‟s swelling on the release of the drug is 
significant. As ulvan membranes are regarded as a non-porous system, drug 
molecules are released through the network meshes within the polymeric phase.30 This 
theoretical scenario is supported by the mathematical modelling of the release of 
dexamethasone from the prepared ulvan membranes. Fitting the power law equation to 
the obtained data, kinetic parameters that describe the mechanism of release 
associated to this membrane system were determined. This is a simple semi-empirical 
mathematical model describing a linear relationship between the logarithm of the 
amount of drug released and logarithm of time, up to 60% of the maximum drug 
released.32-34 
 
Figure 5. 6. Power law applied to the drug release profile of ulvan membranes loaded 
with dexamethasone. 
From the slope of the plot of logarithm of Mt/M  versus logarithm of time, n (the 
exponent characterizing the release process) was calculated (Figure 5.6). In the 
particular case of ulvan membranes, n is close to 1, which indicates that release of 
dexamethasone follows a non-Fickian release mechanism, specifically Case-II 
transport, also described as zero-order kinetic.32 In this particular case, the release of 
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dexamethasone from ulvan membranes is associated with the relaxation of the 
polysaccharide upon hydration. 
 
4. Conclusions 
Ulvan membranes meant to be used as wound dressings or as vehicles to deliver 
therapeutic agents in the context of wound management have been proposed. As part 
of the design of these membranes, successful chemical cross-linking of ulvan was 
achieved with the epoxide BDDE, via the formation of ether bonds through ulvan‟s 
hydroxyl groups. The properties of ulvan membranes herein presented suggest that 
this natural sulphated polysaccharide can be proposed for the envisaged applications 
as wound dressings. Furthermore, the release of dexamethasone from ulvan 
membranes proceeds in a sustained fashion, which supports the feasibility of these 
membranes to be used as drug delivery systems as medicated wound dressings. As 
the application development of this polysaccharide is in its early stages, the herein 
described ulvan processing techniques and envisaged applications pose an innovative 
attempt to add value to this rather unexploited algae derived polysaccharide.  
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Chapter 6 
 
 
Processing of degradable ulvan 3D porous structures for 
biomedical applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Alves A, Sousa RA and Reis RL, Processing 
of degradable ulvan 3D porous structures for biomedical applications. 2012. Submitted. 
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Abstract 
The interest in ulvan within a biomedical framework increases as the knowledge of this 
polysaccharide evolves. Ulvan has been recently proposed as a potential biomaterial, 
and scaffolds based on this polysaccharide are now being studied for different tissue 
applications. In this work, a novel porous structure based on cross-linked ulvan was 
designed and characterized. Its mechanical performance and water uptake ability were 
assessed, morphology analysed through scanning electron microscopy and 
morphometric parameters quantified by micro-computed tomography. Cell viability and 
cell proliferation were evaluated in order to estimate the cytotoxicity of these structures, 
and respective degradation products. Produced ulvan structures revealed remarkable 
ability to uptake water (up to ~2000% of its initial dry weight) and are characterized by 
a highly porous and interconnected structure. Furthermore, these ulvan structures 
underwent non-toxic degradation and cells remained viable through the time of culture. 
These results position ulvan structures as prospective blocks that can be further 
functionalized in order to acquire the desired and needed biological interactivity to be 
used as tissue engineered structures. 
 
  
Processing ulvan into 3D structures 
 
148 
1. Introduction 
Scaffold design is a key aspect of tissue engineering. Scaffolds are intended to support 
cell colonization and neo-tissue formation, mimetizing the tissue extracellular matrix.1-2 
In general, a scaffold should be biocompatible, biodegradable, with suitable 
morphological properties and mechanical performance.1, 3 Ideally, it should not induce 
cytotoxicity and should interact with cells encouraging cellular functions such as 
adhesion, growth and migration. It should degrade in a non-toxic manner as the neo-
tissue forms and possess adequate mechanical integrity to withstand biological forces 
and maintain physical integrity. Finally, it should have adequate porosity and surface 
area in order to ensure cell colonization, survival and support neo-tissue formation.3-4 
Nowadays, polysaccharides are considered, for many reasons, an attractive option for 
the design of a scaffold to repair or regenerate a tissue. First of all, polysaccharides 
are, in general, non-cytotoxic, with different and noteworthy biological activities.3, 5-7 
Secondly, polysaccharides represent a key component of the extracellular matrix, and 
many times determine its properties and functionality.4 Overall, the chosen material 
should be able to mimic, as close as possible, the components and properties of the 
tissue that is going to be repaired, regenerated or substituted.7 Polysaccharides and/or 
proteins naturally present in the human body tend to be a recurrent choice, namely 
hyaluronic acid, chondroitin sulphate, collagen or fibrin.3, 8-12 Polysaccharides that 
present similar traits to these mammalian glycosaminoglycans are also frequently used 
as biomaterials.8, 10, 13-14  
In this context, ulvan remains a rather unexploited green algae polysaccharide. This 
polysaccharide is mainly composed of uronic acids and sulphated rhamnose, which 
represent the basis of its principal constituent unit – ulvanobiuronic acid.15-18 
Ulvanobiuronic acid A is composed of glucuronic acid and rhamnose and 
ulvanobiuronic acid B is composed of iduronic acid and rhamnose.16 The presence of 
both rhamnose and iduronic acid confers a particularly peculiar character to this 
polysaccharide, as both this monosaccharides are rarely found in algal 
polysaccharides.17-18 However, it is the presence of both iduronic acid and a sulphated 
sugar moiety that is the basis of the comparison of ulvan to mammalian sulphated 
glycosaminoglycans, especially sulphated chondroitin or dermatan.15, 18 Given this 
similarity, it is easy to envisage its potential use in areas like the biomedical field. In this 
regard, it is herein proposed a processing method to obtain a three dimensional porous 
structure, based on ulvan, to be applied as a medical device, particularly for tissue 
engineering applications. In order to render these structures suitable for biomedical 
applications, a chemical modification step was introduced in order to confer stability in 
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physiological conditions, control water uptake ability and provide improved mechanical 
properties. Both carboxyl and hydroxyl groups of ulvan are attractive sites for chemical 
modification and it may be achieved with different commercially available cross-linking 
agents. In the present work, we have chosen to work with 1,4- butanediol diglycidyl 
ether (BDDE) due to its acceptability and applicability in biomedical, pharmaceutical or 
cosmetic applications.19-22 As a practical example, this agent is widely used to cross-
link hyaluronic acid to produce commercially available stable fillers for dermatological 
purposes.19  
In summary, the main objective of the herein described research work is to produce a 
3D porous structure based on cross-linked ulvan, with defined physicochemical 
properties and evaluate its feasibility to be applied in a tissue engineering context.  
 
2. Materials and methods 
2.1. Materials 
Ulvan was extracted from green algae, namely Ulva lactuca, using a procedure 
described elsewhere.23 Briefly, Soxhlet extraction of dried Ulva lactuca removed most 
of the lipids and colouring matter. The residual off-white weed was dried and subjected 
to three hot-water extractions, between 75-85ºC. After filtration through a cotton cloth, 
aqueous extracts were centrifuged, and the liquid supernatant was filtered. The water 
extract was concentrated until 10-20% of its initial value, in a rotary evaporator. Starch 
and proteins were removed by enzymatic digestion. Afterwards, the solution was 
decolorized and deodorized by adsorption on activated charcoal. The water extract was 
centrifuged, filtered and precipitated with 4 vol. of absolute ethanol. Finally, the 
recovered precipitate was freeze dried. Yield of a white polysaccharide resulting from 
this extraction methodology is c.a. 10 – 20%. 
Unless otherwise specified, all chemicals were bought from Sigma–Aldrich (Germany) 
and used as received. 
2.2. Synthesis of chemically cross-linked ulvan porous structures 
Ulvan was chemically cross-linked with 1,4 – butanediol diglycidyl ether (BDDE) by 
mixing the polysaccharide with the cross-linking agent in an alkaline medium, to favour 
the formation of stable ether bonds. The reaction was allowed to proceed for 180 
minutes, at 50ºC. Afterwards, the solution was dialyzed against distilled water to 
remove any unreacted cross-linker, placed in an appropriate mould and freeze dried to 
allow the formation of porous samples (condenser temperature: ~80ºC, vacuum: 
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0.030mbar, for a minimum of 3 days). pH of the final ulvan solution prior to freeze 
drying was controlled (pH~6). Ulvan and cross-linker concentrations are reported as a 
weight ratio between cross-linker (referred as XL) and ulvan (referred as UL) and are 
presented in Table 6.1. 
 
Table 6. 1. Different formulations based on ulvan (UL) and cross-linker (XL) used to 
prepare various ulvan porous samples. 
[UL] (% w/v) XL (weight ratio) 
4 0.20; 0.27; 0.53 
5 0.14; 0.50; 1.00; 1.50; 2.00 
6 0.13; 0.18; 0.36; 0.57 
8 0.25; 0.50; 0.75; 2.00 
2.3. Fourier transform infrared spectroscopy (FTIR) 
Chemical modifications introduced by the cross-linking reaction were investigated by 
Fourier transform infrared spectroscopy (FTIR). Infrared spectra were recorded on a 
spectrophotometer (IR-Prestige-21, Shimadzu, Japan), controlled by IRsolution 
software. All spectra were averaged from 32 scans in the range of 600–4400cm-1 with a 
resolution of 4cm-1. 
2.4. Mechanical compression tests  
Samples were mechanically tested by compression experiments in an Instron 5543 
(Instron Int. Ltd., UK) universal testing machine with a load cell of 1kN. Compression 
testing was carried out at a crosshead speed of 2mm/min, until obtaining a maximum 
reduction in samples‟ height of 60%. Compressive modulus is defined as the slope of 
the straight line obtained by linear regression of the stress-strain curve in the near 
elastic region of the material (between 0 and 1.0 % strain). A minimum of five samples 
of each type/condition were tested. 
2.5. Water uptake and degradation tests 
Samples were previously weighted and placed into screw-top plastic tubes. These 
were immersed by adding 5mL phosphate buffered saline (PBS) and allowed to swell 
at 37ºC under agitation (60rpm). After each time point (1, 3, 7, 14 and 21 days), 
samples were placed on a Whatman filter for 10s in order to remove non absorved 
water, and subsequently weighted.  
Water content in the swollen scaffolds was calculated by the following equation: 
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where wi is the initial weight of the specimen before immersion and ws is the weight of 
the swollen structure. A minimum of three samples for each type/condition were 
analysed. 
After each time period, the samples were dried and weighted to determine the weight 
loss, which was calculated according to the equation: 
                                  
where wd is the final weight of the sample (dried after immersion) and wi is the initial 
weight of the sample. Presented data is the result of the average of at least three 
measurements. 
2.6. Scanning electron microscopy (SEM) 
Produced samples were analyzed using a FEI Nova 200 (FEI, USA) scanning electron 
microscope (SEM). All specimens were pre-coated with a conductive layer of sputtered 
gold. 
2.7. Micro-computed tomography (µ-CT) 
Samples herein described were analyzed by micro-computed tomography (µ-CT) using 
a high-resolution micro-CT SkyScan 1072 scanner (Skyscan, Belgium) in order to 
characterize its morphological and morphometric properties. The X-ray source was set 
at 32kV of energy and 191µA of current, and resolution of pixel size of 6.69µm and 
exposure time of 1.8sec. A minimum of three samples of each type/condition were 
analysed. After reconstruction (NRecon, SkyScan, Belgium) of the acquired data, 
bitmap of 1024x1024 pixels were obtained and representative binary images of 
approximately 100 slices with a dynamic threshold of 61–255 (grey values) were 
generated and analyzed (CT Analyser®, SkyScan, Belgium). Different morphometric 
parameters were determined, including porosity, mean pore size and respective 
distribution and scaffold interconnectivity. This last parameter was calculated assuming 
two minimum pore sizes, of 13.4µm and 53.5µm, that is to say that interconnection 
diameter lower than these values were not considered as open pores. In this sense, 
interconnectivity of the scaffold is calculated according to the formula: 
   100/  totalporeedporedisconnecttotalpore VVVI  
where the volume of the disconnected pore stands for the disconnected pore volume.  
2.8. Cell viability and proliferation 
Conﬂuent L929 cell at passages 20–26 were harvested for seeding onto ulvan samples 
at a density of 5.0x105 cells/scaffold.24 The constructs were cultured in standard 
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medium for 1, 3, and 7 days. Cells seeded on standard tissue culture polystyrene were 
used as a negative control, representing cell normal growth in culture media. In this 
experiment cell adherent culture plates were chosen; cells non-adherent to the 
samples were used, as a non standard method to screen possible toxicity of soluble 
components and other degradation products resulting from ulvan samples.  
Cell viability for each culturing time was determined using the CellTiter 96 AQueous 
One Solution Cell Proliferation Assay (Promega, USA), following manufacturer 
instructions. Absorbance was measured at 490 nm for a minimum of four samples per 
condition and time point, using a microplate reader (Synergie HT, Bio-Tek, USA). Cell 
proliferation was quantiﬁed by the total amount of double-stranded DNA (dsDNA), 
along culturing time. Quantiﬁcation was performed using PicoGreen dsDNA Assay Kit 
(InvitrogenTM, Molecular ProbesTM, USA), according to the manufacturer‟s instructions. 
Brieﬂy, cells were lysed by osmotic and thermal shock and the supernatant used for the 
DNA quantiﬁcation assay. Fluorescence was measured at an excitation wavelength of 
485/20nm and at an emission wavelength of 528/20nm, in a microplate reader 
(Synergie HT, Bio-Tek, USA). Quadruplicates were made for each sample and per 
culturing time. dsDNA concentration for each sample was calculated using a standard 
curve relating DNA concentration (ranging from 0.0 to 1.5mg/mL) and ﬂuorescence 
intensity. Cell viability and dsDNA quantification were performed for cells adherent and 
non-adherent to the produced samples. 
2.9. Cell Imaging 
Viability and morphology of cells on ulvan samples were assessed after 1 and 3 days, 
by reflected/transmitted light microscopy, following calcein-AM and propidium iodide 
staining, and by scanning electron microscopy (SEM). For reflected/transmitted light 
microscope visualization, ulvan samples were incubated in culture medium with 
calcein-AM and propidium iodide (InvitrogenTM, Molecular ProbesTM, USA) for 30min. 
Calcein-AM is a non-fluorescent permeable compound that once inside viable cells is 
converted by intracellular esterases into a fluorescent cell impermeable form, being 
used as a green fluorescent indicator of viable cells. Propidium iodide is used as a red 
fluorescent marker of cells with compromised membranes, being used as an indicator 
of dead cells. The calcein-AM/propidium iodide stained samples were placed on a 
microscope slide and observed by reflected/transmitted light microscope (Zeiss, Axio 
Imager.Z1m, Germany). For SEM analysis, ulvan samples were ﬁxed with 2.5% 
glutaraldehyde, in PBS, for 1h at 4ºC. Samples were further dehydrated in increasing 
ethanol concentrations, critical point dried and gold sputter coated prior to SEM 
observation.  
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2.10. Statistical analysis 
Statistical analysis was performed using GraphPad Prism statistic software (Release 
version 5 for Windows). All sample results were previously tested for normal 
distribution using Shapiro–Wilk test. Negative results indicated the adoption of 
nonparametric tests for all comparisons. Therefore, the effect of the produced 
structures over L929 viability and proliferation over time was evaluated by Mann-
Whitney test and Kruskal–Wallis test followed by Dunn‟s test for multiple comparisons. 
Direct comparisons of both produced scaffolds were made by Mann-Whitney test. 
Statistical significance was defined as p<0.05. 
 
3. Results 
In order to confirm the expected mechanism of cross-linking reaction of ulvan with 
BDDE, FTIR spectroscopy was performed on ulvan structures, with and without 
chemical modification.  
 
Figure 6. 1. Infrared spectra of ulvan structures between 600 and 4000cm-1. A: 
structure without cross-linking; B: cross-linked structure. The main difference between 
both spectra is highlighted. 
By means of analyzing FTIR spectra of Figure 6.1, it is possible to identify different 
characteristic bands of ulvan: stretching (st) vibration of polymeric hydroxyl groups at 
3500-3200cm-1; it is also possible to detect the presence of carboxyl groups by a band 
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at 1650cm-1, the asymmetric stretching of the ether glycoside bridge and the symmetric 
and asymmetric stretching of the ether sulphate group in the range of 1315–1220cm-1 
and 1140–1050cm-1.23 The signal detected around 1090 cm-1 present in native ulvan 
structures, without chemical modification, is not detected after cross-linking and may be 
due to the use of –OH groups needed for the cross-linking reaction to occur, as this 
band can be attributed to CH–OH (st). Cross-linking of ulvan with BDDE has already 
been successfully performed to produce ulvan membranes and the proposed 
mechanism of reaction is suggested to involve hydroxyl groups present within the 
backbone of the polysaccharide and epoxide groups of the cross-linker.25 
Different ulvan structures were produced with varying concentrations of polysaccharide 
and cross-linker and characterized and evaluated by different criteria, including 
mechanical performance, water uptake and degradation time represented as structural 
stability over time in PBS. These results are summarized in Table 6.2.  
 
Table 6. 2. Mechanical, hydration and stability properties of different ulvan structures 
produced by varying the concentration of polysaccharide and cross-linker, as described 
in Table 6.1. 
[UL] (% 
w/v) 
XL:UL 
(weight ratio) 
Compressive 
Modulus (MPa) 
24h Water Uptake 
(%) 
Approximate 
Structural Stability 
4 
0.20:1.00 
Readily soluble in aqueous media 0.27:1.00 
0.53:1.00 
5 
0.14:1.00 0.56±0.21 809.60±291.35 Up to 3 days 
1.50:1.00 0.23±0.04 1756.32±93.21 Up to 7 days 
2.00:1.00 0.51±0.11 1482.64±103.03 Up to 7 days 
6 
0.13:1.00 
Readily soluble in aqueous media 0.18:1.00 
0.36:1.00 
0.57:1.00 0.39±0.11 1282.20±158.88 Up to 3 days 
8 
0.25:1.00 1.44±0.34 1404.57±271.78 Up to 7 days 
0.50:1.00 3.60±0.55 1621.35±130.44 Up to 7 days 
0.75:1.00 2.60±0.61 1342.29±82.29 Up to 7 days 
2.00:1.00 1.52±0.29 2000.99±119.01 Up to 7 days 
The analysis of Table 6.2 demonstrates that both cross-linker and polysaccharide 
concentrations markedly influence the final properties of the produced structures, in 
particular their compressive modulus and water uptake ability. In a first analysis, low 
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concentration of polysaccharide and/or cross-linker yield water soluble or rapidly 
degrading structures. On the other hand, increasing concentrations of ulvan appear to 
favour an improvement of mechanical performance of the 3D structures. However, 
regardless of polysaccharide concentration, higher cross-linker concentrations may 
result in a negative effect over this property, as it can be seen for ulvan 8% (w/v) with a 
2.00:1.00 (XL:UL) cross-linker ratio.  
Overall, these results indicate that it is possible to manufacture different structures with 
remarkably different characteristics that can be tuned in order to obtain an optimum 
ratio between functionality and applicability. Presented ulvan structures have a 
compressive modulus that can vary from 0.23 to 3.60MPa, a water uptake ability 
ranging from about 800 to nearly 2000% that can be readily soluble in aqueous media 
or present varying dissolution times within a range of 3 to 7 days.  
In order to better understand the properties of the produced cross-linked ulvan 
structures and the effect of polysaccharide concentration, further structural 
characterization was performed for two conditions featuring the same cross-linker 
amount – 2.00:1.00 (XL:UL) – and different polysaccharide concentrations, namely 
ulvan 5 and 8% (w/v), further referred respectively as UL5 and UL8 conditions or 
samples. This yielded two structures with different mechanical properties (0.51±0.11 
and 1.52±0.29 MPa, respectively) and water uptake ability (1482.64±103.03 and 
2000.99±119.01 %, respectively), with similar stability in PBS (up to 7 days).  
Swelling and weight loss ratios of the produced structures are represented in Figures 
6.2 and 6.3. Both structures demonstrate a remarkable uptake of the surrounding fluid 
since the initial time point and this ability is maintained throughout the time. However, it 
is more pronounced in UL8 when compared to UL5. In UL8, water uptake increases 
until day 5; on the other hand, after one day of immersion in PBS, the water uptake 
ability of UL5 stabilizes. Both these structures are prone to hydrolytic degradation, as 
demonstrated in Figure 6.3. After one day of soaking, significant weight loss is 
observed (10 to 15% in mass). UL8 remains stable until the end of the experiment. 
However, after three days of immersion in PBS, a dramatic increase in weight loss 
occurred in UL5. After five days, this structure revealed signs of significant degradation, 
being to fragile too be handled in the last time point.   
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Figure 6. 2. Swelling ratio of produced ulvan structures (UL5 and UL8) in PBS as a 
function of time. 
 
Figure 6. 3. Weight loss of produced ulvan structures (UL5 and UL8) in PBS as a 
function of time. 
Morphology and pore structure and distribution of a scaffold envisaged for tissue 
engineering applications represent crucial parameters that allow and support cellular 
colonization of the polymeric matrix. In this regard, ulvan structures are highly porous, 
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as demonstrated by SEM micrographs (Figure 6.4) and confirmed by micro-CT 
analysis (Table 6.3).  
 
Figure 6. 4. Scanning electron microscopy micrographs of ulvan produced structures 
from different perspectives – top: top view; left: horizontal cross-section; right: vertical 
cross-section. (Mag. 250x). 
Table 6. 3. Morphometric parameters characteristic of produced ulvan structures, 
determined by micro-CT, from analysis of UL5 and UL8 conditions. The effect of ulvan 
concentration on morphometric properties was analyzed by the Mann Whitney test and 
(*) denotes a significant difference between both structures. 
 UL5 UL8 
Porosity (%) 79.69 ± 0.81 73.10 ± 0.86
(*)
 
Mean Pore Size (µm) 60.40 ± 1.34 47.90 ± 0.89
(*)
 
Interconnectivity (>13µm) (%) 76.15 ± 0.95 67.07 ± 1.44
(*)
 
Interconnectivity (>53µm) (%) 19.08 ± 3.55 4.21 ± 0.13
(*)
 
For UL5 and UL8, porosity was determined to be 79.69±0.81 and 73.10±0.86% and 
mean pore size to be 60.40±1.34 and 47.90±0.89µm, respectively. Interconnectivity 
was calculated assuming two minimum pore sizes, of 13.4µm and 53.5µm for each 
sample. This aimed at evaluating the fraction of pores within the structure that are 
easily reached from the outer surface through openings of a certain minimum size.26 In 
the case of UL5, interconnectivity of pores with a diameter above 13µm was calculated 
to be 76.15±0.95%; for pores with a diameter above 53µm interconnectivity is 
19.08±3.55%. For UL8 samples, the percentage of pores with a diameter above 13 and 
53µm which are interconnected was calculated to be 67.07±1.44% and 4.21±0.13%, 
respectively. Porosity, mean pore size and interconnectivity significantly decreased 
upon increase of ulvan concentration. Furthermore, this decrease in porosity correlates 
well with the observed differences in mechanical performance for both structures, 
where UL8 structure demonstrates higher compressive modulus compared with UL5. 
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Pore distribution is depicted in Figure 6.5 and reveals a relatively homogeneous pore 
size distribution, ranging from 7 to 114µm. 
 
 
Figure 6. 5. Pore size distribution of UL5 and UL8 structures assessed by micro-CT 
analysis.  
MTS assay was performed in order to evaluate cellular metabolic activity in ulvan 
structures, as depicted in Figure 6.6. After 1 day of culture, cells present the same 
metabolic activity for both ulvan structures. This activity significantly increases over 
time until 3 days of incubation, for both structures. However, after 3 days of incubation, 
L929 cells demonstrate a significant increase on metabolic activity in the scaffold with 
the highest concentration of ulvan (UL8) as compared with UL5. Cells cultured on both 
ulvan structures remained viable throughout the time of experience.  
In order to correlate metabolic activity with cellular proliferation, dsDNA quantification 
was also performed and these results are depicted in Figure 6.7. The significant 
increase of metabolic activity observed after 3 days of culture for UL5 condition is 
associated with a significant increase in dsDNA, which can be correlated with cellular 
proliferation. However, and even though metabolic activity of L929 cells cultured in UL8 
structure significantly increased after 3 days of culture, this is not associated with cell 
proliferation, as this significantly decreased. 
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Figure 6. 6. Box plot of metabolic activity of L929 cells cultured on two ulvan 
conditions, UL5 and UL8. Data was analyzed by nonparametric Mann Whitney test: #) 
denotes significant differences when compared with 1 day of culture and §) denotes 
significant differences when compared with UL5 structure for the same time point. 
 
Figure 6. 7. Box plot of L929 dsDNA concentration cultured for two ulvan conditions, 
UL5 and UL8. Data were analyzed by nonparametric Mann Whitney test: #) denotes 
significant differences compared with 1 day of culture and §) denotes significant 
differences compared with UL5 structure for the same time point. 
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When developing degradable materials, it is important to consider leachables resulting 
from possible residual reagents within the polymeric matrix or from polymer 
degradation, which may possess inherent toxicity. In this sense, both MTS assay and 
dsDNA quantification were performed on L929 cells attached to the culture plate, which 
grow in the presence of these products, if available.  
Metabolic activity of L929 cells attached to the culture plate, measured by MTS assay, 
is depicted in Figure 6.8. dsDNA quantification, representing cell number and growth is 
depicted in Figure 6.9.  
 
 
Figure 6. 8. Box plot of the metabolic activity of L929 cells attached to the culture plate 
and growing in the presence of two ulvan conditions, UL5 and UL8. Data were 
analyzed by nonparametric Mann Whitney and Kruskall Wallis tests: #) denotes 
significant differences compared with 1 day of culture, *) denotes significant differences 
compared with 3 day of culture and §) denotes significant differences compared with 
UL5 structure for the same time point. 
In Figure 6.8 it is possible to observe that for the first three days, cells attached to the 
culture plate are viable and there are significant differences between both scaffolds, as 
cells growing in the presence of UL8 demonstrate lower metabolic activity when 
compared with UL5. In this particular context, it is possible to infer that this metabolic 
activity may be related to the number of cells actually attached to the bottom of the 
culture plate, which may be significantly different in both cases. This hypothesis is 
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confirmed by the analysis of Figure 6.9. The number of cells, quantified by dsDNA, for 
the first day of the experiment is significantly different for both structures. There are 
fewer cells attached to the bottom of the culture plate containing UL8 sample as 
compared with the one containing UL5. This fact may explain the differences observed 
in metabolic activity for cells growing for both conditions, even after 3 days of culture. 
Nevertheless, after 7 days of culture, metabolic activity and cellular proliferation of cells 
increased in a significant manner. After 7 days of culture, the differences observed 
between both samples for the first days are no longer observed. After this period, it is 
important to note that both ulvan structures became unstable and showed signs of 
considerable degradation. This suggests a remarkable increase of residual products in 
the cell culture media. Nevertheless, by observing MTS and dsDNA results, after 7 
days, it is possible to note that cells are still viable and growing, even in the presence 
of these products. As a result, it is possible to conclude on the non-cytotoxic behaviour 
of both the samples and respective residual products.  
 
Figure 6. 9. Box plot of dsDNA concentration of L929 cells attached to the culture plate 
and growing in the presence of two ulvan conditions, UL5 and UL8. Data were 
analyzed by nonparametric Mann Whitney and Kruskall Wallis tests: #) denotes 
significant differences compared with 1 day of culture, *) denotes significant differences 
compared with 3 day of culture and §) denotes significant differences compared with 
UL5 structure for the same time point. 
 
Processing ulvan into 3D structures 
 
162 
In order to confirm cell viability and observe cellular morphology, reflected/transmitted 
light microscopy, following calcein-AM and propidium iodide staining, and scanning 
electron microscopy were performed. As it was the case for MTS and dsDNA analysis 
on the polymeric matrices, this microscopic observations were only performed for the 
two first time points (1 and 3 days of culture), as ulvan structures were too fragile too 
be handled in the last time point.  
Reflected/transmitted light microscopy and scanning electron microscopy images are 
grouped in Figure 6.10. In light microscopy observations (A) it is possible to witness the 
presence of viable cells for both conditions; dead cells (stained red) are almost 
undetected. For both cases, and as demonstrated by SEM micrographs (B), attached 
cells appear to retain a round morphology.  
 
Figure 6. 10. Microscopic observation of L929 cells cultured in UL5 and UL8 
conditions. Samples with green calcein-AM (viable cells) and red propidium iodide 
(dead cells) ﬂuorescence staining, observed with reflected/transmitted light microscope 
after 1 and 3 days of culture. (Magnification: 5x). B: Scanning electron microscopy 
micrographs of UL5 and UL8 ulvan conditions cultured with L929 cells after 1 and 3 
days. (Inserts: 5µm scale bar). 
 
4. Discussion 
Ulvan cross-linking was performed by means of a bifunctional polyexpoxide, 1,4 – 
butanediol diglycidyl ether (BDDE). This epoxide is able to react with different 
functional groups present within the polysaccharide backbone.11-12 By varying the pH of 
the reaction media, different linkages are formed.12, 21, 27 In the present research work, 
alkaline pH was preferred in order to try to obtain stable ether linkages. Nevertheless, 
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in the range of polysaccharide concentrations and cross-linker ratios investigated, 
maximum stability of the scaffolds upon PBS immersion was 7 days. Within this 
context, it is possible to infer on the low efficiency of cross-linking procedure herein 
applied to chemically modify ulvan and produce 3D porous structures, especially 
considering the stability at physiological pH of ether bonds that are expected to be 
formed when chemical reaction occurs in alkaline media.12, 21, 27 However, Malson21 has 
highlighted the importance of the pH of the reaction mixture immediately prior to drying 
as this will also influence bonds that will be formed during drying. During drying, 
polysaccharide chains may come closer allowing the formation of novel 
interconnections.21 In this second reaction step, it is possible to hypothesize on the role 
played by available epoxide pendent groups introduced during the first cross-linking 
reaction.25 As the first cross-linking reaction is performed in alkaline media and the pH 
of solution prior to drying is close to neutral, it is possible to infer the presence of a 
mixture of hydrolytic degradable ester and stable ether bonds in the final cross-linked 
structure, which may explain the degradation time observed for the produced ulvan 
structures. Another possible explanation to these results may lay on the polysaccharide 
itself, particularly its composition and conformation in solution. In fact, it has been 
demonstrated that ulvan adopts a closed bead-like conformation in aqueous solutions, 
enhanced by alkaline pH, which may limit the availability of ulvan‟s functional groups to 
chemical modification and cross-linking in aqueous alkaline media.28 On the other 
hand, molecular cross-links may be impaired by highly negative sulphate groups and/or 
hydrophobic methyl groups ubiquitous in ulvan backbone.29-30 
Nevertheless, in vitro stability will define the limits of applicability of these ulvan 
structures and impair their use towards applications where prolonged stability is 
required. In this regard, several approaches should be further investigated in order to 
improve stability, including an increase of the cross-linking ratio or even applying a 
double cross-linking technique.12 
In the present study, different structures with different properties were produced by 
varying the amount of polysaccharide and cross-linker. Resulting cross-links influence 
the final properties of structures as reflected by the results herein obtained. Observed 
differences between different structures may be related with the cross-linking efficiency 
and/or with the concentration of the polysaccharide itself. Even though it is possible to 
hypothesize on the individual effects of each factor, obtained results may be a 
compound effect of both parameters. In fact, observed differences regarding 
mechanical performance, water uptake ability and weight loss may be attributed to an 
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increase in polysaccharide interactions that can result from increasing polysaccharide 
concentration or chemical cross-links.31  
Since ulvan samples were produced applying a methodology that relies on solvent 
freezing, using ice crystals as porogens, resulting porous architecture is strongly 
influenced by solution properties as well as by molecular arrangements. In this context, 
the decrease in porosity, mean pore size and interconnectivity observed when 
polysaccharide concentration increases may be related with the increase in the volume 
occupied by the polysaccharide, restricting the growth of ice crystals.32 This decrease 
in porosity may also contribute to the increase in the compressive modulus, observed 
in UL8.  
Pore architecture plays a key role on the ability of a scaffold to ensure a suitable 
framework for cellular organization and neo-tissue formation.2, 10, 13, 33 Produced ulvan 
structures are highly porous and interconnected. Although, resulting mean pore size 
varies from 47 to 60 µm, interconnections are in the range of 13 to 53µm, which may 
restrain normal cellular spreading throughout the overall structure. This observation is a 
possible explanation for the behaviour of cells cultured on these ulvan structures. Cells 
are viable in the presence of produced ulvan samples and related by-products. 
However, when cultured in these structures viable L929 cells present a round 
morphology. As cells remain viable in the presence and/or cultured in the produced 
structures, these observations are not due to possible cytotoxic effects of the material 
itself and its by-products. Incoming cells are sensitive and able to recognize the 
chemical composition and structural organization of the polymeric matrix.2, 13, 34 For 
example, the considerable hydration of ulvan structures may hamper the ability of the 
scaffold to attract adhesion molecules and cells. It is generally accepted that highly 
hydrophilic materials when in an aqueous environment will uptake large amounts of the 
surrounding fluids, allowing absorption and diffusion of various solutes.35 This 
considerable hydration may mask surface chemistry and incoming molecules and cells 
will first sense these water molecules and may not be able to recognize the appropriate 
material‟s functional groups.2, 13, 34-36 As ulvan possesses various groups that can bind 
water molecules via hydrogen bonds (carboxyl, hydroxyl and sulphate groups), this 
may be a possible explanation for the presented results. Another explanation could be 
the morphology of the produced structures, which is considered paramount for cell 
adhesion, spreading and proliferation.2, 10, 13, 33 Pores that are too small and reduced 
limits of interconnectivity, as the ones observed for ulvan samples by SEM and micro-
CT, may limit cell colonization and proliferation.9, 13, 36 These observations are 
particularly relevant for ulvan structures with higher polysaccharide concentration 
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(UL8), when compared with UL5. UL8 structures present higher compressive modulus 
and water uptake ability and decreased porosity and pore size. Although cells remain 
viable cultured on UL8, proliferation, quantified as dsDNA concentration, is not 
observed after 3 days of culture. UL5 structures, on the contrary, appear to support 
both cellular viability as well as growth.  
 
5. Conclusions 
The main goal of the herein described research work was to produce 3D porous 
structures, based on cross-linked ulvan, and evaluate their feasibility to be applied in a 
tissue engineering context. Produced structures present different mechanical 
properties and water uptake ability and are characterized by a porous architecture and 
undergo non-cytotoxic degradation. Increasing the concentration of ulvan revealed a 
striking effect both over the obtained structure and cellular behavior. Herein presented 
results justify further work, namely in terms of functionalization of these ulvan 
structures in order to optimize and attain envisaged physicochemical and biological 
interactions necessary to confirm the potential of ulvan for tissue engineering 
applications. 
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Abstract 
A marine derived polysaccharide, ulvan, extracted from green algae, was combined 
with poly-D, L-lactic acid (PDLLA) in order to produce a novel scaffold for bone tissue 
engineering applications. Three dimensional (3D) scaffolds of PDLLA loaded with ulvan 
particles were originally prepared by subcritical fluid sintering with carbon dioxide at 
40ºC and 50bar. Prepared matrices were characterized in order to validate their 
suitability to be used as scaffolds for bone tissue regeneration. Characterization 
included micro-computed tomography, mechanical compression testing, water uptake 
and degradation testing, and cytotoxicity assays. In addition, ulvan particles loaded 
with dexamethasone, were also dispersed within the PDLLA matrix and the respective 
release profile from the samples was evaluated. Prepared PDLLA scaffolds enriched 
with ulvan particles demonstrated appropriate physicochemical and cytocompatible 
features to be used for the envisaged applications. On the other hand, the release of 
dexamethasone from ulvan particles embedded within the PDLLA matrix revealed that 
the designed systems can be potentially suitable for localized drug delivery. These 
results further contribute to the establishment of ulvan as a potential novel biomaterial. 
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1. Introduction 
Tissue engineering of musculoskeletal tissues aims to surpass their limited healing 
capacity. Within this context, a possible approach combines three dimensional (3D) 
structures with biological cues and cells to stimulate tissue regeneration while 
controlling cellular behavior.1-5 This is still a rather challenging task, especially on what 
concerns scaffold design per se. An ideal scaffold must possess suitable porosity and 
interconnectivity, mechanical properties compliant to the site of implantation and good 
biocompatibility.1-2, 6-7 Several polymeric materials have been proposed for the design 
of scaffolds for bone engineering, including synthetic and/or natural origin polymers.6 
These can be processed into different shapes and morphologies, according to the 
purpose of the application.2, 8-9 Combination of both synthetic and natural materials is 
many times advantageous and broadens the range of applicability and enhances the 
performance of these materials. 
Polyesters represent attractive synthetic materials for bone tissue engineering 
applications, especially poly-lactic acid and its derivative poly-D,L-lactic acid (PDLLA).1, 
6, 10 In the present research work, hydrophobic PDLLA is used as the major supporting 
matrix due to its appropriate degradability, compatibility and suitable mechanical 
performance.11-12 In an integrated approach and in order to optimize the applicability of 
a PDLLA based scaffold, it is enriched with hydrophilic ulvan particles which can be 
used as potential vehicle for localized delivery of bioactive compounds. Ulvan is a 
natural polysaccharide, composed of sulphated rhamnose, xylose, glucoronic and 
iduronic acids, which is extracted from the cell wall of green algae Ulva, the common 
sea lettuce, which has been recently proposed for biomedical applications, with special 
emphasis to drug delivery.13-14 Beyond their inherent properties, association of both 
these polymers would take advantage from the easiness of processing PDLLA into a 
three dimensional porous and stable structure, suitable for bone engineering 
applications, and from the feasibility of ulvan to be used as a drug delivery system. 
A variety of processing techniques have been developed for the preparation of three-
dimensional matrices and include solvent casting and particles leaching, compression 
moulding and particle leaching, thermally induced phase separation, gas-foaming 
processes, among others.15-16 The main disadvantages of these methods are the use of 
organic solvents and the high temperatures that are often required. Furthermore, the 
presence of residual solvents in medical devices is restricted and ideally the levels of 
these residues should be minimized, if not avoided. Recently, Singh and co-workers17 
proposed a subcritical sintering method that takes advantage of carbon dioxide under 
subcritical conditions to prepare highly porous and interconnected structures, under 
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mild conditions. Carbon dioxide, under supercritical fluid conditions, is the most 
commonly used solvent due to its low critical parameters (T= 31ºC and P= 74bar) and 
to the fact that it is environmentally benign, nontoxic, non-flammable, noncorrosive, 
readily available and inexpensive. The subcritical sintering technique, similarly to the 
supercritical fluid foaming relies on the plasticizing effect of carbon dioxide which 
reduces the glass transition temperature of PDLLA. In the sintering process, the 
polymer is plasticized in mild conditions and the polymer particles are fused together, 
creating a 3D scaffold with appropriate morphological properties for tissue engineering 
and regenerative medicine.18 This method eliminates the need of organic solvents and 
the high temperatures generally required to process synthetic polymers, with the 
additional advantage of allowing the processing of synthetic PDLLA enriched with 
particles loaded with labile bioactive agents.17, 19-23 On the other hand, it has been 
shown24 that the introduction of natural-based particles within a polyester matrix can 
enhance the application of these porous structures in bone tissue engineering 
applications, as they play an interesting role in the delivery of bioactive agents to signal 
and direct tissue growth. 
In this work, the combination of ulvan, a novel hydrophilic marine origin polysaccharide 
loaded with a bioactive agent, with PDLLA, a hydrophobic synthetic polymer, was 
attempted. The effect of ulvan particles over the final structure was evaluated and the 
feasibility of these scaffolds focused for bone engineering applications was assessed, 
particularly for applications where a sustained release of dexamethasone may be 
desired. 
 
2. Experimental procedure 
2.1. Materials 
Ulvan was extracted and purified from green algae, namely Ulva lactuca, applying a 
procedure developed by the authors.25 Briefly, Soxhlet extraction of dried Ulva lactuca 
removed most of the lipids and colouring matter. The residual off-white weed was dried 
and subjected to three hot-water extractions, between 75-85ºC. After filtration through 
a cotton cloth, aqueous extracts were centrifuged, and the liquid supernatant was 
filtered. The water extract was concentrated until 10-20% of its initial value, in a rotary 
evaporator. Starch and proteins were removed by enzymatic digestion. Afterwards, the 
solution was decolorized and deodorized by adsorption on activated charcoal. The 
water extract was centrifuged, filtered and precipitated with 4 vol. of absolute ethanol. 
Finally, the recovered precipitate was freeze dried. Yield of a white polysaccharide 
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resulting from this extraction methodology is c.a. 10 – 20%. PDLLA with an inherent 
viscosity of 1.87dL/g was purchased from Purasorb (The Netherlands). Carbon dioxide 
(99.998mol %) was supplied by Air Liquide (Portugal).  
Chitosan was purchased from Sigma–Aldrich (Germany), with medium molecular 
weight and purified through a re-precipitation method, described by Signini and Filho.26 
Briefly, a solution of chitosan 1% (w/v) in 2% (v/v) aqueous acetic acid is prepared and 
filtered twice to remove any insoluble material. Chitosan is precipitated with 1M 
aqueous sodium hydroxide. Precipitate is recovered by filtration, extensively washed 
with distilled water, until a neutral pH is reached, and freeze dried. White flakes of this 
polysaccharide are obtained. 
Unless otherwise stated, chemicals were bought from Sigma–Aldrich (Germany) and 
used as received. 
2.2. Ulvan particles 
Ulvan particles were produced by extrusion - dripping method. Briefly, an aqueous 
ulvan solution (6% w/v) is prepared and placed in a syringe to be added in a drop wise 
manner to a chitosan solution (1% w/v in 1% v/v acetic acid). This procedure was 
performed at room temperature. Contact time of ulvan particles with chitosan solution 
was 2h. After stabilization, ulvan particles were collected, extensively washed and 
dried. For the incorporation of dexamethasone, identical conditions were applied. In 
this case, the drug was directly added to ulvan solution at a concentration of 15% 
(w/w).27 
2.3. Subcritical sintering 
Scaffolds were prepared by subcritical fluid assisted sintering method at 50bar and 
40ºC. Approximately 120 mg of a mixture of PDLLA and ulvan particles (non loaded or 
loaded with dexamethasone) were placed in a mould, which was inserted in a high 
pressure vessel. The vessel was heated by means of an electric thin band heater 
connected to a temperature controller. The sintering occurred within 30 minutes, which 
was the optimum contact time to allow the plasticization of the polyester. After this, the 
system was quickly depressurized.  
2.4. Micro-computed tomography (µ-CT) 
Scaffolds herein described were analyzed by micro-computerized tomography using a 
high-resolution micro-CT SkyScan 1072 scanner (Skyscan, Belgium) to characterize its 
morphological and morphometric properties. The X-ray source was set at 54kV of 
energy and 183µA of current, Resolution of pixel size was set at 14.71µm and an 
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exposure time of 1.6sec was used. Approximately 450 projections were acquired with a 
rotation range of 180º and, using a rotation step of 0.45º. After reconstruction (NRecon, 
SkyScan, Belgium) of the acquired data, images of 1024x1024 bitmap were obtained 
and representative binary images of approximately 175 slices with a dynamic threshold 
of 50–255 (grey values) were generated and analyzed (CT Analyser®, SkyScan, 
Belgium). Different morphometric parameters were determined, including porosity, 
mean pore size and respective distribution and scaffold interconnectivity. This last 
parameter was calculated assuming a minimum pore size of 59µm for interconnected 
pores; that is to say that interconnection diameters lower than this value were not 
considered as open pores. In this sense, interconnectivity of the scaffold is calculated 
according to the formula: 
   100/  totalporeedporedisconnecttotalpore VVVI  
where the volume of the disconnected pore stands for the disconnected pore volume 
which was defined to be higher than 59µm.  
2.5. Mechanical compression tests 
Compressive mechanical properties of the prepared scaffolds (cut into a final cylindrical 
shape with 5mmx5mm) were measured using an Instron 5543 (Instron Int. Ltd., UK) 
universal testing machine with a load cell of 1kN. Compression testing was carried out 
at a crosshead of 2mm/min, until a reduction in samples height of 60% was attained. 
Compressive modulus is defined as the slope of the straight line obtained by linear 
regression of the stress-strain curve in the near elastic region of the material (between 
0 and 1.0 % strain).  Presented data is the result of the average of at least five 
measurements. 
2.6. Water uptake and degradation tests 
Samples were weighted out into screw-top plastic tubes. The samples were immersed 
in 5 mL phosphate buffered saline (PBS) and allowed to swell at 37ºC, under gentle 
agitation (60rpm) in a precision water bath. After each time point (1, 3, 7, 14 and 21 
days), the samples were brought to surface dryness, on a Whatman filter, for 10s, and 
weighted.  
The content of water in the swollen scaffolds was calculated by the following equation: 
                                  
where wi is the initial weight of the specimen before immersion and ws is the weight of 
the swollen structure.  
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After each time period, the samples were dried and weighted to determine the weight 
loss, which was calculated according to the equation: 
                                  
where wd is the final weight of the sample (dried after immersion) and wi is the initial 
weight of the sample. 
Presented data is the result of the average of at least three measurements. 
2.7. In vitro drug release profile 
Four specimens of the prepared samples were immersed in 5 ml PBS (pH 7.4) and 
incubated at 37°C for a period of 21 days. The release of dexamethasone was 
periodically monitored by extracting 500 µl aliquots. Retrieved aliquots were 
replenished with 500µl of PBS. The concentration of dexamethasone was determined 
by UV–Vis spectroscopy at 242nm (Shimadzu UV 1601, Japan). Presented results are 
an average of four measurements for each time point condition. 
2.8. Cytotoxicity studies 
In order to assess the cytotoxicity of the obtained scaffolds, extracts of the materials 
were prepared and placed in contact with mouse C3H/An connective tissue fibroblast-
like cells (L929)  (European Collection of Cell Culture, UK). Cell viability was evaluated 
by MTS assay in accordance to ISO/EN 10993 part 5 guidelines.28  
In summary, 5x103 cells.ml-1 were cultured in Dulbecco‟s modified Eagle‟s medium, 
supplemented with 10% fetal bovine serum (Alfagene, USA) and 1% 
antibiotic/antimycotic solution (Gibco, UK) and allowed to grow until a desirable 
confluency was reached. At this time, culture media was replaced with material 
extracts, prepared in culture media. L929 cells viability was determined for each extract 
and compared to latex extracts, used as a positive control of cell death, and to cells 
growing in the absence material extracts (negative control, representing cell growth in 
culture media). After each time point (24, 48 and 72 h of incubation) MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
test was performed to assess cellular viability, following the manufacturer‟s instructions 
(CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega, USA). Optical 
density was measured at 490nm, on a multi-well microplate reader (Synergy HT, Bio-
Tek Instruments, USA). All cytotoxicity screening tests were performed on 15 
replicates. 
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2.9. Statistical analysis 
Statistical analysis was performed using the GraphPad Prism statistic software 
(Release version 5 for Windows). Initial statistical results indicated that nonparametric 
tests should be used for all comparisons. Therefore, the effect of ulvan particles on 
mechanical performance was analysed by the Mann Whitney test. Furthermore, the 
effect of the produced structures over L929 viability was evaluated by Kruskal–Wallis 
test, followed by Dunn‟s test for multiple comparisons. Statistical significance was 
defined as p<0.05.  
 
3. Results and Discussion 
A marine derived polysaccharide – ulvan - extracted from green algae was processed 
into particles by adding an ulvan solution, in a drop wise manner, to a solution 
composed of chitosan (Figure 7.1).  
 
 
Figure 7. 1. Schematic representation of the method used to produce ulvan particles 
by addition of an ulvan solution in a drop wise manner to a coagulation bath composed 
of chitosan solution.  
 
Particles are formed by the static attraction between the opposite charged 
polysaccharides, ulvan and chitosan. In this way, ulvan, an anionic polysaccharide, 
reacts with the cationic chitosan to form a well defined polyelectrolyte complex. In this 
scenario, the main purpose of the polycation is to induce the formation of a strong outer 
layer which stabilizes and strengthens the polyanion network. Consequently, the 
processed particles are stabilized by these electrostatic interactions formed between 
both polymers.29-30 Complexed particles of ulvan/chitosan present a homogeneous 
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distribution of size, are hollow and exhibit well defined teardrop morphology (Figure 
7.2).  
 
Figure 7. 2. Ulvan particles loaded with dexamethasone (UL+DX), visualized with a 
magnifying lens, presenting a tear-drop like morphology: Diameter ~3mm, height ~4.5 
– 5mm. 
Produced ulvan particles were combined with PDLLA in order to produce a novel 
scaffold, processed by subcritical sintering in the presence of subcritical carbon 
dioxide, targeted for bone tissue engineering. This is a rather challenging field of 
research. In this context, several requirements must be obeyed by the scaffold to be 
used in order to achieve ideal regeneration of bone, including morphological and 
mechanical properties, biodegradability and biocompatibility.7  
3.1. Morphological Characterization 
Through modern imaging techniques, such as micro-computed tomography (micro-CT), 
which has already proven to be a quite powerful in scaffold characterization31, it is 
possible to obtain and analyse detailed 3D reconstructions of the matrix structure. 
Produced scaffolds of PDLLA enriched with ulvan particles (PDLLA+UL) present a well 
defined porous morphology. The introduction of ulvan particles within the PDLLA matrix 
had a clear effect on scaffolds‟ morphometric properties as it is demonstrated by 
comparison with PDLLA scaffolds without ulvan particles (Table 7.1). Numerical 
comparisons of different parameters demonstrate that the presence of ulvan particles 
within the PDLLA matrix lead to a significant increase in the overall porosity (from 
45.8±6.0 to 75.7±1.2 %), mean pore size (from 601.3±84.7 to 1005.5±74.0 µm) and 
interconnectivity (29.8±9.4 to 48.7±8.5 %) (Table 7.1). Produced PDDLA and 
PDLLA enriched with ulvan particles 
 
179 
PDLLA+UL scaffolds present a heterogeneous pore size distribution ranging from 30 to 
1600µm (Figure 7.3). An ideal scaffold for bone engineering should be porous, 
interconnected and rich in macropores.12, 31-32 Random, open and interconnected pores 
favors cell penetration and nutrient exchange into the scaffold preventing the rapid 
formation of tissue on the surface, which would ultimately result in a necrotic core.33 
 
Table 7. 1. Morphometric parameters characteristic of produced scaffolds determined 
by micro-CT analysis of PDLLA and PDLLA+UL scaffolds. 
 PDLLA PDLLA+UL 
Porosity (%) 45.8±6.0 75.7±1.2 
Mean Pore Size (µm) 601.3±84.7 1005.5±74.0 
Interconnectivity (%) 29.8±9.4 48.7±8.5 
 
 
Figure 7. 3. Pore size distribution of PDLLA and PDLLA/Ulvan scaffolds prepared by 
subcritical sintering and assessed by micro-CT analysis. 
3.2. Mechanical Properties 
Besides the morphological aspects, mechanical performance of the matrices is one of 
the key issues when designing scaffolds for tissue engineering applications. Bone 
possesses remarkable mechanical properties, which are difficult to mimic. It is a 
complex structure which requires mechanical stimuli to induce tissue growth, 
remodeling and regeneration.7, 34 In this sense, mechanical properties assume a crucial 
role in scaffold design for bone engineering. In fact, an implant with higher mechanical 
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properties will absorb the entire load, causing a stress shielding effect and resulting in 
bone resorption around the implanted scaffold.7 So, a material should mimic the 
mechanical properties of the tissue that is being engineered.  
In the present study, enrichment of PDDLA scaffolds with ulvan particles resulted in a 
significant decrease of the compressive modulus, as compared with the compressive 
modulus of the PDLLA structure without ulvan particles (Table 7.2). This negative effect 
on the mechanical performance of PDLLA+UL structures can be related with observed 
changes on morphological properties of structures enriched with ulvan particles, 
namely the increase in porosity and mean pore size.32  
 
Table 7. 2. Mechanical properties, given as compressive modulus (defined as the 
slope of the straight line obtained by linear regression of the stress-strain curve in the 
near elastic region of the material, between 0 and 1.0 % strain), of the prepared 
scaffolds: PDLLA and PDLLA+UL. The effect of ulvan particles on mechanical 
performance was analysed by the Mann Whitney test and (*) denotes a significant 
difference. 
 Compressive Modulus (MPa) 
PDLLA 14.4±2.9 
PDLLA+UL 8.3±1.5
(*)
 
3.3. Degradation 
Ideally, in tissue engineering, a scaffold is usually intended to temporary fill a defect, 
while gradually degrading as neo-tissue is formed. In due course, the scaffold is 
replaced by new bone tissue.7 After implantation, the scaffold interacts with the tissue 
ﬂuids, uptaking them at some extent, starting the degradation process.35 Degradation 
of biodegradable polymers occurs as a result of different biological processes, 
including enzymatic reactions or passive hydrolytic degradation, among other 
mechanisms.36  
In order to try to understand the swelling ability and hydrolytic degradation of the 
produced scaffolds, as well as the influence of ulvan particles on both these 
parameters, water uptake and weight loss studies were performed for different time 
periods for samples immersed in PBS solution (Figures 7.4 and 7.5). Although there is 
a higher initial increase in swelling for PDLLA+UL scaffolds as compared with PDLLA, 
the overall swelling is maintained over the course of time (21 days) (Figure 7.4). 
PDDLA is slowly degraded by hydrolytic reactions at physiological temperature.11-12 
This is demonstrated by the experimental results, as the weight loss of PDLLA 
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scaffolds is close to 0.5% and it maintains this behaviour over 21 days (Figure 7.5). 
The introduction of ulvan particles increased weight loss by 5%. This may be a net 
effect related with degradation of ulvan particles and increased porosity of the 
PDLLA+UL structure. Nevertheless, the overall process remains slow and the scaffold 
revealed to be very stable. 
 
 
Figure 7. 4. Water uptake profile of PDLLA and PDLLA/Ulvan porous scaffolds 
immersed in PBS solution. 
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Figure 7. 5. Weight loss profile of PDLLA and PDLLA/Ulvan porous scaffolds 
immersed in PBS solution. 
3.4. PDDLA/Ulvan scaffold for local drug delivery 
The release of dexamethasone from PDLLA scaffolds enriched with ulvan particles 
loaded with dexamethasone (PDLLA+UL+DX) and ulvan particles (UL+DX) was 
evaluated in vitro and the profile of drug release is presented in Figures 7.6 and 7.7. 
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Figure 7. 6. Dexamethasone concentration and percentage of drug released from the 
produced scaffolds and ulvan particles. 
 
 
Figure 7. 7. Detail of dexamethasone concentration and percentage of drug released 
from the produced scaffolds and ulvan particles. 
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Ulvan particles loaded with dexamethasone demonstrate a steady release during the 
first 3 hours, releasing 52% of the drug. Afterwards, a slower release is observed and 
at day 21, a total of 60% of dexamethasone is released from this system. Incorporation 
of ulvan particles within a PDLLA matrix resulted in a slower release of 
dexamethasone, although the profile of release is maintained. In this system, after 21 
days of immersion, only 13% of dexamethasone is released out of the PDLLA+UL 
structure. In order to understand this result, it is important to stress that different 
mechanisms govern the drug release rate and different phenomena might be involved 
in the release profile depending on the type of drug, polymer matrix, processing 
technique, geometry and dimensions of the carrier system.37 The most pronounced 
effects are based on drug diffusion out of the release system into the release medium 
and water uptake ability of the matrix components.38 The differences observed between 
the amount of drug released from ulvan particles per se and ulvan particles 
incorporated within the PDLLA scaffold can be attributed to these different mechanisms 
of drug release, particularly to the water uptake ability of the overall matrix. Water 
uptake measurements carried out in the present work did not reveal significant 
differences between the PDLLA scaffold alone and the PDLLA scaffold enriched with 
ulvan particles. The general swelling ability of PDLLA scaffolds is limited by the 
hydrophobic nature of poly-lactic acid, restraining the high swelling ability inherent to 
ulvan.13 For this reason, it is possible to infer that dexamethasone release from ulvan 
particles entrapped within the PDLLA scaffold is governed mainly by drug diffusion out 
of the matrix. In the case of ulvan particles per se, it may be expected that they follow a 
case II transport as referred in a recent study for ulvan membranes. The potential of 
ulvan membranes to be used as drug delivery devices as been recently proposed and 
the analysis of their release profile indicated that the mechanism of release from this 
ulvan matrix falls in the case II transport. This means that the release of 
dexamethasone from ulvan membranes is associated with the relaxation of the 
polysaccharide upon hydration.13 
3.5. Cytotoxicity 
Despite the morphological and physicochemical properties of a scaffold, the most 
important and decisive factor defining its applicability as a tissue engineering construct 
is its biocompatibility.7  
In this regard, prepared scaffolds were subjected to a cytotoxicity screening. This 
analysis was performed by culturing cells in the presence of extracts of those materials, 
which may traduce potential toxicity of their leachables and degradation products, and 
by evaluating subsequent cell viability by MTS. This assay reveals the presence of 
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metabolically active cells and it is considered a realistic test to evaluate cytotoxicity. For 
this cytotoxicity screening, both the constituent structures (PDLLA and UL+DX) and the 
overall scaffolds (PDLLA+UL and PDLLA+UL+DX) were evaluated. Results are 
depicted in Figure 7.8. 
 
 
Figure 7. 8. Box plot of L929 metabolic activity cultured in the presence of PDLLA, 
PDLLA+UL, PDLLA+UL+DX and UL+DX extracts. Data were analyzed by 
nonparametric Kruskal–Wallis test followed by Dunn‟s test: *) denotes signiﬁcant 
differences compared with negative control; #) denotes significant differences 
compared with PDLLA and §) denotes significant differences compared with 
PDLLA+UL. 
In a first stage and after 24h of incubation in the presence of the different material 
extracts, cells demonstrate equal metabolic activity, i. e., the effect of the different 
materials over L929 cells is not significantly different as compared with each other. 
However, cells‟ metabolism is significantly lower than the one exhibited by the cells 
growing in normal conditions (negative control, CTR -). After 48 hours, this negative 
effect on cell viability is only observed for the structures incorporating dexamethasone 
(PDLLA+UL+DX and UL+DX). Cells‟ metabolism in the presence of these structures is 
affected and significant differences are observed as compared with the cells growing in 
the absence of material extracts and cells growing in the presence of PDLLA and 
PDLLA+UL. After 72h, cells cultured in the presence of PDLLA, PDLLA+UL+DX and 
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UL+DX extracts are significantly different from those growing in the absence of these 
materials. However, at this time point, cells cultured in the presence of PDLLA+UL 
extract demonstrate normal metabolism by comparison with cells growing in normal 
conditions. In spite of the differences observed by comparison with the negative control 
for each time point, cellular metabolism appears to be increasing over the time of 
incubation, for each material extract. In summary, produced PDLLA scaffold enriched 
with ulvan particles demonstrate good cytocompatibility after 72 hours of culture. In 
fact, the presence of ulvan within the polymeric matrix appears to have a positive effect 
on cellular viability, when compared with PDLLA alone.  
 
4. Conclusions 
In the present research work, a subcritical carbon dioxide sintering process was 
successfully employed to process a scaffold composed of PDLLA and ulvan particles. 
The incorporation of these particles within the PDLLA matrix resulted in a scaffold with 
appropriate morphometric features, with suitable mechanical performance and 
adequate cytocompatibility. Furthermore, entrapment of ulvan particles loaded with 
dexamethasone within the PDLLA matrix may enhance the applicability of this scaffold 
as a system able to sustain the delivery of relevant bioactive agents.  
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Conclusions and perspectives 
The main objective of the herein presented thesis was the study of the potential of 
ulvan, a rather unexploited polysaccharide extracted from green algae, to be used in a 
biomedical context. The use of ulvan as a medical device in tissue engineering and 
regenerative medicine applications is still in its early stages, particularly on what 
concerns polysaccharide modification and processing and biomaterial design. 
Nevertheless, it is possible to envisage the use of this polysaccharide in a biomedical 
area, where it can act as a support for therapy of damaged/diseased cells and tissues. 
On the other hand, it is known to possess a variety of distinctive biochemical properties 
that may enhance and define its applicability in this context. 
Different industries, including biomedical and biotechnological ones, are continuously 
searching for new functional and better performing materials. The use of algae 
polysaccharides in biomedical applications is not a novelty as these polymers have 
been used for a long time. Agarose, carrageenan and alginates are some of the most 
known examples. Their uses extend from food to biomedical applications, for instance 
as food additives or scaffolds for cellular growth and tissue regeneration. In this context 
and considering ulvan‟s unique structure and inherent properties, it is valid to envisage 
ulvan as a novel polymer for potential biomedical applications.  
In order to propose ulvan as a novel biomaterial, an integrated strategy should be 
pursued, starting with the design of a novel and effective extraction methodology 
followed by processing of the obtained polysaccharide into different structures that can 
be envisaged as potential medical devices. 
In a first stage, a new and simple method of extracting ulvan from green algae was 
designed and the obtained polysaccharide was characterized. Developed extraction 
procedure has proven to be effective in yielding a non-cytotoxic polysaccharide with 
interesting physicochemical properties. It is a non-meltable semi-crystalline 
polysaccharide, highly hygroscopic and rich in sulphate groups; it is mostly composed 
of ulvanobiuronic acid A with minor amounts of ulvanobiuronic acid B. In general, this is 
a high molecular weight polysaccharide, composed of rhamnose, glucuronic acid, 
xylose, iduronic acid and glucose.  
In order to understand the processability of ulvan extracted from green algae, different 
polymer processing methodologies were investigated. These included solvent casting, 
freeze drying and an extrusion-dripping methodology, in order to process ulvan into 
membranes, 3D porous structures and particles, respectively. 
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Ulvan membranes, designed as vehicles to deliver therapeutic agents to wounds, have 
been produced by solvent casting. The introduction of a bioactive agent widens the 
range of applicability of these membranes, as drug delivery systems, particularly as 
medicated wound dressings. These ulvan membranes present interesting mechanical 
properties, but their most distinctive feature is related with water uptake ability, which 
can reach values as high as 1800%. This ability demonstrates a strong influence in the 
delivery of a drug from these ulvan membranes; in fact, the mechanism that drives the 
release of the drug from these membranes is mostly related with the swelling of the 
polymeric matrix.  As swelling is a property related with the polymer itself, it may be 
tuned to introduce further control to the release of the bioactive agent, if desired. 
Although a biocompatibility study should still be performed, these properties suggest 
that this natural sulphated polysaccharide can be proposed for the envisaged 
applications as a wound dressing, in order to provide control of wound surface 
hydration, absorbing excess exudates and assuring proper moisture, while delivering 
appropriate therapeutic agents to assist the healing process.  
As part of the design of ulvan membranes, successful chemical cross-linking of ulvan 
was achieved with the epoxide 1,4 – butanediol diglycidyl ether (BDDE). The 
knowledge gathered on ulvan‟s chemical cross-linking was applied in the production of 
freeze dried 3D ulvan porous structures. Different formulations were attempted, with 
varying polysaccharide concentration and cross-linker ratio. Resulting structures 
demonstrated diverse compressive modulus and water uptake ability, as well as 
varying stability. This indicates that these properties can be tuned, by means of varying 
processing conditions, in order to obtain suitable structures for the envisaged 
applications. Among these matrices, two were further characterized and revealed a 
micro-porous, highly interconnected architecture and undergo non-cytotoxic 
degradation. For a tissue engineering approach, further work needs to be performed in 
order to assure the desired physicochemical and biological interaction.  
Confirming ulvan‟s processing versatility, it was also processed into particles, by an 
extrusion-dripping method; these particles were then incorporated within a poly-DL-
lactic acid matrix. Polyesters like poly-DL-lactic acid are widely used for biomedical 
applications and the incorporation of ulvan particles within a PDLLA matrix resulted in a 
scaffold with enhanced properties. The introduction of ulvan particles resulted in an 
increase of the overall porosity, pore size and interconnectivity. However, the presence 
of these ulvan structures induced a decrease in the compressive modulus of the 
structure, which can be related with the increase in porosity and mean pore size 
observed after the introduction of ulvan particles within the PDLLA matrix. Besides the 
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overall effect over the properties of the polyester matrix with the introduction of ulvan 
particles as such, the functionality of this novel scaffold can be increased with the 
effective introduction of an active agent. In this regard, ulvan particles embedded within 
a PDLLA matrix can also function as a delivery system, widening the applicability of 
this scaffold.  
In spite of the work herein described and others reported in the literature, the study of 
the potential of ulvan to be used in a biomedical context, as a medical device, is still in 
its early stages. The herein described ulvan processing techniques and envisaged 
applications pose an innovative attempt to add value to this marine derived 
polysaccharide, aiming to expand the knowledge on novel applications of ulvan. 
Although the major focus of the present thesis was towards the study of potential 
application in a biomedical context of a polysaccharide extracted from green algae, the 
reality is that there is still a lot to be done at the fundamental level to clarify the 
knowledge about ulvan. If we compare the evolution of this polysaccharide with other 
algae origin polysaccharides, it has been remarkably slow. At this point, it is possible to 
speculate on the influence of ulvan‟s peculiar chemical composition and structure, 
complicated by the fact that there isn‟t yet a standardized commercial form of this 
polysaccharide. In this regard, the design of a novel and effective extraction procedure 
becomes crucial, but also opens the way to the possibility of scaling up. This is an 
important consideration, if continuous research on ulvan is intended. Furthermore and 
as greatly discussed throughout this thesis, ulvan has a peculiar structure; it is 
composed of rare sugars, scarcely found in algae and it is highly sulphated. This 
confers various properties to this polysaccharide that are still not completely studied, 
and both properties and this particular chemical composition and structure are still 
being researched, side by side with the advent of its potential development into medical 
devices to be applied in a biomedical context.  
The work performed and described throughout the present thesis demonstrates the 
feasibility to extract ulvan from green algae and process it into different structures 
envisaged for biomedical applications. The exploitation of this polysaccharide in this 
context and considering the diversity of developed structures may lead to novel 
research opportunities. This can be considered an open field of research where novel 
and different polysaccharide modifications may be studied, including chemical 
modifications as the ones described throughout this work. Furthermore and given the 
processing versatility demonstrated by ulvan, novel design methodologies should be 
followed in order to maximize the production of optimized ulvan structures. Finally and 
in order to increase ulvan-cellular interactivity, studies should be performed, for 
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instance, on surface modification of produced structures through chemical or physical 
approaches. Nevertheless, the present thesis may be positioned as a transition 
between theoretical considerations towards a pratical knowledge leading to realistic 
solutions based on ulvan for specific therapeutic problems.  
Despite the fact that this polysaccharide is known and being researched for several 
decades, its knowledge and evolution is still quite constrained. The author would like to 
think that this scenario is shifting and hopefully the present thesis can contribute to a 
better understanding of ulvan and its processability and serve as a stepping stone to 
future work on ulvan‟s applicability, especially in a biomedical highly demanding arena.  
 
 
 
 
